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“One may walk over the highest mountain one step at a time.” 
Barbara Walters 
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Abstract 
 
Altitude training is frequently used by elites athletes. Several hypoxic methods have been developed to 
improve sea-level performances and the Live High–Train Low approach, where athletes live and sleep 
at altitudes between 2200 and 2500 m and train under 1200 m is recognized as effective. Recent 
research focused on the potential differences between normobaric (NH) and hypobaric hypoxia (HH), 
i.e. simulated and real altitudes. Slight physiological differences have been found between either acute 
or chronic hypoxic exposure in NH and HH. Taken together, these differences intimate larger 
physiological responses to hypoxic exposure in “terrestrial” (i.e. HH) versus “simulated” altitudes (i.e. 
NH). However, there is not a sufficient body of knowledge to confirm if one hypoxic condition could 
induce larger performance enhancement than the other, either during or after acute hypoxic exposure 
or altitude camps (i.e. chronic hypoxic exposure). Many confounding factors and the large inter-
individual variability to hypoxic exposure make the comparison very challenging. 
Consequently, we first designed a crossover study to assess these potential differences and confirmed 
for the first time with direct comparison on the same subjects that HH induces different physiological 
adaptations compared to NH during a 3 weeks LHTL camp. However, physiological differences were 
not clinically sufficient to induce sea-level performance disparities. Secondly, we showed that acute 
high altitude hypobaric hypoxia (24h, 3450 m) is more demanding than normobaric hypoxia and 
induces larger performance impairments on a 250-kJ cycle time trial. Finally, our work demonstrated 
that sleep is further disturbed in HH compared to NH in both acute and chronic hypoxia. 
As previously suggested, HH seems to be a more stressful stimulus than NH at iso-PiO2. 
Consequently, NH and HH should not be used interchangeably and the main factor seems to be the 
lower peripheral oxygen saturation in HH at rest, as well as during exercise.   
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Résumé 
 
L’utilisation de l’entrainement en altitude par les athlètes d’élite est de plus en plus courante. Plusieurs 
méthodes hypoxiques ont été développées pour améliorer les performances au niveau de la mer et 
l’efficacité de l’approche « Vivre en haut–s’entrainer en bas » (LHTL) où les athlètes vivent et 
dorment à des altitudes entre 2200 et 2500 m et s’entrainent en-dessous de 1200 m est reconnue. Par 
ailleurs, les recherches récentes ont mis l’accent sur les différences potentielles entre l’hypoxie 
normobare (NH) et hypobare (HH), i.e. altitude simulée et réelle, et de légères distinctions 
physiologiques ont été décelées en hypoxie aigue et chronique. Les réponses physiologiques semblent 
plus marquées en hypoxie réelle que simulée. Par contre, il n’y a pas suffisamment de preuves pour 
confirmer que l’une des conditions amène de meilleures améliorations de la performance après des 
camps LHTL ou lors d’expositions hypoxiques aigues. La multitude de facteurs confondant ainsi que 
la large variabilité interindividuelle à l’hypoxie rendent les comparaisons difficiles. Par conséquent, 
nous avons mis en place une étude croisée et avons confirmé pour la première fois avec une 
comparaison directe sur les mêmes sujets que HH est plus sévère que NH lors d’un camp LHTL de 3 
semaines. Cependant, les différences physiologiques n’étaient pas cliniquement suffisantes pour 
engendrer des écarts de performance au niveau de la mer. Nous avons ensuite démontré que HH est 
plus exigeante que NH en aigue (24 h, 3450m) et impacte la performance de manière plus importante 
sur un contre la montre de 250 kJ. Finalement, notre travail a attesté que le sommeil est d’avantage 
perturbé en HH comparé à NH, à la fois lors d’expositions hypoxiques chroniques et aigues. Comme 
suggéré précédemment, HH semble être un stimulus plus stressant que NH à même PiO2. Par 
conséquent, ces conditions ne devraient pas être utilisés de manière indifférenciées et l’un des 
principaux facteurs responsable de ces différences s’avère être une saturation périphérique en oxygène 
plus basse en HH au repos comme pendant l’exercice.  
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 Introduction 1.
 
1.1 General introduction 
1.1.1 Hypoxia 
Hypoxia is defined as a combination of barometric pressure (PB) and the inspired fraction of 
oxygen (FiO2) that results in any inspired pressure of oxygen (PiO2) under a normoxic value 
of 150 millimetres of mercury (mmHg) (Conkin & Wessel, 2008).  
Oxygen cascade and diffusion. 
Before reaching the tissues, oxygen must traverse several steps from the ambient air to the 
mitochondria. These pathways are called the “oxygen cascade” (Figure 1A) and the partial 
pressure of oxygen (PO2) along each step is directly linked to the PO2 available in the inspired 
air. At sea level (PB=760 mmHg, FiO2=21%; PiO2=149 mmHg), the O2 in the lungs (alveoli) 
easily passes to the blood due to a high-pressure gradient, and then passes to the tissues. The 
overall oxygen cascade from the environment to the mitochondria can be partitioned into the 
following four major resistances in series: ventilatory resistance, circulatory resistance, tissue 
resistance, and mitochondrial resistance (Di Prampero, 2003). Each single step of the O2 
cascade can be viewed as a resistance overcome by a specific pressure gradient. In addition, 
because the resistances are arranged in series, the overall resistance to oxygen flow is given 
by the accumulation of all the individual resistances, and, likewise, the overall pressure 
gradient from the environment to the mitochondria is equivalent to the sum of the individual 
pressure gradients.  
In comparison, a decreased PiO2 due to a lower PB with increasing altitude (e.g., the summit 
of Mt. Everest (8,848 m), PB=253 mmHg; PiO2=50 mmHg) reduces the rate of O2 diffusion, 
which results in a decrease in the arterial blood O2 content (Figure 1B). Thus, less oxygen will 
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be supplied to the tissue, which leads to a diminished endurance performance at altitude 
(Sutton et al., 1988; Milledge et al., 2007).  
 
 
Figure 1 Decrease in oxygen pressure and barometric pressure. (A) Oxygen pressure (PO2) decrease from ambient air to 
the cells for sea level (full line) and Mt. Everest (dashed line) depending to the different steps of the oxygen cascade. 
Adapted from (Richardson et al., 1995). (B) Barometric pressure measured at different altitudes (grey circles and dashed 
line) and the global theoretical average reported by the International Civil Aviation Organization. Adapted from (West, 
1996). 
 
Respiratory responses. 
Hypoxia is a potent stimulus, and different physiological systems will change to adapt to this 
environmental stress. Many of these physiological changes begin immediately upon exposure 
and are continuously re-adjusted as long as the exposure lasts and even after exposure (Fulco 
& Cymerman, 1987). The following two successive phases are generally described: an acute 
adaptation phase to hypoxia, followed by a chronic acclimatization period. The acute 
adaptation phase lasts eight to ten days and starts as soon as the body is exposed to hypoxia. 
The increase in minute ventilation (VE) is the primary defense against low oxygen availability 
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in the ambient air that begins immediately upon exposure (i.e., 30 minutes) and decreases 
with time (Fulco et al., 2011; Dempsey & Morgan, 2015). The aim of this increase in VE is to 
counteract the reduction in oxygen transport induced by hypoxic environments. The carotid 
chemoreceptors (which are sensitive to the drop in arterial O2 pressure (PaO2) but also to an 
increase in arterial CO2 pressure and decrease in arterial pH) react to arterial hypoxemia 
within a few seconds by eliciting sympathetic nerve activity and, thus, hyperventilation 
Therefore, there is a strong relation between peripheral oxygen saturation (SpO2) and VE in 
hypoxic environments. This increase in ventilation is an indicator of acclimatization as 
follows: the more acute the ventilation, the better the acclimatization. Thus, the aim of 
hyperventilation is to limit the above-mentioned decrease in PaO2. Moreover, hyperventilation 
leads to subsequent hypocapnia, which induces a decrease in cerebral perfusion, as well as 
cardiac and respiratory instability (Lipsitz et al., 1995). In addition, during an exercise in a 
hypoxic environment, the end-tidal carbon dioxide pressure (PETCO2) decreases with as a 
consequence of a respiratory alkalosis due to the reduced plasma concentrations of CO2 and 
H+ (Ursino et al., 2001). Simultaneously, hyperventilation partially counterbalances the 
decrease in PAO2, and therefore PaO2 and arterial O2 saturation (SaO2). Thus, the blood pH is 
elevated and shifts the oxyhaemoglobin dissociation curve to the left (Figure 2) (Calbet et al., 
2003).  
Haematological responses. 
The chronic acclimatization period generally occurs after eight days of exposure to hypoxia. 
The main adaptations of this second phase concern our haematological properties. A 
progressive increase in the total haemoglobin mass (Hbmass) driven by an expansion of red 
cells, which is stimulated by erythropoiesis (Boutellier et al., 1990; Stromme & Ingjer, 1994), 
occurs during this chronic phase. Hypoxia Inducible Factor 1 alpha (HIF-1α) is an O2-
sensitive transcription factor that acts as a master regulator of hypoxia-induced gene 
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expression. The messenger ribonucleic acid (mRNA) destined to the HIF-1α regulation unit 
only appears in hypoxia and is undetectable in normoxia (Vogt et al., 2001). One major HIF-
mediated adaptation is to stimulate erythropoietin (EPO) production, leading to the above-
mentioned red cell production in the bone marrow. However, it is important to keep in mind 
that the total erythrocyte volume is expressed as a fraction (in %) of the total blood volume 
according to the haematocrit (Hct) and that red blood cells are diluted in plasma. Altitude 
exposure triggers a diminution of the plasma volume caused by fluid transfer outside of the 
vascular compartment. This efflux occurs as a consequence of the greater respiratory loss of 
water (due to the dryer air at altitude), increased diuresis and augmented exudation at altitude 
(Hogan et al., 1973; Maher et al., 1974; Butterfield et al., 1992). Subsequently, peripheral 
resistances are augmented due to the higher blood viscosity, Hct and [Hb] are increased, and 
blood circulation is altered (Berglund, 1992). On the other hand, the affinity of oxygen for 
haemoglobin is reduced at high altitudes by 2,3 diphosphoglycerate (2,3 DPG), which 
facilitates O2 delivery to the tissues (Mairbaurl, 1994). The compound 2,3 DPG is produced 
by red blood cell metabolism during prolonged hypoxic exposure (Mines, 1981) to counteract 
the leftward shift of the oxyhaemoglobin dissociation curve (Figure 2).  
 
Figure 2. Impact of hypoxia–hyperventilation on the haemoglobin dissociation curve. Effect of acute hypoxia on the O2 
dissociation curve of the haemoglobin during exercise in normoxia (white triangles; fine line) and hypoxia (black triangles; 
thick line). From (Calbet et al., 2003).  
mained close to this value during maximal exercise (Fig. 2A)
(Sutton et al., 1988).
Exercise VE in chronic hypoxia
Compared to acute hypoxia, submaximal exercise VE re-
mains at the same level with altitude acclimatization, while
peak exercise VE is increased at moderate to high altitudes
(Calbet et al., 2003b; Marconi et al., 2004) and reduced at
4000m (Lundby et al., 2004a). However, peak exercise VE in
altitude- acclimatized lowlanders may be similar (Calbet
et al., 2003b), higher (Marconi et al., 2004), or slightly lower
than observed in normoxia (Lundby et al., 2004a).
The ventilatory response to exercise in hypoxia is blunted
in altitude natives compared to lowlanders. This is also true
when acclimatized lowlanders are compared with Andean
altitude natives, both measured at altitude (Wagner et al.,
2002; Lundby et al., 2004a). Unlike Caucasians, second-
generation Tibetans living at 1300m do not increase VEmax in
response to acclimatization to 5050m above sea level (Mar-
coni et al., 2004). D spite the lower VEmax, low-alt ude-
residing Tibetans acclimatized to 5050m during 26 to 28 days
were able to attain almost the sameVo2max as at sea level (only
8% less, not statistically significant), while Caucasians having
a similar normoxic Vo2max as the Tibetans only reached a
Vo2 ax 31% below that at 1300m (Marconi et al., 2004). These
differences are most likely determined by the genetic back-
ground in both Andeans (Brutsaert et al., 2005) and Tibetans
(Marconi et al., 2004).
Thus, the extra-hyperventilation observed during exercise
in hypoxia has a critical impact on blood oxygenati n, par-
ticularly in severe acute hypoxia, when the arterial Po2 lies in
the steep region of the ODC. This is illustrated in Fig. 3 using
the data from Calbet and colleagues (2003a) at maximal ex-
ercise in severe acute hypoxia (Fio2¼ 0.105). In that study,
hyperventilation allowed for an el vation of Pao2 and re-
duced Paco2 and was associated with 0.1 higher pH at ex-
haustion in hypoxia than in normoxia. Consequently, the
ODC was shifted to the left in hypoxia, improving by 8 per-
centage units the level of Sao2 at exhaustion compared with
the Sao2 expect d from the ODC corresponding to normoxia
(Calbet et al., 2003a). The drop in Sao2 that occurs with ex-
ercise in hypoxia is inversely related to HVR, explaining why
sojourners with high HVR may perform better at extreme
altitude (Schoene et al., 1984). In addition, replacing the N2–
O2 gas mixture by helium–O2 (both with a Fio2¼ 0.11) al-
lowed increases in VEmax by 31%, Pao2 by 17%, Sao2 by 6%,
and Vo2max by 14% (Esposito and Ferretti, 1997), thus em-
phasizing the impact of hyperventilation on O2 transport and
exercise capacity in hypoxia.
FIG. 2. Influence of Vo2 on the level of hyperventilation
and [P-P] at sea level and at the altitude equivalent to the
summit of Mt. Everest. (A) O2 pressure difference from in-
spired air to alveolus (Pio2–Pao2). (B) O2 pressure difference
from alveolus to arterial blood (Pao2"Pao2) as a function of
_Vo2. # Sea-level measurements (Pio2¼ 150mmHg). ! Mea-
surements at barometric pressure of 253mmHg (Pio2¼
43mmHg), equivalent to the summit of Mt. Everest (Sutton
et al., 1988).
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FIG. 3. Impact of hypoxia–hyperventilation on the hemo-
globin dissociation curve. Effect of severe acute hypoxia
(Fio2¼ 0.105) on the O2 dissociation curve of the Hb during
exercise in normoxia (white triangles; fine line) and hypoxia
(black triangles; thick line). Note the left shift caused by
hyperventilation and its impact on Sao2 at maximal exercise
in hypoxia. Points on the graph represent the mean arterial
or femoral venous values for each condition in nine subjects.
(Po2 values corrected for blood temperature) (Calbet et al.,
2003a).
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Other mechanisms and adaptations appear after longer exposures to hypoxia (more than 4 
weeks), such as weight loss, as a function of both the absolute altitude and the duration of 
exposure (Kayser, 1994; Westerterp-Plantenga et al., 1999). Indeed, body and muscle mass 
are significantly reduced after exposure to hypoxia. As a consequence, muscle fibre size is 
also reduced. The capillary density of muscle tissue is increased because of the reduction in 
muscle fibre size. The activities of enzymes of the oxidative pathways are also decreased in 
skeletal muscle tissue (Hoppeler & Desplanches, 1992). However, these long exposures are 
not the topic of the present thesis, and we will not focus on them. 
Cardiovascular responses 
In acute hypoxia, the arterial O2 content (CaO2) decreases in parallel with SaO2, which 
requires a higher cardiac output (Q) to preserve the convective O2 transport. This mechanism, 
which is assisted by nitric oxide (NO)-dependent local vasodilation with haemoglobin acting 
as a hypoxic sensor (Crawford et al., 2006), is easy to observe because the heart rate (HR) is 
increased during submaximal exercise (and at rest). Indeed, the activation of the sympatho-
adrenergic axis (with a release of catecholamines) increases the sympathetic tone to increase 
the HR (Koller et al., 1988; Mazzeo et al., 1994). The increased HR increases the cardiac 
output and compensates for the decreased stroke volume (mainly due to the reduced plasma 
volume) (Calbet & Lundby, 2009; Fukuda et al., 2010; Siebenmann et al., 2015). The 
magnitude of the increase in Q is related to the severity of hypoxia. Although it is usually 
sufficient to preserve SaO2 in moderate hypoxia, it is generally not the case in severe hypoxia, 
particularly during exercise (Lador et al., 2008). After prolonged exposure (i.e., chronic 
hypoxia), the increase in CaO2 is primarily related to a reduction in PV and a partial recovery 
of SaO2 induced by ventilatory acclimatization. Moreover, a reduction of Q, similar to or 
below sea level values, is also observed. The primary cause of this reduction is a further 
reduction in SV, and not a reversion of tachycardia, due to a sustained decrease in plasma 
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volume caused by elevated diuresis, increased exhaled water, and the loss of fluids from 
gastrointestinal disturbances at altitude (Wagner, 2000). An overview of cardiac output 
regulation in both acute and chronic hypoxia is presented in Figure 3 (adapted from 
Siebenmann et al., 2015). 
 
 
Figure 3. Regulation of cardiac output in acute and chronic hypoxia. Adapted from (Siebenmann et al., 2015) 
1.1.2 Exercise and training in hypoxia 
The incapacitating effect of hypoxia has been recognized since humans started to ascend to 
altitude, but the underlying mechanisms were not really understood. From the beginning of 
the 20th century, the reduced partial pressure of oxygen (PO2) has been identified as the 
perpetrator of the incapacitating effect of hypoxia instead of the barometric pressure per se 
(Douglas et al., 1913); then, research focused on how the aerobic capacity is impaired by 
these environmental conditions. The key event for altitude training and exercise is certainly 
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the 1968 Olympic Games in Mexico City at ~2,300 m. Since then, research and knowledge 
about altitude training have increased continuously. Prior to these competitions, the impact of 
altitude on aerobic performance was proposed, but the significant below-records 
performances in endurance disciplines during these Olympiads confirmed the hypothesis. 
Moreover, numerous Olympic medals and world records in endurance sports were beaten by 
athletes residing above sea level or in high altitude environments. Thus, it seems rational to 
assume that living and/or training at altitude is beneficial, in one-way or another, at improving 
aerobic performance. Aerobic performance is related to the following three components: i) 
maximal oxygen uptake (VO2max), which represents the upper limit for aerobic performance, 
ii) the fraction of VO2max, and iii) the exercise efficiency. The first component (VO2max) is the 
one that is most impacted by the decrease in PO2 induced by altitude. Numerous studies have 
reported decreases in aerobic performance and maximal oxygen uptake in hypoxia (Squires & 
Buskirk, 1982; Chapman et al., 1999; Peltonen et al., 1999; Friedmann et al., 2005; Mollard 
et al., 2007; Peltonen et al., 2007; Chapman et al., 2011). This decrease has been described as 
a linear relation by Wehrlin & Hallen (Wehrlin & Hallen, 2006) (Figure 4). However, other 
authors described the relationship between VO2max and PiO2 as a faithful reflection of the 
oxygen equilibrium curve (Ferretti et al., 1997); thus, this relation would be curvilinear. 
Nevertheless, it is now generally assumed that each 1,000 m step is associated with an 
approximately 7.7% decrease in performance. It should be noted that altitude adaptations and 
performance decreases are under the influence of a great inter-individual variability 
(Schouweiler & Stray-Gundersen, 2002; Chapman, 2013).  
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Figure 4. Percent decrease in maximal oxygen uptake (VO2max) with altitude compared to sea level values (0-
363 m). From (Wehrlin & Hallen, 2006). 
Currently, athletes commonly use altitude training with the aim of enhancing their ability to 
compete successfully at a high level, and a variety of hypoxic training and/or exposure 
approaches have been applied and investigated within the last few decades (Figure 3). Before 
the 1990s, the most widely used method was the Live High-Train High (LHTH) method, 
which was aimed at spending the maximum time at altitude. Nevertheless, the decrease in 
aerobic capacity with altitude (Figure 4) limits the training intensities during LHTH. 
Scientists and the endurance training community then moved to another altitude training 
alternative, which allows athletes to maintain optimal training intensities for enhanced sea-
level performance. This new mixed altitude training modality appeared in the 1990s and is 
called “Live High-Train Low”, where athletes live at high altitudes but train at lower altitudes 
(LHTL) (Levine & Stray-Gundersen, 1997; Stray-Gundersen et al., 2001; Stray-Gundersen & 
Levine, 2008). Since then, more than 15 years of research have revealed that LHTL is an 
effective training method to enhance sea level performance in endurance athletes, and it 
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provided 1-3% of additional benefit compared to similar normoxic training. However, in a 
recent study using a simulated altitude set-up (Siebenmann et al., 2012), neither endurance 
performance nor the associated physiological responses were modified after 4 weeks of 
LHTL. However, LHTL is still recognized as an effective method that can improve 
performance in athletes, despite the large inter-subject variability in responses (Lundby et al., 
2012).  
During the past few years, more than 70 studies have analysed diverse modalities of LHTL 
(Bonetti & Hopkins, 2009). Beyond the classical parameters of these types of altitude training 
camps (i.e., duration, ratio between training and living, or altitude level), the development of 
several altitude simulation methods (nitrogen house, hypoxic chamber, and portable devices, 
such as the AltiTrainer®) allowed researchers to design many new combinations of training 
strategies (Figure 5, from (Millet et al., 2013)) using either “simulated” (i.e., normobaric 
hypoxia, NH) or “real” (i.e., hypobaric hypoxia, HH) hypoxia. The purpose of the present 
thesis was to assess the physiological differences between these two types of hypoxia and 
their implications on sea level or altitude performances. The next chapter introduces the state 
of the actual literature about the potential differences between these two modalities, which 
underpins the rationale for this thesis. 
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Figure 5. Actual altitude training panorama. LHTH, live high train high; LHTL, live high train low; LHTLH, 
live high train low and high; LLTH live low train high; IHE, intermittent hypoxic exposure; CHT, continuous 
hypoxic training; IHT, interval hypoxic training; RSH, repeated sprint training in hypoxia; IHIT, IHE during 
interval-training; NH, normobaric hypoxia; HH, hypobaric hypoxia. From (Millet et al., 2013). 
. 
1.2  Normobaric versus hypobaric hypoxia 
1.2.1 General considerations 
Since Paul Bert published his monograph on barometric pressure in 1878 (Bert, 1878), it has 
been admitted that the combination of the inspired fraction of oxygen (FiO2) and ambient 
pressure (PB) that produces the same inspired partial pressure of oxygen (PiO2) will produce 
the same physiological responses. This model is called the equivalent air altitude model 
(EAA), which is an isoPiO2 model where PiO2 = (PB – 47) * FiO2, where 47 mmHg is the 
partial pressure of water vapour at 37°C. The EAA model has been used to describe 
isohypoxia, which is “the same distribution of hypoxia signs and symptoms under any 
circumstances of equivalent hypoxic dose” (Conkin & Wessel, 2008). However, these authors 
concluded that this EAA model was inaccurate (Conkin & Wessel, 2008). The symptoms of 
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AMS (acute mountain sickness) and physiological measures diverge for a same hypoxic PiO2, 
depending on the barometric pressure. However, at that time, the underlying mechanisms 
remained elusive. 
Nevertheless, in a very recent a short communication, Conkin reminded us of the historical 
conception concerning the alveolar gas composition (Conkin, 2016). This paper is based on 
the work of Fenn et al. and Rahn & Otis (Fenn et al., 1946; Rahn & Otis, 1949), who derived 
the alveolar gas equation (AGE) and named it the alveolar air equation: 
 
PAO2 = (PB – 47) x FiO2 – PACO2 x [FiO2 + ((1-FiO2) / RER)] 
 
In this equation, in addition to the previously explained terms, RER is respiratory exchange 
ratio (VCO2/VO2 ml.min-1 in STPD) and PAO2 and PACO2 are the alveolar partial pressures of 
oxygen and carbon dioxide, respectively. In addition, “1- FiO2” is the dry-gas fraction of 
nitrogen (FiN2), and thus FiN2 is a contributor to PAO2. Through the study of five different 
conditions resulting in the same PiO2 (including NH and HH), the authors discovered different 
PAO2 values that were attributed to a N2 dilution effect or the respiratory exchange effect. By 
noting these forgotten facts, Johnny Conkin made an appreciable step in the comprehension of 
the underlying mechanisms of different physiological adaptations under NH and HH and 
confirmed that these conditions cannot be used interchangeably (Conkin, 2016).  
Nevertheless, one should be aware of the different ways to induce hypoxia itself (Figure 6), 
all of which lead to a decrease in arterial pressure (PaO2) and oxygen saturation (SaO2), to 
better interpret the potential differences between normobaric and hypobaric hypoxia.  
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Figure 6. Different methods inducing hypoxia, and thus decreased arterial pressure in oxygen (PaO2). O2, 
oxygen; N2, nitrogen; PB, barometric pressure; FO2, oxygen fraction; FN2, nitrogen fraction; FiO2, inspired 
oxygen fraction; SaO2, arterial oxygen saturation. Adapted from (Millet & Schmitt, 2011). 
 
As stated above, hypoxia can result from a decreased partial pressure of O2 in the inspired air 
that is either caused by reduced barometric pressure (hypobaric hypoxia, HH) or a decreased 
fraction of inspired O2 (normobaric hypoxia, NH). Normobaric hypoxia has been developed 
within the last 20 years because of the lack of sufficiently high mountains in many countries 
(e.g., Australia), and thus the impossibility of remaining or staying at natural high altitudes 
(hypobaric hypoxia). Therefore, natural altitude environments were simulated via either O2 
filtration, inspiration of low-O2 gas mixtures, or the addition of nitrogen to ambient air 
(Figures 5 and 6, (Millet et al., 2013)). Oxygen filtration was used throughout the different 
studies conducted in the present thesis. It is really fundamentally necessary to understand that 
the inspired pressure of oxygen (PiO2) can be perfectly matched between natural and 
simulated altitudes, despite the differences in the oxygen fraction and barometric pressure 
(Figure 7). 
Real altitude  
Hypobaric rooms 
Hypoxic rooms 
(decrease in O2%) 
Hypoxic rooms 
(increase of N2%) 
Altitrainer 
(increase of N2%) 
PB ↘ 
FO2 ↘ 
FN2↗ 
FiO2↘ 
PaO2 
SaO2 
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Figure 7. Fraction of inspired oxygen (FiO2, %) (A), barometric pressure (PB, mmHg) (B) and corresponding 
pressure of inspired oxygen (PiO2, mmHg) (C) before (Pre1-Pre2), during (D01-D18, grey part) and after (Post1-
Post2) a Live High–Train Low altitude training camp in either normobaric (NH) or hypobaric hypoxia (HH). 
Adapted from (Saugy et al., 2014). 
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1.2.2 NH versus HH: State of the actual literature  
A growing body of literature has reported physiological differences between NH and HH in 
various scientific areas over the past few years. A recent point-counterpoint (Millet et al., 
2012) brought the debate to the top of the scientific reflexion in the associated fields. Since 
then, altitude studies have considered that their results could be different based on the way in 
which hypoxia is induced. Recently, Coppel et al. reviewed the physiological effects of 
hypobaric and normobaric hypoxia in crossover trials and confirmed that these two hypoxic 
conditions cannot be used interchangeably (Coppel et al., 2015). This conclusion is shared by 
other recent studies (Fulco et al., 2011; DiPasquale et al., 2015b; Conkin, 2016). The aim of 
this sub-chapter is to present the actual state of the scientific literature about the above-
mentioned differences between the two hypoxic conditions. 
 
Ventilation responses.  
The main perceived consequence of a decrease in PiO2 following exposure to hypoxia is an 
increase in pulmonary ventilation to maintain oxygen delivery to the tissues (Wagner et al., 
1986). The peripheral chemoreceptors in the carotid bodies, which are sensitive to the drop in 
arterial oxygen pressure (PaO2), are stimulated by hypoxia to centrally regulate ventilation 
through the cortical respiratory centres (Teppema & Dahan, 2010). However, this ventilatory 
adaptation to hypoxia is not applied to the same extent when individuals are exposed to either 
normobaric or hypobaric hypoxia. Tucker et al. already highlighted the potential effect of 
hypobaria on ventilation more than 30 years ago (Tucker et al., 1983). Subjects were exposed 
to either terrestrial, 4,570 m, or normobaric hypoxia with an oxygen fraction of 14%. 
Although the arterial desaturation levels were similar between conditions, breathing 14% O2 
resulted in a greater hyperventilatory response compared to altitude exposures. These 
conclusions were later confirmed by Loeppky et al. (Loeppky et al., 1997), who observed 
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higher ventilation in NH (FiO2 = 14.2%) compared to HH (PB = 432 mmHg) after a 3 h 
exposure that was still higher after 6 and even 9 hours. A few years later, Savourey et al. 
compared the potential physiological differences between these two types of hypoxia after 
chronic exposure to high altitudes (40 min, 4,500 m) and found that compared to NH, HH 
leads to a greater hypoxemia, hypocapnia, and blood alkalosis, but lower oxygen arterial 
saturation and ventilation (Savourey et al., 2003). Recently, our team also observed lower 
ventilatory responses both at rest and during exercise in HH versus NH at 3,000 m that lasted 
for 24 h (Faiss et al., 2013). Finally, in their review of the crossover trials comparing NH and 
HH (Coppel et al., 2015), Coppel et al. highlighted the decrease in minute ventilation and 
alveolar ventilation in HH compared to NH.  
These lower ventilation levels in HH compared to NH are in accordance with smaller tidal 
volumes (see Figure 8) and most often, but not always, with higher respiratory frequencies 
(Coppel et al., 2015). Overall, HH induced greater respiratory frequencies, lower tidal 
volumes, and minute ventilation values over short time periods, suggesting a higher alveolar 
physiologic dead space, which is associated with ventilatory alkalosis and hypocapnia 
(Savourey et al., 2003; Millet et al., 2012). Similar conclusions have also been reported by 
Richard and Koehle (Richard & Koehle, 2012) and Faiss et al. (Faiss et al., 2013). The N2 and 
oxygen concentrations in the cerebrospinal fluid could be influenced by the barometric 
pressure, which could change the central regulation of ventilation (Conkin & Wessel, 2008). 
Moreover, fluid circulation and trans-alveoli-capillary flux are also known to be modified by 
the barometric pressure (Levine et al., 1988). This modification could induce greater 
pulmonary vasoconstriction in hypobaric hypoxia and thus alter the oxygen diffusion by 
decreasing the pressure gradient. Finally, the PETCO2 values observed in several studies did 
not change significantly between conditions, despite the decreased ventilation (Coppel et al., 
2015), but the PETCO2 values were lower for NH than for HH in other cases (Loeppky et al., 
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1997; Loeppky et al., 2005; Faiss et al., 2013). Twenty years ago, Reeves et al. described 
PETCO2 as ‘a good indicator of acclimatization’ (Reeves et al., 1993). This ventilatory 
acclimatization, characterized by an increased hypoxic ventilatory response, is obviously of 
great importance for altitude acclimatization and results in a decreased PETCO2 associated 
with an increased SaO2 (Fulco et al., 2013). 
 
Figure 8. Differences in tidal volume between normobaric (NH) and hypobaric hypoxia (HH) over time. Each 
point represents data obtained from a study in the systematic review of Coppel et al. From (Coppel et al., 2015). 
Fluid balance.  
Levine et al. first showed that ascent to a hypobaric hypoxic environment induced significant 
changes in both pulmonary fluid balance and O2 transport and provided some theoretical basis 
for the clinical maxim that descent is the treatment of choice for high-altitude illness (Levine 
et al., 1988). Later, Loeppky et al. confirmed that the fluid balance is not influenced in the 
same way by normobaric and hypobaric hypoxia (Loeppky et al., 2005). The effects of 
barometric pressure and reduced PO2 seem to be combined with reduced antidiuretic hormone 
(ADH) and plasma aldosterone (ALDO) levels, which induce fluid retention (i.e., lower urine 
volume in HH). However, the significant decrease in plasma volume, higher diuresis and 
lower ADH level in NH compared with HH results in a negative fluid balance (i.e., greater 
urine volume in NH).  
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Acute mountain sickness. 
Most studies have shown that the severity of acute mountain sickness symptoms was higher in 
HH compared to NH at high altitudes of approximately 4,500 m (Roach et al., 1996; Loeppky 
et al., 2005; Conkin & Wessel, 2008). In 2004, Beidleman et al., designed a study to assess 
the effect of intermittent altitude exposure (IAE) on AMS (a 3-week period of IAE for 4 
h/day, 5 days/week, at 4,300 m). The authors concluded that intermittent altitude exposure 
was more effective for altitude acclimatization and the reduction of the severity of AMS than 
normobaric hypoxia (Beidleman et al., 2004). In addition, Coppel et al. also concluded that 
AMS symptoms increased to a larger extent in HH compared to NH (Coppel et al., 2015). 
These results were later confirmed by DiPasquale et al. in their latest study showing that 
AMS severity was not equivalent when individuals were exposed to either NH or HH 
(DiPasquale et al., 2015b). Furthermore, a recent review evaluated six altitudes and hypoxia 
preacclimatization strategies to determine their effectiveness at reducing AMS. These 
strategies used either NH or HH and the differences in the main physiological response 
parameters to acclimatization (e.g., PETCO2 and SaO2) were between the hypoxic conditions. 
Thus, it seems that pre-acclimatization with HH is far more effective at reducing AMS 
symptoms (Fulco et al., 2013). The potential mechanisms that induce differences in AMS 
severity or the efficiency of pre-acclimatization strategies that prevent AMS in NH and HH 
are still unclear. The roles of the density of the breathing gas, nitrogen movement, and the 
influence of the central nervous system have been discussed (Conkin & Wessel, 2008; 
Conkin, 2016). Moreover, the higher peripheral oxygen saturation level in NH compared to 
HH may be involved in these differences in AMS.  
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Nitric oxide metabolism and oxidative stress. 
Nitric oxide (NO) is of great importance in the physiological responses to hypoxia. A 
decreased partial pressure of exhaled NO (exNO) at high altitude (Donnelly et al., 2011) has 
been observed and could influence pulmonary vasoconstriction. On the other hand, exNO was 
reported to be higher in NH compared to HH after an acute exposure to high altitude (up to 10 
minutes at 5,000 m) (Dweik et al., 1998; Hemmingsson & Linnarsson, 2009; Hemmingsson 
et al., 2012), and the barometric pressure plays a role in this difference (Kerckx et al., 2010). 
Recently, Faiss et al. also reported a higher amount of exNO in NH than HH after 24 h of 
exposure at 3,000 m (Faiss et al., 2013). The potential underlying mechanisms for these 
reductions in exhaled NO in HH could be a higher back-diffusion to the alveoli and then to 
the haemoglobin in HH, suggesting that more NO is recaptured by the blood compartment in 
HH (Millet et al., 2012). Moreover, nitrate and nitrite (i.e., precursors of plasma NO and 
NOx) concentrations are also higher in NH than in HH (Faiss et al., 2013), suggesting 
decreased systemic NO bioavailability in HH. A potential explanation for this decrease in the 
NOx concentrations in HH compared to NH could be a larger increase in oxidative stress in 
HH, as revealed by higher plasma concentrations of advanced oxidation protein products 
(AOPPs) and superoxide dismutase (SOD). Taken together, these results suggest that the 
lower minute ventilation in HH described above could be due to a decrease in NO 
bioavailability as an indirect consequence of the decreased barometric pressure in this 
condition (Millet et al., 2012; Faiss et al., 2013). 
 
Performance. 
As mentioned before, aerobic performance is decreased at altitude, whereas hypoxic exposure 
can increase sea-level performances. Nevertheless, it is important to be aware that it is very 
difficult to compare the training benefits between different hypoxic training methods because 
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of the multitude of parameters that induce changes in performance. Moreover, training 
content and the hypoxic dose are key factors for sea-level performance enhancement (Millet 
et al., 2010). In addition, responses to training and competition at high altitudes and the 
timing of the return to competition after altitude training is specific to each individual 
(Chapman, 2013; Chapman et al., 2014b). However, differences between NH and HH have 
been shown in both of these performance fields. On one hand, a recent meta-analysis 
highlighted that the mean performance improvements (represented by power output increases) 
following LHTL were lower when the altitude camps were accomplished under NH compared 
to HH conditions (0.6% and 1.4% vs. 4.0% and 4.2% for elite and non-elite athletes, 
respectively) (Bonetti & Hopkins, 2009). In addition, most of the LHTL studies with NH 
conditions did not produce any performance enhancement, although some induced positive 
erythropoietic responses (Clark et al., 2009; Robertson et al., 2010). However, most studies 
reporting both erythropoietic and performance enhancements were completed under HH 
conditions (Wehrlin et al., 2006; Chapman et al., 2014a). Nevertheless, at this time, no study 
has directly compared LHTL camps in NH vs. HH to confirm whether the benefits would 
really be greater following training in HH compared to NH. Thus, we designed a complete 
crossover study over a period of two years with the aim of assessing this interesting point (see 
studies 1 and 3 in the summary of results, discussion, and in the annexes).  
On the other hand, and as mentioned above, the decrease in VO2max (Figure 4, (Wehrlin & 
Hallen, 2006)) is the main mechanism for endurance performance impairments in hypoxia, 
which is strongly linked to SpO2 levels that are also decreased by altitude (Millet et al., 2012; 
Chapman, 2013). These performance impairments with altitude have already been reported 
either in NH or HH by several authors. These decreases do not seem as large when the 
exercises are conducted under normobaric hypoxia compared to hypobaric hypoxia. At 
simulated altitudes of approximately 3,000 m, performance impairments of 10% (Chapman et 
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al., 1998), 18% (Faiss et al., 2014) or 20% (Ventura et al., 2003) were reported versus 10% at 
a lower real altitude of 2,100 m (Chapman et al., 2011). When considering higher altitudes, 
HH seems also to induce larger performance impairments (41% (Fulco et al., 2011) and 44% 
(Richalet, 2010)) in HH versus 30% (Bourdillon et al., 2014) in NH. Regarding all these 
studies, we can conclude that some differences in the decreased performance might arise from 
the type of hypoxic stimulus (e.g., NH or HH). However, considering the large inter-
individual variability in hypoxia sensitivity (Chapman et al., 1998; Chapman, 2013) and the 
considerable number of variables affecting these results, one can only speculate that these 
differences are effective without a direct comparison. To our knowledge, only one study has 
compared aerobic performances in both hypoxic conditions to date, but they did not use a 
direct comparison with the same subjects (Beidleman et al., 2014). In this study, two different 
groups of subjects were exposed to either NH or HH and performed a 720-kJ time trial (TT). 
Compared to the control condition (i.e., sea-level, normobaric normoxia = NN) the TT 
performance was decreased to a larger extent in HH (-65%) compared to NH (-36%). 
Accordingly, we designed an experimental crossover protocol to directly compare the 
decreases in aerobic performance in the same subjects at the same acute exposure durations to 
both NH and HH, with a normoxic control condition (see studies 2 and 6 in the summary of 
results, discussion, and in the annexes). 
 
Sleep. 
Sleep quality in hypoxia is impaired at both high (Sargent et al., 2013) and moderate altitudes 
(Latshang et al., 2013), which could compromise aerobic performance (Davenne, 2008; 
Oliver et al., 2009). Until now, sleep and its disturbances have been studied in either NH or 
HH. On one hand, oxygen transport has been shown to decrease during sleep both in 
continuous (Berssenbrugge et al., 1983) and intermittent normobaric hypoxia (Tamisier et al., 
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2009), as well as in high altitude hypobaric hypoxia (Bloch et al., 2010). Periodic breathing 
has been observed in NH at a simulated altitude of 2,650 m, and the rate of rapid eye-
movement during sleep (%REM) was increased compared to normoxia (Kinsman et al., 2003; 
Kinsman et al., 2005a; Kinsman et al., 2005b). In addition, ventilation has been shown 
closely related to O2 and CO2 chemosensitivity during sleep in NH (Nespoulet et al., 2012). 
On the other hand, several authors have reported that sleep is disordered when an individual is 
exposed to hypobaric hypoxia. Reductions in REM sleep and periodic breathing during the 
night have been observed at a terrestrial altitude of 3,600 m (Roach et al., 2013; Sargent et al., 
2013). These periodic breathing events lead to nocturnal intermittent hypoxia (IH), which 
implies intermittent arterial hypoxemia and its maladaptive consequences (Berssenbrugge et 
al., 1983; Kinsman et al., 2002; Dempsey et al., 2010). Moreover, these maladaptive effects 
could persevere after waking and become deleterious to the athlete’s training and 
performances (Dempsey & Morgan, 2015). Consequently, sleeping in hypobaric hypoxia has 
been reported to induce maladaptive effects that directly alter aerobic performance, even at 
sea level, through alterations in night ventilatory physiology. 
In contrast, recent studies considered that periodic breathing in either normobaric or 
hypobaric hypoxia was a protective mechanism. Indeed, average nocturnal peripheral oxygen 
saturation seems to be decreased to a lower level in subjects experiencing more 
hypopneas/apneas compared to others who do not experience these conditions (Nespoulet et 
al., 2012). Based on these results, it is obvious that hypoxia has an influence on sleep patterns 
and recovery in response to NH or HH. In light of all the differences exposed above, it could 
be supposed that barometric pressure might also have an influence on sleep. Nevertheless, 
these hypoxic conditions have never been directly compared in the field of nocturnal and 
sleep pattern disturbances. Therefore, in this context, we designed two different studies to 
compare sleep and breathing disorders during either acute or chronic normobaric versus 
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hypobaric hypoxia (see studies 4 and 5 in the summary of results, discussion, and in the 
annexes).  
 
The aim of the present thesis work was then to further comprehend the mechanisms 
underlying the potential differences between normobaric and hypobaric hypoxia. As 
presented above, several disparities have been identified in many physiological areas between 
these two hypoxic conditions. We have tried to provide new insights by designing carefully 
controlled protocols that allow us to directly compare NH and HH. The main results of our 
work are presented in the next chapter.  
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Chapter Two 
Summary of experimental results 
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 Summary of experimental results 2.
 
2.1 Performance changes after Live High–Train Low in normobaric versus 
hypobaric hypoxia. 
 
With a study design replicating the “real” practices of endurance athletes, we investigated 
both performance and physiological parameters resulting of Live High–Train Low (LHTL) 
altitude training camps under either normobaric (NH) or hypobaric hypoxia (HH). Breathing 
frequency was lower (13.9 ± 2.1 vs. 15.5 ± 1.5 breath.min-1, P<0.05) and night SpO2 was 
higher (92.1 ± 0.3 vs. 90.9 ± 0.3%, P<0.001) for NH compared HH during the whole LHTL 
camps. Similar increases in Hbmass (2.6 ± 1.9 vs. 3.4 ± 2.1%) and VO2max (6.1 ± 6.8 vs. 5.2 ± 
4.8%) were measured in NH and HH groups, respectively, immediately after the camps, 
where no 3-km running performance was observed. However, this aerobic performance was 
improved to a larger extent for HH compared to NH 21 days following the LHTL (3.3 ± 3.6 
vs. 1.2 ± 2.9%, P<0.05, Figure 9). 
 
Figure 9. Relative change in 3-km run time from Pre- to Post-, Post-7, and Post-21 as determined on a running 
track near sea level for the normobaric hypoxia (NH) and hypobaric hypoxia (HH) groups (in %). Data are mean 
± standard error *P<0.05 for differences with Pre- and #P<0.05 for differences between groups. 
Pre- Post- Post-7 Post-21
 * #
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2.2  Performance changes during acute exposure to normobaric versus hypobaric 
hypoxia. 
 
The aim of this study was to assess the aerobic performance changes during a cycle time trial 
in acute exposure to normobaric (NH) versus hypobaric hypoxia (HH) (24 h at 3450 m) with a 
control condition in normobaric normoxia (NN). 
The mean time trial (TT) performance in NN was significantly faster than in the two hypoxic 
conditions (P<0.001, Figure 10) and the time trial performance was also faster in NH 
compared to HH (P<0.01, Figure 10). Mean peripheral oxygen saturation (SpO2) during the 
TT was significantly higher in NN compared to hypoxic conditions (P<0.001, Figure 11) and 
significantly lower for HH than NH (P<0.05, Figure 11). 
 
Figure 10. Mean time trial performance in normobaric normoxia (NN), normobaric hypoxia (NH) and hypobaric 
hypoxia (HH). Data, expressed in seconds (s) are mean ± standard errors. **P<0.01 and ***P<0.001 for 
differences between conditions. 
NN
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NH HH
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Figure 11. Mean pulse oxygen saturation (SpO2) during the time trial in normobaric normoxia (NN), normobaric 
hypoxia (NH) and hypobaric hypoxia (HH). Data are mean ± standard errors. *P<0.05 and ***P<0.001 for 
differences between conditions. 
2.3  Same performance changes after Live High–Train Low in normobaric versus 
hypobaric hypoxia. 
 
The aim of the study was to investigate the changes in physiological and performance (3-km 
run) parameters after a Live High–Train Low (LHTL) altitude camp in either normobaric 
hypoxia (NH) or hypobaric hypoxia (HH) using a crossover designed protocol reproducing 
the actual training practices of endurance athletes. This study complete the first study 
presented above. 
Nocturnal peripheral oxygen saturation was higher for NH than HH during the whole LHTL 
(92.3 ± 1.2 vs. 91.3 ± 1.0%, P<0.001, Figure 12). VO2max increased to the same extent in both 
conditions (4.9 ± 5.6 vs. 3.2 ± 5.1%, for NH and HH) while no difference was found in 
haematological parameters. No difference was found between conditions at any time for the 
3-km running time. However, the performance was significantly improved 21 days after the 
camps compared to before LHTL (4.5 ± 5.0 vs. 6.2 ± 6.4% for NH and HH, Figure 13). 
NN NH HH
***
***
*
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Figure 12. Mean values of night oxygen pulse saturation (SpO2) for the crossover data. Data are presented as 
mean ± standard error. Pre1-Pre2: measurements before the camps (1150 m, Prémanon, France); D01-D18: 
measurement during the camps (NH: hypoxic room in Prémanon, France; HH: Fiescheralp, Switzerland); Post1-
Post2: measurements after the camps (1150 m, Prémanon, France). #P<0.05, ###P<0.001 for differences between 
conditions. 
 
Figure 13. Relative change in 3-km run time from Pre- to Post-1, Post-7, and Post-21 as determined on a 
running track near sea level for the normobaric hypoxia (NH) and hypobaric hypoxia (HH) conditions (in %) for 
the crossover (n = 16). Data are mean ± standard error *P<0.05, **P<0.01 and ***P<0.001 for differences with 
Pre-; $$$P<0.001 for differences with Post-1; †††P<0.001 for differences with Post-7. 
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2.4  Sleep assessment in acute normobaric versus hypobaric hypoxia. 
 
The aim of the study was to assess the sleep disorders induced by acute high altitude exposure 
(3450 m) in either normobaric (NH) or hypobaric hypoxia (HH), compared to a control 
condition in normobaric normoxia (NN) using the gold standard nocturnal sleep 
polysomnography (PSG). 
Heart rate was higher in HH than in NH (61±10 vs. 55±6 bpm; P<0.05) and NN (48±5 bpm; 
P<0.001). Breathing frequency did not differ between conditions, while mean nocturnal 
oxygen saturation was further decreased during HH than in NH (81.2±3.1 vs. 83.6±1.9%; 
P<0.01) when compared to NN (95.5±0.9%; P<0.001). Total sleep time was longer in HH 
than in NH (351±63 vs. 317±65 min, P<0.05), and both were shorter compared to NN 
(388±50 min, P<0.05). Apnea-hypopnea index was higher in HH than in NH (20.5 [15.8-
57.4] vs. 11.4 [5.0-65.4]; P<0.01) and NN (8.2 [3.9-8.8]; P<0.001). Oxygen desaturation 
index 3% (ODI 3%) was higher in HH (47.6 [22.1-82.2]) compared to NH (22.7 [13.1-73.8]) 
and NN (4.4 [2.2-4.8]). Subjective sleep-quality was similar between hypoxic conditions but 
lower than in NN. 
 
2.5  Disordered sleep during Live High–Train Low in normobaric versus 
hypobaric hypoxia. 
 
We investigated for the first time sleep quality and disordered breathing during a 18-days 
LHTL altitude camp using either NH or HH in a controlled crossover designed study.  
The night breathing frequency was lower for NH than HH during the whole camps (14.6 ± 3.1 
vs. 17.2 ± 3.4 breath.min-1, P<0.001, Figure 14). The nocturnal peripheral oxygen saturation 
was lower for HH compared to NH for all LHTL nights (90.8 ± 0.3 vs. 91.9 ± 0.2, P<0.001) 
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and the number of oxygen desaturation index 3% (ODI 3%) was higher for HH compared to 
NH (15.1 ± 3.5 vs. 9.9 ± 1.6, P<0.001, Figure 15).  
 
Figure 14. Values (mean ± standard error) of breathing frequency (f) measured during the night with 
instrumented t-shirts for NH and HH groups. Pre1-Pre2: measurements before the camps (1150 m); D01-D18: 
measurement during the camps (NH: hypoxic room; HH: ski resort). #P<0.05, ###P<0.001 for differences 
between conditions. 
 
Figure 15. Values (mean ± standard error) of night oxygen desaturation index larger than 3% ≥per hour (ODI > 
3%). Pre1-Pre2: measurements before the camps (1150 m); D01-D18: measurement during the camps (NH: 
hypoxic room; HH: ski resort). #P<0.05, ###P<0.001 for differences between conditions. 
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2.6  Pacing strategies during time trial performances in normobaric versus 
hypobaric hypoxia. 
 
The aim of the present study was to assess the pacing strategies and exercise regulation during 
a self-paced cycle time trial of 250 kilojoules (kJ) in normobaric normoxia (NN), normobaric 
hypoxia (NH) and hypobaric hypoxia (HH). For this purpose, the exercises were divided in 25 
slices of 10 kJ. We demonstrated that compared to NN the whole time trial pace was reduced 
for both hypoxic conditions and that HH power output was significantly further reduced 
compared to NH from 140 to 220 kJ (Figure 16, P<0.05). The near infrared spectroscopy 
(NIRS) measurements showed lower oxygenation values in HH compared to NH in pre-
frontal cortex (PFC) HbDiff at the beginning of the time trial (20-120 kJ, P<0.05, Figure 
17A), while higher values were observed in HH compared to NH in motor cortex (MC) 
HbDiff in the second part of the time trial (160-240 kJ, P<0.05, Figure 17B). The SpO2 was 
lower for both hypoxic conditions during the whole time trial and it was further decreased in 
HH compared to NH at rest and during the first half of the time trial (from 0 to 140 kJ Figure 
18A; P<0.05). Mean middle cerebral artery blood flow velocities (MCAv) at rest was not 
different between conditions while it was increased in the first quarter of the time trial in all 
conditions, the increase being lower in NH compared to HH (from 10 to 150 kJ, P<0.05) and 
NN (from 10 to 100 kJ, P<0.05) while no difference was found along time trial between HH 
and NN (Figure 18B). Muscle HbDiff was lower for NN compared to NH from 20 to 210 kJ 
(P<0.05) and lower for HH compared to NN from 190 to 240 kJ (P<0.05, Figure 19A). 
HbDiff was also lower in NH compared to HH from 50 kJ onward (P<0.05). Muscle THb 
were higher in HH compared to both NN and NH conditions from 90 kJ onward (P<0.05) 
with no difference between NN and NH (Figure 19B). No difference was found between 
hypoxic conditions in any subjective feeling assessments (i.e. RPE, VAS for legs and 
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breathing discomfort) while the subjective breathing discomfort was lower in NN compared 
to hypoxic conditions. 
 
Figure 16. Power output during the self-paced 250-kJ time trial in normobaric normoxia (NN), normobaric 
hypoxia (NH) and hypobaric hypoxia (HH). ***P<0.001 for difference between NN and both hypoxic 
conditions; #P<0.05 for difference between NH and HH. 
 
Figure 17 Mean changes in cerebral haemoglobin difference (HbDiff = O2Hb-HHb) for the pre-frontal cortex 
(A) and the motor cortex (B) during the self-paced 250-kJ time trial in normobaric normoxia (NN), normobaric 
hypoxia (NH) and hypobaric hypoxia (HH). ***P<0.001 for difference between NN and both hypoxic 
conditions; #P<0.05 for difference between NH and HH. 
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Figure 18 (A) Peripheral oxygen saturation (SpO2) and (B) middle cerebral artery blood flow mean velocity 
(MCAv, panel B) during the self-paced 250-kJ time trial in normobaric normoxia (NN), normobaric hypoxia 
(NH) and hypobaric hypoxia (HH). ***P<0.001 for difference between NN and both hypoxic conditions; 
$P<0.05 for difference between NN and NH; #P<0.05 for difference between NH and HH. 
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Figure 19. Mean changes in muscle haemoglobin difference (HbDiff = O2Hb-HHb, panel A), deoxy-(HHb, 
panel B) during the self-paced 250-kJ time trial in normobaric normoxia (NN), normobaric hypoxia (NH) and 
hypobaric hypoxia (HH) for the vastus lateralis. $P<0.05 for difference between NN and NH;£P<0.05 for 
difference between NN and HH; #P<0.05 for difference between NH and HH. 
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Chapter Three 
Discussion and perspectives 
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 Discussion and perspectives 3.
 
3.1 General Discussion 
 
Spending time at altitude to pursue several recreational mountain sports, such as ski touring, 
trekking or alpinism, has become increasingly widespread over the past few years. In 
addition, altitude/hypoxic training is similarly more and more frequently adopted by athletes 
to enhance their sea level or altitude performances through an improved oxygen transport 
capacity as a result of a hypoxia-induced erythropoietic response (Millet et al., 2010) or better 
altitude acclimatization (Fulco et al., 2013). 
During the last decade, there has been a growing interest in the following two different types 
of hypoxia: normobaric and hypobaric hypoxia. It is still highly debated whether both hypoxic 
conditions bring equivalent patho-physiological responses, despite the recent increasing body 
of evidence presented above. Therefore, our work focused on direct comparisons of the same 
subjects under both chronic and acute hypoxic exposures. 
 
First, we investigated both physiological and performance parameters after an 18-day LHTL 
altitude camp under either normobaric or hypobaric hypoxia, based on the current real 
practices of endurance athletes (i.e., elite triathletes). We had hypothesized that an LHTL 
camp conducted under HH would be more demanding regarding the physiological adaptations 
(e.g., peripheral oxygen levels, haematological parameters, Hbmass, etc.) compared to NH and 
therefore result in a larger post-hypoxic increase in performance. This project was conducted 
over two years to complete the first real crossover-designed study on this topic. The crossover 
design indisputably increased the statistical power of our analysis compared to the first part of 
the project (Saugy et al., 2014). Our results partially confirmed our hypothesis because larger 
night desaturation levels and (in our ecological design) longer hypoxic exposures were 
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observed in the HH condition compared to the NH condition. However, the 3-km running 
performances were not different between conditions at any measurement point (Figure 13), 
which was unlike the first phase of the project. Nevertheless, both conditions induced sea-
level performance enhancements at Post-21 (i.e., 21 days after returning to sea level) 
compared to Pre- (i.e., before the LHTL camps). This result is consistent with the highest 
plateau in performance observed after the altitude training camps (beginning on day 18) 
described by Sinex & Chapman (2015) and Millet et al. (2010). These enhanced 
performances could be partially explained by the VO2max increases, which were equivalent 
between the two conditions (4.9 ± 5.6 vs. 3.2 ± 5.1% for NH and HH, respectively). Running 
economy and efficiency upon return from altitude camp are highly debated (Schmitt et al., 
2006; Lundby et al., 2007; Chapman, 2013), but were not involved in the subsequent 3-km 
running performance in our case, as VO2, ventilation and the HR modifications were not 
different between conditions after the LHTL intervention during a maximal aerobic test (i.e., 
conducted both Pre- and Post-LHTL). 
Different sea-level performance enhancements have been observed between the two phases of 
the project (i.e., larger improvements for HH in the first phase, but no difference in the second 
phase), but our crossover analysis reduced this trend and highlighted the substantial 
importance of inter-individual variations in response to altitude training (Friedmann et al., 
2005; Garvican et al., 2010; Chapman, 2013; Sinex & Chapman, 2015).  
Daily hypoxic exposures were consistent with the common recommended exposures in the 
literature (8-12 h.d-1 (Roberts et al., 2003; Saunders et al., 2004) and 18 h.d-1 (Levine & 
Stray-Gundersen, 1997; Wehrlin & Marti, 2006) in NH and HH, respectively) and induced 
higher total hypoxic exposures for HH compared to NH (230 vs. 310 h). However, the aim of 
our work was to construct two LHTL camps with real conditions in an ecological manner to 
obtain recommendations for athletes and coaches. Moreover, this exposure disparity is not the 
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central factor for the SpO2 difference between NH and HH because it was lower for HH from 
the first night of exposure and remained stable (i.e., lower) throughout the camps (Figure 12). 
Moreover, these peripheral oxygen saturations recorded throughout the protocol are central 
parameters of great importance. To date, no study has directly compared LHTL using both 
normobaric and hypobaric hypoxia with a crossover design. This result is consistent with 
previous studies using short exposures and higher altitudes (Savourey et al., 2003; Savourey 
et al., 2007; Self et al., 2011), but not studies using longer exposures (Roach et al., 1996; 
Loeppky et al., 2005; Miyagawa et al., 2011; Faiss et al., 2013). The underlying mechanisms 
inducing this lower SpO2 in HH compared to NH were not directly measured, but could be 
postulated based on previous findings. Greater respiratory frequencies in HH were first 
reported by Savourey et al. (Savourey et al., 2003) and then confirmed in our work (Saugy et 
al., 2014; Saugy et al., 2016b). Lower tidal volume and minute ventilation values have also 
been highlighted, implying higher amounts of alveolar physiologic dead space, which is 
associated with ventilatory alkalosis and hypocapnia in hypobaric hypoxia (Millet et al., 
2012; Richard & Koehle, 2012; Faiss et al., 2013). In addition, changes in fluid balance have 
also been shown, with a significant decrease in plasma volume and higher diuresis for NH 
(i.e., greater urine volume in NH) (Loeppky et al., 2005). Furthermore, barometric pressure 
modifies fluid circulation and trans-alveoli-capillary membrane flux (Levine et al., 1988). 
Taken together, these results might induce a stronger pulmonary vasoconstriction in 
hypobaric hypoxia and modify oxygen diffusion by decreasing the pressure gradient (Millet et 
al., 2012). The N2 and O2 concentrations in the cerebrospinal fluid could also be influenced 
by PB, as well as the central regulation of ventilation (Conkin & Wessel, 2008). Overall, these 
alterations could be the trigger for the lower mean nocturnal SpO2 values reported in the HH 
group. 
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Our findings also led us to highlight the differences in the prooxidant/antioxidant balance 
under LHTL in NH and HH. Lower oxidative stress levels following LHTL in NH were 
observed compared to HH, which were explained by the lower hypoxic dose and different 
physiological responses between conditions (Debevec et al., 2015). In addition, the influence 
of the LHTL paradigm in HH vs. NH on Hbmass was also analysed by our group and resulted 
in similar values for the same hypoxic dose, with large individual variability in the responses 
(Hauser et al., 2016). 
Our work on chronic hypoxic exposure during both normobaric and hypobaric LHTL hypoxic 
camps then allows us to conclude that these conditions are definitely not interchangeable 
(Fulco et al., 2011; Millet et al., 2012; Saugy et al., 2014; Coppel et al., 2015). Slight 
physiological differences have been highlighted but were apparently not clinically sufficient 
to induce sea level performance differences. However, regarding the large individual 
variability in the responses to both hypoxia types, athletes and coaches should definitely 
consider NH as a surrogate to HH when including altitude training in their complex 
programmes.  
 
The second major purpose of the present work was to directly compare the physiological 
parameters and aerobic performances during acute high altitude exposures in either 
normobaric or hypobaric hypoxia. Regarding the slight physiological differences observed 
between these hypoxic conditions and the apparently greater severity of HH, we hypothesized 
that performance at real altitude would be more impaired compared to performance at 
simulated altitude. With the growing interest in recreational altitude sports and the increasing 
use of altitude training in national teams and elite athletes, several authors have already 
compared performance between normoxia and either real or simulated altitude. Nevertheless, 
it was astounding that only one study directly compared endurance performance after acute 
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exposure to NH versus HH (Beidleman et al., 2014). Although the latter study was neither a 
direct comparison with the same subjects nor with the same protocol, it provides some clues 
to strengthen our hypothesis of a more severe hypoxic stimulus in HH compared to NH. 
However, as the main cardiovascular, ventilatory and haematologic responses did not differ 
between conditions during rest or exercise, the mechanisms underpinning the greater 
performance impairments in HH were not clear and require further investigations. One 
plausible reason for the lack of physiological differences between the hypoxic conditions in 
this study could be that the hypoxic exposure was too short (2 hours), particularly when we 
consider that most of the differences in the physiological adaptations between NH and HH 
were observed after longer durations. Nonetheless, our results confirmed this greater 
performance impairment in HH compared to NH, and, for the first time, directly compared 
identical subjects using the same protocol (Saugy et al., 2016a). Compared to the control 
condition (i.e., 25 and 33% longer than NN for NH and HH, respectively), the decreases were 
consistent with the existing literature, which describes an approximately 30% decrease in NH 
(Bourdillon et al., 2014) versus 40% in HH (Richalet, 2010; Fulco et al., 2011). The main 
cause of the greater decrease in endurance performance in HH compared to NH (i.e., 8%, 
Figure 10) seems to be the lower SpO2 measured at rest and during exercise in HH (Figure 
11), which was already explained above as the modified oxygen diffusion induced by the 
decreasing pressure gradient between alveoli and capillaries in HH (Levine et al., 1988; 
Loeppky et al., 1997; Conkin & Wessel, 2008). Furthermore, the amplified oxidative stress 
reported in HH by Faiss et al. (Faiss et al., 2013) and confirmed by our work (Ribon et al., 
2016) might affect NO bioavailability and thus weaken oxygen unloading to the tissues. 
Furthermore, the sensitivity to hypoxia determined by cerebral oxygenation (Bourdillon et al., 
2014), the changes in muscle activity (Amann et al., 2006a), and the cerebral perturbations 
that deeply affect motor output and performance in hypoxia (Verges et al., 2012) are all 
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significant clues that prompted us to further analyse cerebral blood flow and oxygenation, as 
well as muscular oxygenation.  
Thus, we assessed the physiological regulations implying different pacing strategies of these 
exercises (i.e., distribution of work or energy expenditure through a given exercise duration or 
distance) to better understand the performance differences between NH and HH. Prolonged 
self-paced exercise is enjoying a growing success in sport sciences due to its relevance to real 
competitions (Racinais et al., 2015). Different models have been proposed to explain the 
regulation of such exercises. Most models involve central and peripheral regulations through 
different sensitive feedbacks selected by the central nervous system (St Clair Gibson et al., 
2006; Edwards & Polman, 2013; Roelands et al., 2013; Renfree et al., 2014). One of the most 
frequently used pacing concepts was proposed by Tucker (Tucker, 2009), called the 
anticipatory feedback rate of perceived exertion (RPE) model. The aim is to maintain the 
homeostasis of the athlete so that he/she can finish the exercise using the brain as a central 
governor (Figure 20). 
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Figure 20. Schematic Figure proposed by R. Tucker to explain the anticipatory regulation of exercise 
performance during self-paced exercise (e.g. time trials). From (Tucker, 2009). 
Hypoxia is a major environmental factor that is thought to mediate central motor command, 
as well as afferent feedbacks at rest and during exercise (Verges et al., 2012; Goodall et al., 
2014). Numerous aspects of the supraspinal function, such as cortical oxygenation and 
cerebral blood flow, seems to have a predominant role in the aerobic performance impairment 
with hypoxia either with incremental (Subudhi et al., 2009) or constant (Amann et al., 2007) 
workload. In addition, motor output is likely influenced by an effect on peripheral locomotor 
muscles through decreased arterial oxygenation (Amann et al., 2006b; Amann et al., 2007; 
Amann & Calbet, 2008). 
Currently, there are only a few studies that have investigated self-paced exercise in hypoxia 
versus normoxia, and they have suggested minor differences (Clark et al., 2007; Beidleman et 
al., 2014; Bourdillon et al., 2014) or similar trends (Amann et al., 2006b; Periard & Racinais, 
2016). Our results highlighted the different pacing strategies used between NN and the 
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hypoxic conditions, with reduced power output until an end spurt in hypoxia, whereas a 
slightly positive trend was observed in normoxia over the same period (Figure 16). In 
addition, variations in power outputs (as a function of mean power during the trial) from the 
start to 85% of time trial were increased two-fold in hypoxia compared to normoxia (~22% 
and ~11%, respectively). These differences in pacing regulation between normoxia and 
hypoxia agree with some studies on the acute exposure to higher altitude (~5,000 m, NH; 
(Fan & Kayser, 2013; Bourdillon et al., 2014)) but not with most of the studies that were 
conducted on acute exposure to lower altitudes for shorter (5-min or 5-km cycling, ~3,200 m 
in HH or ~2,700 m in NH; (Clark et al., 2007) and (Amann et al., 2006b), respectively), 
similar (30-min cycling, 3,800 m, HH;(Van Cutsem et al., 2015)) or longer periods (750-kJ 
cycling, ~3,000 m, NH (Periard & Racinais, 2016)).  
Moreover, NIRS is now widely used as an appropriate tool for studying muscle and cerebral 
haemodynamic and oxygenation responses to exercise with challenging environmental 
conditions, such as altitude (Verges et al., 2012). However, previous studies almost 
exclusively considered the pre-frontal cortex (PFC), which synthesizes information from 
several different brain systems and exerts control over both executive and cognitive 
behaviours. The PFC is indeed of particular interest in our work, but the central motor drive is 
ultimately regulated by the premotor and primary motor areas. These cortical regions have 
never been investigated during self-paced exercise and could give us substantive clues to 
understand not only pacing and regulation in hypoxia but also the potential differences 
between self-paced aerobic exercises under both hypoxic conditions (i.e., NH and HH). In 
addition, Rupp et al. recently showed that the PFC and motor cortex (MC) oxygenation 
profiles could differ during submaximal fatiguing exercise (Rupp et al., 2013). For the first 
time, we simultaneously studied macro-circulation (i.e., cerebral blood flow) and both PFC 
and MC micro-haemodynamics and oxygenation during a self-paced exercise. These 
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innovative assessments give us an exclusive opportunity to further comprehend the 
underlying mechanisms driving the performance differences between NH and HH, as 
previously described (Saugy et al., 2016a).  
As observed by Beidleman et al. (Beidleman et al., 2014), the power outputs followed the 
same trend under both hypoxic conditions. However, where they only found a trend towards a 
lower power in HH compared to NH (P=0.08), in our case, the difference was great enough to 
become significant in the second part of the time trial (Figure 16). The reason why it was only 
a trend for Beidleman et al. could be the lower pre-exposure duration (approximately 2 hours) 
in their study.  
A closer look at the different physiological parameters measured during the exercise allows us 
to better understand their regulation. First, the initial power output was the same under both 
hypoxic conditions (Figure 16), although a lower SpO2 was observed for HH at rest and 
during the first part of the TT (Figure 18A). In addition, cerebral oxygen delivery (cDO2) 
remained matched between NH and HH, due to higher vasodilatory compensation in HH, 
where hypoxemia is significantly enhanced (Figure 18B). Moreover, the prefrontal cortex 
oxygenation was further diminished compared to NH (Figure 17A); thus, subjects must 
decrease their power production to prevent a larger deoxygenation of the brain when the 
cerebral blood flow is substantially decreased in HH. In addition, a lower work rate was 
achieved by the alteration in the degree of skeletal muscle recruitment (i.e., lower iEMG 
activity for HH) in accordance with a previous result (Peltonen et al., 1997), corresponding to 
the lower MC activity (Figure 17B) and lower muscle deoxygenation (Figure 19, i.e., lower 
mechanical and energetic demands). 
 
Based on all these results, it seems that aerobic exercises in NH and HH are not regulated in 
the same way. Several physiological mechanisms are involved to allow the maintenance of 
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acceptable values and prevent the brain from disturbances or damage. The system seems to be 
regulated in a protective way, according to the central governor model proposed by Tucker 
(Tucker, 2009). Nevertheless, considering the higher adaptive cost of hypobaric hypoxia 
induced by a more severe environment, the strategies adopted need to be more protective. 
 
The third intent of the present work was to directly compare sleep-disordered breathing 
parameters during the night in either normobaric or hypobaric hypoxia both at chronic and 
acute altitudes. The addition of altitude to their training programmes implies that athletes will 
spend time sleeping in hypoxic environments, which seems to have an impact on respiratory 
physiology in both NH (Berssenbrugge et al., 1983; Tamisier et al., 2009) and HH (Bloch et 
al., 2010). Our work confirmed that both hypoxic conditions induced a decreased sleep 
quality and an increase nocturnal breathing disturbances. The main finding is that the addition 
of hypobaria to hypoxia (i.e., HH) amends sleep quality and nocturnal breathing to a larger 
extent than hypoxia alone (i.e., NH). This result was observed after several hours spent at 
high altitude (Heinzer & Saugy, 2016) and during LHTL camps using chronic, moderate 
altitude exposures (Saugy et al., 2016b). 
The larger nocturnal SpO2 decrease observed in HH compared to NH after one night of acute 
hypoxia (3,450 m) agreed with previous studies (Saugy et al., 2014; DiPasquale et al., 2015a, 
b). The potential underlying mechanisms for this lower peripheral oxygen saturation in HH 
have already been explained in detail in this discussion, but it is important to consider that the 
mechanisms remain speculative. The breathing frequency was not different between 
conditions during our study conducted in acute hypoxia, but differences in breathing pattern 
have already been observed (Saugy et al., 2014; Coppel et al., 2015; Saugy et al., 2016b), 
with a higher breathing frequency in HH, even if this point is still debated (Coppel et al., 
2015). 
 -63- 
Both hypoxic conditions induced night respiratory events (i.e., central apneas and hypopneas), 
and they might be associated with a hypoxia-induced increase in higher loop gain with greater 
chemoreceptor sensitivity (Edwards et al., 2014). However, the breathing and respiratory 
disorders seem more severe in HH compared to NH, with a higher apnea-hypopnea index 
(AHI) and more hypopnea in acute hypoxia. Moreover, the oxygen desaturation index 3% 
(i.e., number of times per hour of sleep that SpO2 level drops by 3 percent or more, ODI 3%) 
was increased in both acute (Heinzer & Saugy, 2016) and chronic hypobaric hypoxia during 
LHTL (Saugy et al., 2016b; Saugy et al., 2016c) compared to an equivalent PiO2 in 
normobaric hypoxia. This oxygen desaturation index is considered a consistent marker of 
sleep apnea (Hang et al., 2015) and significantly decreases the sleep quality, leading to 
disordered sleep.  
Our present work on sleep-disordered breathing in either acute or chronic NH versus HH 
showed that differences also exist in the field of sleep patterns between the tested hypoxic 
conditions. Real altitude seems to have a greater impact on nocturnal breathing and sleep 
structure than simulated altitude induced by reducing the inspired oxygen fraction (i.e., NH). 
The main trigger for these differences seems the same as the trigger for the previous 
performance disparities, namely alterations in peripheral oxygenation. One cannot exclude the 
possibility that NO metabolism has also an important role in these differences. Hence, our 
results add significant elements to the growing body of evidence stating that NH and HH 
cannot be used interchangeably (Fulco et al., 2011; Millet et al., 2012; Saugy et al., 2014; 
Coppel et al., 2015; Ribon et al., 2016; Saugy et al., 2016a).  
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3.2 Potential mechanisms 
 
One cannot rule out the possibility that the potential underlying mechanisms that were not 
measured in the present work could induce the above-described differences between 
normobaric and hypobaric hypoxia. Therefore, it is important to consider them in further 
studies in this field. Some of the main conceivable clues that are yet to be explored are 
presented here. However, these parameters have not yet been compared between NH and HH, 
and future studies are required to assess their hypothetical responsibilities in the differences 
between hypoxic conditions. 
3.2.1 Ventilation-Perfusion inequality 
Inhomogeneous pulmonary vasoconstriction could lead to greater ventilation-perfusion 
inequality, due to the changes in NO metabolism described above. The relative contribution 
of each factor to the efficiency of gas exchange in humans during exercise in hypoxic 
environments has been studied for a long time (Gale et al., 1985). It is now well settled that 
pulmonary gas exchange efficiency, which is determined by the alveolar-to-arterial PO2 
difference (A-aDO2) and thus incorporates contributions from pulmonary (i.e., alveolar 
ventilation-to-perfusion inequality, diffusion limitation, and the intrapulmonary right-to-left 
shunt) and non-pulmonary factors (i.e., the extrapulmonary right-to-left shunt), is 
progressively exacerbated (i.e., the A-aDO2 increases) during exercise at sea level in a 
workload-dependent manner (Dempsey & Wagner, 1999). This impairment in pulmonary gas 
exchange proficiency during exercise is exacerbated in acute hypoxia, such that for any given 
VO2, the A-aDO2 is greater than the value observed during exercise while breathing room air 
at sea level (Wagner et al., 1986). Although the overall topographical distributions of 
perfusion and ventilation in the lungs become more uniform with exposure to high altitude 
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(Dawson, 1972), there is evidence suggesting that the functional ventilation-perfusion 
relationships are actually reduced at high altitude (Haab et al., 1969).  
3.2.2 Patent foramen ovale 
The patent foramen ovale (PFO) is interatrial communication that allows the blood flow to 
bypass the pulmonary circulation during foetal life. The initiation of breathing room air 
causes a reduction in pulmonary vascular pressure, which reverses the atrial pressure 
gradients such that the foramen ovale closes in the majority of people. However, PFO 
prevalence has been suggested to be as high as 38% in the general population (Woods et al., 
2010). It has been suggested that a shunt through a PFO can be as high as 21% of the cardiac 
output (Devuyst et al., 2004). Recently, Lovering et al. explored the consequences of an intra-
cardiac right-to-left shunt via the PFO in healthy humans during exercise while breathing 
room air and in acute normobaric hypoxia at sea level (Lovering et al., 2015). During these 
investigations, it became obvious that the presence of a PFO could be critical to the 
interpretation of studies where pulmonary gas exchange efficiency is a key parameter. 
Moreover, the contribution of this right-to-left shunt has been shown to be reduced at altitude 
and may only partially explain the lack of improvement in pulmonary gas exchange efficiency 
at 5,260 m (Elliott et al., 2015). In this study, subjects with a PFO exhibited a less pronounced 
degree of ventilatory acclimatization to 5,260 m, as determined by the significant increase in 
PaCO2 and concomitant increase in A-aDO2 and decrease in PaO2 and SaO2.  
 
3.3  Conclusion 
 
Our work intended to provide new insights into the potential differences between normobaric 
and hypobaric hypoxia and their underlying physiological mechanisms. We first highlighted 
the conclusive differences between both hypoxic conditions during chronic moderate altitude 
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exposure using a complete and well-controlled crossover study of Live High-Train Low 
camps. A greater decrease in the peripheral oxygen saturation level was observed in HH, and 
one of the underlying mechanisms seems to be NO metabolism (Debevec et al., 2015). 
However, the physiological differences between NH and HH do not appear to be clinically 
sufficient to induce sea level performance distinctions. Nevertheless, the type of hypoxia may 
now systematically be reported and considered by athletes and coaches when they are 
contemplating including altitude training in their programmes.  
Second, our work on direct comparisons of acute exposure to high altitude exposure also 
highlighted the physiological differences between the two hypoxic conditions, which were 
substantial enough to induce greater performance impairments when the subjects were 
exposed to real altitude. Once again, peripheral oxygen saturation seems to be a main factor, 
in addition to muscle oxygenation, cerebral blood flow and oxygenation. NO metabolism and 
oxidative stress are also involved in these differences (Ribon et al., 2016). Finally, the present 
work shows that hypobaric hypoxia has a greater impact on sleep structure and nocturnal 
breathing. 
 
Regarding the strong reliability of our results, which used direct comparisons with crossover 
studies for the first time, we added substantial insights into the growing body of evidence 
claiming that normobaric and hypobaric hypoxia cannot be used interchangeably. 
 
3.4  Perspectives 
 
We did not state that one hypoxic condition is better than the other, instead each condition is 
different and has advantages and drawbacks for coaches and athletes from a practical point of 
view. HH leads to longer hypoxic doses for a given training period, which could be easier for 
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coaches to include in the complex training plans for elite athletes, but the costs and logistics 
could be harmful. In contrast, NH requires longer time periods to obtain sufficient hypoxic 
doses, but it provides individualization opportunities. An interesting perspective would be to 
conduct altitude-training camps where the hypoxic dose could be adjusted depending on the 
athlete’s physiological responses and training levels. 
 
In addition, we showed that acute exposure to hypoxia in NH versus HH does not result in the 
same physiological adaptations. However, it is still not clear whether the combination of 
hypoxic stimulus and lowered barometric pressure induced such differences or if the modified 
pressure itself could induce significant adaptations. It would be interesting to make 
assessments using every possible combination (i.e., normobaric hypoxia, normobaric 
normoxia, hypobaric hypoxia and hypobaric normoxia) under the same experimental 
conditions (e.g., using a hypobaric chamber and hypoxic/hyperoxic devices) to further 
understand the underlying physiological mechanisms. These considerations could have 
important implications for aerospace physiology. 
 
Finally, anti-doping is a constant battle, and the Athlete Biological Passport (ABP) is actually 
the best way to detect cheaters. However, the ABP principally monitors an athlete’s biological 
variables over time to identify abnormal biases on a longitudinal basis, and several factors are 
known to influence the results of these markers. Altitude is one of these factors, and the 
method by which it is evaluated still needs to be standardized. This standardization is even 
more crucial in the current era, due to the wide combination of hypoxic methods being 
developed. Causal relationships between the haematological variables and the use of hypoxia 
should be properly integrated into ABP analyses. In particular, modifications of 
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haematological parameters during and after exposure to different altitudes/hypoxia protocols 
(i.e., using either NH or HH) must be properly considered in detection models. 
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Abstract 
We investigated changes in both performance and selected physiological parameters 
following a Live High-Train Low (LHTL) altitude camp in either normobaric hypoxia (NH) 
or hypobaric hypoxia (HH) replicating current ‘real’ endurance athletes’ practices. Well-
trained triathletes were split into two groups (NH, n=14 and HH, n=13) and completed an 18-
d LHTL camp during which they trained at 1100-1200 m and resided at 2250 m (PiO2 =111.1 
± 1.1 vs. 111.5 ± 1.0 mmHg) under either NH (hypoxic chamber; FiO2 17.9 ± 0.2%) or HH 
(real altitude; barometric pressure 580 ± 23 mmHg) conditions. Oxygen saturations (SpO2) 
were recorded continuously daily overnight. PiO2 and training loads were matched daily. 
Before (Pre-) and 1 day after (Post-) LHTL, blood samples, VO2max, and total haemoglobin 
mass (Hbmass) were measured. A 3-km running-test was performed near sea level twice before 
and 1, 7, and 21 days following LHTL. During LHTL, hypoxic exposure was lower for NH 
than HH group (220 vs. 300 h; P<0.001). Night SpO2 was higher (92.1 ± 0.3 vs. 90.9 ± 0.3%, 
P<0.001), and breathing frequency was lower in NH than HH group (13.9 ± 2.1 vs. 15.5 ± 1.5 
breath.min-1, P<0.05). Immediately following LHTL, similar increases in VO2max (6.1 ± 6.8 
vs. 5.2 ± 4.8%) and Hbmass (2.6 ± 1.9 vs. 3.4 ± 2.1%) were observed in NH and HH groups, 
respectively, whilst 3-km performance was not improved. However, 21 days following 
LHTL, 3-km run time was significantly faster in HH (3.3 ± 3.6%; P<0.05) versus NH (1.2 ± 
2.9%; ns) group. In conclusion, the greater degree of race performance enhancement by day 
21 after an 18-d LHTL camp in HH group was likely induced by a larger hypoxic dose. 
However, one cannot exclude other factors including differences in sleeping desaturations and 
breathing patterns, thus suggesting higher hypoxic stimuli in HH. 
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Introduction 
Live High - Train Low (LHTL) training camps are commonly used by athletes under either 
normobaric hypoxia (NH) [1-5] or hypobaric hypoxia (HH) [6-10] conditions. These two 
types of hypoxia are obtained by the combination of a lowered value of barometric pressure 
(PB) and/or a reduced inspired fraction of oxygen (FIO2) (NH: FIO2 < 20.9%; PB = 760 
mmHg vs. HH: FIO2 = 20.9%; PB < 760 mmHg) resulting in an inspired partial pressure of 
oxygen (PIO2) less than 150 mmHg. NH and HH were, until recently, thought to be 
interchangeable since PIO2 was assumed as the only factor influencing the physiological 
responses to hypoxia [11]. This “equivalent air altitude model” [12] has now been criticized 
and a growing body of literature has reported physiological differences between acute 
exposures to NH and HH [13,14]. Specifically, acute mountain sickness (AMS) symptoms are 
less severe under NH than HH conditions [15]. Pre-acclimatisation at real altitudes (HH) 
resulted in a significant decrease in the severity of AMS under HH conditions [16], which was 
not the case in individuals subjected to pre-acclimatisation under NH conditions [16]. 
Furthermore, according to Fulco et al., 2011, NH and HH could not “be used 
interchangeably“ and do not exhibit the same levels of effectiveness relative to pre-
acclimatisation strategies for the prevention of AMS (e.g., significant decrease in the severity 
of AMS under HH conditions following pre-acclimatization under HH but not NH) and for 
the improvement of exercise performance at higher altitudes [16]. In addition, minute 
ventilation was lower under HH than NH conditions and was associated with the combination 
of lower tidal volumes and higher respiratory frequencies [17]. Interestingly, oxidative stress 
markers were also elevated when individuals were continuously exposed to HH conditions in 
reference to NH for 24 h, whereas nitric oxide (NO) in exhaled air and plasma was lower 
under HH versus NH [18]. Moreover, exhaled NO and NO end-products (NOx) decreased in 
HH but remained stable in NH [18]. Finally, differences in fluid balance were highlighted by 
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larger volumes of urine excretion and significant decreases in plasma volume under NH 
conditions [15]. While the afore-mentioned studies support our recent suggestion that “HH is 
a more severe environmental condition” [14], this would also make the assumption that larger 
physiological adaptations would occur after prolonged hypoxic exposure under HH compared 
to NH conditions realistic. This still needs to be demonstrated in research.  
 
Of interest is that the training practices of athletes are dependent upon hypoxic conditions, 
which reflect protocols described in the literature. It has indeed been reported that: 1) daily 
hypoxic exposure is shorter in NH (i.e. 8-12 h.d-1; [4,5]) compared to HH (i.e. 16-18 h.d-1 in 
HH; [7,19]) during LHTL protocols; 2) total hypoxic dose is reduced accordingly in NH (i.e. 
~150-300 h; [1,4,5,20,21]) compared to HH (i.e. 300-600 h; [9,22-25]); 3) total camp duration 
varies between NH (0 to 23 days [2,3,26]; and HH (13 and 28 days; [9,22-25]). Moreover, the 
mean performance improvements (i.e. power output increases) following LHTL were lower 
when the intervention was completed under NH compared to HH conditions (0.6% vs. 4.0%) 
[27]. Finally, most of the LHTL studies conducted under NH conditions did not elicit any 
performance improvement, although some induced positive erythropoietic responses [1,28], 
and most of the studies reporting both performance and erythropoietic enhancements were 
performed under HH conditions [19,29]. However, these findings of the differences in the 
physiological responses to NH vs. HH, which suggest larger adaptations in the HH condition, 
are based only on short-term hypoxic exposure. To the best of our knowledge, no study to 
date has directly compared altitude-induced adaptations (i.e. haematological, peripheral 
oxygen saturation, etc.) and performance changes following LHTL training camps under both 
NH and HH conditions. This is an important issue as the development of NH facilities (e.g., 
nitrogen houses; hypoxic rooms, etc.) worldwide is increasing, and since coaches and athletes 
often consider NH and HH conditions to provide the same hypoxic stimulus. The issue of 
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whether additional benefits occur by LTHL using HH conditions rather than NH conditions 
has never been directly investigated. Therefore, the present study aimed to compare the 
physiological responses and the performance gains in trained triathletes during and after 
LHTL camps with matched PiO2 in NH versus HH conditions. Of importance is that we 
replicated common or ‘real’ altitude training practices of endurance athletes (e.g., daily 
exposure, total hypoxic doses under NH and HH conditions, respectively). We hypothesised 
that a LHTL intervention conducted under HH compared to NH was more detrimental to the 
physiological adaptations (e.g., desaturation level, Hbmass, haematological parameters, 
breathing pattern, etc.) and the post-hypoxic increases in performance. 
 
Methods 
Experimental Design. Our experimental design (Figure 1) consisted of a 33-week period 
divided into the following four phases: 1) 24 weeks (January to May) were completed at sea 
level where training loads were quantified; followed by 2) a 3-wk lead-in period at sea level 
during which all training sessions were supervised and loads were quantified; 3) an 18-d 
LHTL training camp under either NH or HH conditions; and 4) a 3-wk post-altitude period at 
sea level during which all training sessions were once again supervised and loads were 
quantified.  
Two groups (NH, n=14 and HH, n=13) were matched based on the VO2 max values prior to 
the training camp and completed an 18-d LHTL camp during which all athletes trained at 
1100-1200 m and resided at an altitude of 2250 m (PIO2=111.1 ± 1.1 vs. 111.5 ± 1.0 mmHg) 
under either NH (hypoxic house; exposure 12.2 ± 0.3 h.d-1; FiO2 17.9 ± 0.2%, Prémanon, 
France) or HH conditions (real altitude; 16.8 ± 3.1 h.d-1; barometric pressure 580 ± 23 mmHg, 
Fiescheralp, Switzerland). Normobaric hypoxia was obtained by extracting oxygen from 
ambient air (OBS, Husøysund, Norway). Calculations of FIO2 values corresponding to the 
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required altitude took into account the altitude of Prémanon. As gas compositions were 
continuously monitored, O2 fractions were permanently adjusted during sessions in order to 
maintain stability. Moreover, it was determined that opening the door several times for 
periods of a few seconds did not change FIO2 values. For safety reasons, O2 and CO2 
compositions were monitored. Each room was connected to a central monitoring station under 
the control of an independent investigator. 
The NH group was split into smaller groups of seven athletes and alternated using the hypoxic 
chamber, whereas the HH athletes went into the valley twice daily via cable car to perform 
the training.  
Before (Pre-) and 24 h after (Post-) the LHTL period, several physiological tests were 
performed on both groups in the same location (Prémanon, France, 1150 m). These sessions 
were conducted in a well-ventilated laboratory (temperature 22 ± 1 °C) in the same order and 
at the same time of the day in the Pre- and Post- testing condition. Measurements included 
blood samples, anthropometric measurements, maximal incremental tests on an cycle 
ergometer (VO2max), and total haemoglobin mass (Hbmass) assessments. Subjects performed 
five 3-km running tests at the following times: prior to lead-in, before LHTL, after LHTL, 
seven days after LHTL (Post-7), and twenty one days following LHTL (Post-21). All 3-km 
running tests were performed near sea level (100-390 m). 
Subjects. Twenty-seven well-trained male triathletes living at or near sea level (age 23 ± 4 
years, body height 179 ± 5 cm, body weight 71 ± 7 kg, fat mass 10.1 ± 1.6%, and VO2max 66.9 
± 8.4 mL·kg-1·min-1) participated in this study. Three subjects were excluded following the 
lead-in period due to insufficient training loads and fitness. All subjects were non-smokers 
who had not been acclimatised or recently exposed to testing altitudes. Volunteers provided 
their written, voluntary, informed consent before participation. The experiment was approved 
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by a Medical Ethics Committee (Commission Cantonale Valaisanne d’Ethique Médicale, 
CCVEM; Agreement 051/09) and performed in accordance with the Declaration of Helsinki.  
 
Figure 1. Overview of the study design separated by weeks (W.) and in order of the testing altitude, including 
the six months before the lead-in period where the training loads were assessed, the lead-in, the LHTL camp of 
18 days, and the lead-out period. Testing included 3-km test = the 3-km running tests on the track near sea level; 
Pre-, Post-, Post-7 and Post-21 = testing sessions; LHTL= Live High-Train Low training camp for normobaric 
hypoxia (NH) and hypobaric hypoxia (HH), where athletes were exposed to both higher altitude for living and 
sleeping and lower altitude for training. 
 
Measurements 
Training content and training loads. Two experienced certified coaches supervised and 
advised the athletes during all training sessions of the lead-in period and matched training 
content and loads for both groups during the LHTL period. Additionally, each subject’s daily 
training loads were quantified individually by both subjective and objective means to evaluate 
their effects on physiological adaptation and each subject’s subsequent performance. Training 
load quantification was performed using the ‘Objective Load Scale’ (ECOs) [30]. The 
training loads for the triathletes included in our study were similar to those described in other 
studies involving endurance athletes. The Objective Load Scale allowed for the quantification 
of all training loads in each sport of the triathlon (swim, bike, run, and transitions). The daily 
and weekly training loads (ECOs) of each subject were quantified based on each subject’s 
physical characteristics and training program intensity. Volume was quantified by time and 
allowed for better comparisons of different performance levels and conditions (e.g., ground 
 -92- 
surface, environmental temperature) [30]. 
3-km run test. The 3-km running tests were completed on a 400 m outdoor synthetic track 
near sea level. To avoid any group or pacing influences, starts were given in time-trial form 
(e.g., 30 s between each start and randomisation of the order in which each athlete competed).  
Incremental cycling test. VO2max was tested before and after LHTL using subjects’ own 
bicycles, which were linked to a computerised ergometer system (Cyclus 2, RBM elektronik-
automation GmbH, Leipzig, Germany). The exercise protocol began with a warm-up period 
of 5 min at a workload of 90 W. The workload was subsequently increased by 30 W·min-1 
until voluntary exhaustion. During the final minutes of the test, subjects were strongly 
encouraged to perform until they reached maximal exhaustion and had achieved VO2max based 
on the standard criteria for all tests. Each subject wore a mouthpiece and nose clip for breath 
collection. O2 and CO2 levels in expired gas were continuously measured and monitored as 
breath-by-breath values (Ultima Cardio 2 gas exchange analysis system, MGC Diagnostics 
with Breezesuite software, Saint Paul, MN, USA). Both the gas analyser and the flowmeter of 
the gas analyser were calibrated prior to each test. The highest 30 s average value served as 
the VO2max. Maximal heart rates (HRmax) and the lowest SpO2 values were each recorded 
during the same time period. The maximal power output (Pmax) was the load of the last stage 
completed.  
Anthropometrics values. Athletes’ body weights and heights were measured in the morning 
before breakfast. 
Haemoglobin mass. Hbmass was measured in duplicate by using a slightly modified version 
[31] of the optimised carbon monoxide (CO)-rebreathing method described by Schmidt and 
Prommer [32]. The subjects inhaled a bolus of 100 mL of pure CO (Multigas SA, Domdidier, 
Switzerland), followed by 3.5 L of oxygen. Each Hbmass measurement was performed in 
duplicate on two consecutive days (12- to 24-h time lag between measurements). In average 
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over all measurement time points, the typical error for duplicate Hbmass measurement was 
2.1% in our mobile laboratory. Hbmass data are expressed as the mean values of the duplicate 
measurements.  
Values of red cell volume (RCV), blood volume (BV), and plasma volume (PV) were 
estimated using the following formulas: RCV = Hbmass/MCHC x 100, BV = RCV x (100/Hct) 
and PV = BV – RCV, where MCHC is the mean corpuscular haemoglobin concentration, and 
Hct is the haematocrit corrected to whole-body haematocrit by the cell factor of 0.91. For the 
calculation of RCV, BV, and PV, venous haemoglobin concentrations [Hb] and venous Hct 
were used. Blood gas analyses were conducted using an ABL 800flex (Radiometer A/S, 
Copenhagen, Denmark). 
Blood samples. Antecubital vein blood samples (4.9 mL EDTA tube, Sarstedt, Nümbrecht, 
Germany) were taken during three time periods including either before breakfast or 
immediately after waking up, before LHTL, and after LHTL. Blood was subsequently 
analysed via fluorescent flow cytometry and hydrodynamic focusing (XT-2000i, Sysmex 
Europe, Norderstedt, Germany), and the following primary haematological parameters were 
quantified: red blood cells (RBC), haemoglobin (Hb), haematocrit (Hct), mean cell volume 
(MCV), mean cell haemoglobin (MCH), mean cell haemoglobin concentration (MCHC), 
reticulocyte percentage (RET%), absolute number of reticulocytes (RET#), and immature 
reticulocyte fraction (IRF). The Sysmex XT-2000i underwent regular internal quality control 
procedures as required by the standards of laboratory medicine. During the period of our 
study, the coefficient of variations (CV), which was determined using internal quality 
controls, was far below 1.5% for Hb and 1.5% for RET% (within CV limits accepted by the 
manufacturer of the instrument). Plasma EPO was quantified using a standard procedure with 
an ELISA kit (Stemcell Technologies, Grenoble, France). Plasma EPO concentrations below 
the limit of quantification (1.6 mU/mL) were excluded from the analyses. CVs determined by 
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three internal quality controls (levels: low, medium and high) were below 15% in our WADA 
(World Anti-Doping Agency) accredited laboratory [33]. All plasma samples were analysed 
in duplicate, where the mean values of the duplicate were used for this study. Additionally, 
baseline ferritin was quantified using standard laboratory procedures (Dimension EXL, 
Siemens Healthcare Diagnostics SA, Zürich, Switzerland) to evaluate the subject’s iron 
stores. It is important to note that all athletes were tested for doping by the accredited 
laboratory according to the standards of the biological passport. This was done to avoid 
performance enhancement via doping. 
Questionnaires. Subjects completed three different questionnaires on a daily basis 
immediately after waking up (hypoxic rooms for NH and normal rooms for HH, but all were 
hypoxic) and during three phases before, during, and after the LHTL training camp. The three 
questionnaires were as follows: 1) The Lake Louise score questionnaire, 2) The Daily 
Analysis of Life Demands for Athletes (DALDA), and 3) Sleep assessment questionnaire. 
The Lake Louise score questionnaire is scoring system developed by the 1991 International 
Hypoxia Symposium consensus committee, which met at Lake Louise in Alberta, Canada. It 
is widely used today to assess the severity of AMS. The DALDA is a self-reported sport-
specific tool describing the stress sources and characteristics of each person, which allows for 
the differentiation of the individuality of stress responses. This questionnaire is divided into 
two parts; Part A describes the general stress sources that occur in everyday life for an athlete 
(diet, home life, school, work, friends, training, climate, sleep, recreation, and health); and 
Part B determines which symptoms of any existence in stress reactions of the athlete. The 
sleep assessment questionnaire was the Groningen Sleep Quality Scale (GSQS), which was 
used to evaluate for high altitude sleep (HAS) disturbances. It consists of a sleep quality score 
(GSQSS) and two visual analogue scales (VAS), which yield a score between 0 and 10 for 
sleep quality and waking state. 
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Sleep assessment. SpO2 and HR were recorded each evening at 0.25 Hz with a wrist oximeter 
connected to a finger sensor (Wristox 3150 with 8000SM-WO Sensor, Nonin, Plymouth, 
MN). Subjects wore an instrumented t-shirt (model SEW, CSEM, Neuchâtel, Switzerland) 
each night (including the 2 nights before and the 2 nights after LHTL), a device made of 
comfortable fabric that was used to measure breathing frequency via an elastic sensor 
included in the textile, as well as each subject’s sleeping position via accelerometers. 
Data Analysis and Statistics. Data are reported as the means and standard deviations. Data 
were tested for equality of variance (Fisher-Snedecor F-test) and for normality (Shapiro-Wilk 
test). When both conditions were met, a two-way ANOVA was performed for repeated 
measures for each condition (NH and HH) to determine time effects for variables measured 
on several occasions during the camps with pairwise multiple comparison procedures (Holm-
Sidak method). Differences between results obtained before and after LHTL for both the NH 
and HH groups were subsequently also compared using a two-way ANOVA. Differences in 
percentage changes between the groups were tested with a Wilcoxon signed rank sum test. 
When either equality of variance or normality were not satisfied, variables were analysed for 
each condition using a Friedman test for repeated measures to determine time effects using 
pairwise multiple comparison procedures (Bonferroni test). In this case, differences between 
the NH and HH groups at baseline (Pre-) were tested using a Mann-Whitney rank sum test. 
The correlation between values of Hbmass initial (in g) or pre-to-post change (in %) and 
VO2max (mL.kg-1.min-1) as well as correlations between all haematological and physiological 
parameters were calculated via the Pearson product moment correlation. Null hypotheses 
were rejected at P<0.05. All analyses were completed using Sigmaplot 11.0 software (Systat 
Software, San Jose, CA).  
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Results 
Training loads. No differences were found in daily or average training loads between the two 
groups during the 18-d LHTL camp (232 ± 159 vs. 217 ± 129 ECOs for the NH and HH 
groups, respectively; Figure 2A). Additionally, no differences were found in weekly training 
loads monitored during the 6 months prior to the study (1161 ± 130 vs. 1208 ± 168 ECOs per 
week for the NH and HH groups, respectively; Figure 2B), nor were any differences noted 
during the lead-in period or the post-hypoxic period.  
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Figure 2. A. Daily objective training (D01-D18: day 01 to day 18) loads during the Live High-Train Low 
(LHTL) camp for normobaric hypoxia (NH) and hypobaric hypoxia (HH) groups. B. Weekly objective training 
loads during the six months before the intervention for NH and HH groups. 
3-km performance test. Compared to Pre-, 3-km performance remained unchanged at Post- 
and Post-7 in both groups. Whereas run performance did not improve significantly in the NH 
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group (630.1 ± 64.8 vs. 621.8 ± 54.8 s, P>0.05) from Pre- to Post-21, however, faster 3-km 
run times occurred in the HH group (611.1 ± 48.5 vs. 588.3 ± 32.2 s; -3.3 ± 3.6%, P<0.05, 
Figure 3). No differences were found between the groups during the lead-in period, before 
LHTL, after LHTL, or 7 days post-LHTL. In addition, no differences were found between 
Lead-in and Pre- for both groups (626.3 ± 63.8 vs. 630.1 ± 64.8 s and 602.4 ± 44.3 vs. 611.1 
± 48.5 s, for NH and HH at Lead-in vs. Pre-, respectively). 
 
Figure 3. Relative change in 3-km run time from Pre- to Post-, Post-7, and Post-21 as determined on a running 
track near sea level for the normobaric hypoxia (NH) and hypobaric hypoxia (HH) groups (in %). Data are mean 
± standard error *P<0.05 for differences with Pre- and #P<0.05 for differences between groups. 
 
Maximal test on cycle ergometer. These results are presented in Table 1. Both groups 
increased their maximal oxygen uptake values and power output values by the same amount 
immediately after the LHTL training camp period (+6.1 ± 6.8 vs. +5.2 ± 4.8% VO2max and 
+9.6 ± 5.2 vs. +6.6 ± 4.7% Pmax, for the NH and HH groups, respectively).  
 
Pre- Post- Post-7 Post-21
 * #
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Table 1 Physiological parameters before (Pre-) and after (Post-) the Live High-Train Low 
(LHTL) camps for the normobaric hypoxia (NH) and hypobaric hypoxia (HH) groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VO2max maximal oxygen uptake; HRmax maximal heart rate; Pmax maximal power output; VEmax maximal 
ventilation. Data are mean ± SD; **P<0.01 and ***P<0.001 for differences between Pre- and Post-. 
 
Body fat mass and weight. Body weight (69.5 ± 5.9 vs. 69.6 ± 5.6 kg for the NH group and 
69.9 ± 6.4 vs. 69.1 ± 6.2 kg for the HH group) and fat mass percentage (9.9 ± 1.8 vs. 9.1 ± 
1.3% for the NH group and 10.3 ± 1.4 vs. 8.4 ± 0.7% for the HH group) did not differ 
between groups. 
Night SpO2 and heart rate. No differences in average values of night HR were found between 
the groups or between different days (51 ± 1 and 50 ± 2 bpm, for the NH and HH groups, 
respectively). Conversely, although mean SpO2 values (Figure 4B) were similar during the 
control nights (before the camps, Pre1 and Pre2), they were higher in the NH group than in 
the HH group between day 1 and day 18 (D1 to D18) (92.1 ± 0.3 vs. 90.9 ± 0.3, for the NH 
and HH groups, respectively; P<0.001) and remained higher (P<0.05) during each of the two 
  Pre- Post- Delta % 
VO2max 
[mL.·kg-1·.min-1] 
NH 65.4 ± 7.8 69.1 ± 5.6 ** 6.1 ± 6.8 
HH 69.2 ± 8.9 73.2 ± 7.1 ** 5.2 ± 4.8 
HRmax 
[b·.min-1] 
NH 187 ± 7 188 ± 5 0.6 ± 2.6 
HH 185 ± 9 185 ± 8 0.1 ± 1.9 
Pmax 
[W] 
NH 353 ± 43 385 ± 38 *** 9.6 ± 5.2 
HH 378 ± 24 403 ± 32 *** 6.6 ± 4.7 
VEmax 
[l·.min-1] 
NH 178.9 ± 17.8 184.3 ± 14.6 3.7 ± 10.2 
HH 182.6 ± 34 188.1 ± 19.3 4.5 ± 9.3 
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nights following the camps (Post 1: 94.7 ± 0.5 vs. 93.5 ± 0.9% and Post2: 94.8 ± 0.6 vs. 93.7 
± 1.3%). 
Breathing frequency. The average values of night breathing frequency were similar between 
the groups during the two evenings prior to the camp (14.0 ± 1.8 and 13.9 ± 1.5 breath.min-1 
for NH and HH, respectively). However, breathing frequencies were lower in the NH group 
than in the HH group (13.9 ± 2.1 vs. 15.5 ± 1.5 breath·min-1, P<0.05) during the LHTL camp 
(D1 to D18) and remained lower upon the camp’s completion (13.7 ± 1.9 vs. 15.1 ± 1.3 
breath·min-1, P<0.05). 
Total Haemoglobin Mass. All results are presented in Table 2. Both groups increased their 
total haemoglobin masses during the study period (912 ± 96 vs. 936 ± 103 g and 950 ± 115 
vs. 967 ± 122 g for the NH and HH groups, respectively, P<0.001). 
Blood Parameters. All blood parameters are presented in Table 2. The RBC number, [Hb] 
and Hct were each lower in the NH group than in the HH group following camp. 
Additionally, the initial ferritin values were not different between groups and were within 
reference ranges (98.7 ± 75.9 vs. 105.3 ± 51.9 ng/mL for NH and HH, respectively). A larger 
decrease in [EPO] was noted in the HH group compared with the NH group with return to 
1150m (table 2). 
Hypoxic doses and PiO2. The daily (12.2 ± 0.3 vs. 16.8 ± 3.1 h, P<0.001) and total (220.1 ± 
0.9 vs. 302.9 ± 5.5 h, P<0.001) hypoxic doses were lower in the NH group than in the HH 
group. No differences were found in either daily or average PiO2 values between the two 
training camps (111.1 ± 1.1 vs. 111.5 ± 1.0 mmHg for the NH and HH groups, respectively, 
Figure 4A). 
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Figure 1. A. Daily values of inspired pressure of oxygen (PiO2 in mmHg) during the Live High-Train Low 
(LHTL) camps for the normobaric hypoxia (NH) and hypobaric hypoxia (HH) groups. B. Mean values of night 
oxygen pulse saturation (SpO2). Data are presented in mean ± standard error. Pre1-Pre2: measurements before 
the camps (1150 m, Prémanon, France); D01-D18: measurement during the camps (NH: hypoxic room in 
Prémanon, France; HH: Fiescheralp, Switzerland). #P<0.05, ###P<0.001 for differences between groups. 
###
#
1150m 1150m2250m
A
B
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Questionnaires. The mean Lake Louise Score was 1.2 ± 0.4 for the NH group and 1.1 ± 0.4 
for the HH group. No differences were found between the groups. DALDA Part B results 
were not different between the groups, and scores did not change across days (2.3 ± 0.7 vs. 
2.3 ± 0.6 for the NH and HH groups, respectively). DALDA Part A results included a 
significantly higher score for the NH group than for the HH group from D07 to D11 and D15 
to D16 (P<0.05). The average VAS value for the sleep quality of the entire camp was lower in 
the NH group (6.0 ± 0.4 vs. 6.4 ± 0.4 for the NH and HH groups, respectively; P<0.001). The 
GSQSS was significantly higher for the NH group (4.7 ± 1.1 vs. 3.6 ± 0.8 for the NH and HH 
groups, respectively; P<0.001), indicating poorer sleep quality for the NH group than for the 
HH group. However, waking state VAS scores were not different between the groups (5.9 ± 
0.5 vs. 5.7 ± 0.5 for the NH and HH groups, respectively). 
Correlations. A positive correlation was found between the mean Hbmass (in g) and VO2max 
(mL.kg-1.min-1) values of both groups following camp (r=0.68, P<0.01; r=0.86, P<0.001 for 
the NH and HH groups, respectively). We did not find any correlations between changes in 
Hbmass and VO2max or between initial value of Hbmass and any other parameter. 
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Table 2 Haematological parameters before (Pre-) and after (Post-) the Live High-Train Low 
(LHTL) camps for the normobaric hypoxia (NH) and hypobaric hypoxia (HH) groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Pre- Post- Delta % 
EPO 
[mU/mL] 
NH 3.85 ± 1.42 3.37 ± 1.59 -14.1 ± 18.3 
HH 4.96 ± 3.73 3.92 ± 3.94* -34.5 ± 27.5# 
RBC  
[u/µl] 
NH 5.26 ± 0.39 5.08 ± 0.46 -3.5 ± 4.8 
HH 5.15 ± 0.36 5.18 ± 0.43 ## 0.6 ± 3.8 
# 
HGB  
[g/dl] 
NH 15.75 ± 1.07 15.75 ± 1.14 0.1 ± 5.1 
HH 15.53 ± 0.88 16.18 ± 1.08 *# 4.2 ± 3.9 # 
Hct  
[%] 
NH 46.25 ± 2.89 45.19 ± 2.97 -2.2 ± 5.6 
HH 45.24 ± 2.43 46.33 ± 2.62 *# 2.5 ± 3.8 # 
MCV  
[fl] 
NH 88.06 ± 3.71 89.22 ± 3.16 ** 1.4 ± 1.3 
HH 88.06 ± 4.74 89.69 ± 4.51 *** 1.9 ± 1.4 
MCH  
[pg] 
NH 29.96 ± 1.13 31.09 ± 1.27 *** 3.8 ± 0.9 
HH 30.22 ± 1.27 31.32 ± 1.34 *** 3.6 ± 1.2 
MCHC  
[g/dl] 
NH 34.03 ± 0.72 34.85 ± 0.58 *** 2.4 ± 1.2 
HH 34.33 ± 1.01 34.92 ± 0.79 *** 1.7 ± 2.0 
RET  
[%] 
NH 0.89 ± 0.31 1.03 ± 0.28 ** 21.6 ± 30.0 
HH 0.98 ± 0.24 1.18 ± 0.38**# 23.2 ± 34.1# 
IRF  
[%] 
NH 6.72 ± 3.61 5.37 ± 2.17 -9.02 ± 33.95 
HH 6.06 ± 1.77 4.76 ± 2.75 -19.09 ± 36.46 
Hbmass 
[g] 
NH 912.4 ± 96.6 935.9 ± 102.6 *** 2.6 ± 1.9 
HH 946.8 ± 126.7 978.6 ± 131.6 *** 3.4 ± 2.1 
RCV 
[ml] 
NH 2675.8 ± 295.4 2692.1 ± 289.9 0.7 ± 2.8 
HH 2734.1 ± 306.5 2778.7 ± 324.1 1.64 ± 3.1 
BV 
[ml] 
NH 6358.3 ± 583.8 6553.6 ± 664.1 3.1 ± 4.8 
HH 6617.1 ± 744.1 6557.5 ± 821.4 -1.0 ± 4.2 ## 
PV 
[ml] 
NH 3682.6 ± 384.6 3861.6 ± 460.9 5.1 ± 8.6 
HH 3883.1 ± 505.3 3778.8 ± 551.8 -2.7 ± 6.1 ## 
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EPO erythropoietin; RBC red blood cells; HGB haemoglobin; Htc haematocrit; MCV mean cell volume; MCH 
mean cell haemoglobin; MCHC mean cell haemoglobin concentration; RET reticulocytes; IRF immature 
reticulocyte fraction; Hbmass haemoglobin mass; RCV red cell volume; BV blood volume; PV plasma volume. 
Data are mean ± SD; *P<0.05, **P<0.01 and ***P<0.001 for differences between Pre- and Post-; #P<0.05 and 
##P<0.01 for differences between NH and HH. 
 
Discussion 
The present study demonstrated that an 18-d LHTL altitude camp performed under either NH 
or HH conditions induced different physiological and systemic responses: (i) during LHTL, 
longer hypoxic exposure, larger night desaturation levels, and higher breathing frequencies 
were noted in the HH group; (ii) immediately after LHTL, larger haematological changes 
occurred in the HH group, but similar increases were observed in Hbmass and VO2max; (iii) 
finally, larger performance enhancements were measured in the HH group after 3 weeks at 
sea level. 
 
Differences in daily responses were found between our experimental groups. The hypoxic 
dose was higher for the HH group than for the NH group (300 vs. 220 h). The present study 
aimed to compare two LHTL altitude training camps (simulated versus real altitude) in “real 
conditions”, corresponding to those encountered by elite athletes in their training practices. In 
this context, the daily exposures reported in the present study (12 vs. 17 h·d-1 in the NH and 
HH groups, respectively) are consistent with those reported previously with hypoxic 
exposures of 8-12 h·d-1 [4,5] and 18 h·d-1 [7,19] in NH and HH conditions, respectively. Meta-
analysis results would suggest that optimal durations are of 11 and 18 h·d-1 [27]. There is a 
clear dose-response effect between the hypoxic dose and the haematological responses, as 
highlighted by Levine and Stray-Gundersen’s study [23]. However, differences in hypoxic 
doses between the NH and HH groups cannot be easily reduced, as long duration stays in 
confinement for individuals of the NH group may cause other complications, including 
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detrimental reductions in plasma volume [34]. Aside from the difference in total hypoxic 
exposure, the HH group also experienced fewer transitions between “high” (2250 m) and 
“low” altitudes. LHTL under NH conditions implies numerous daily exposures to normoxia 
and many transitions to and from hypoxic conditions. Therefore, the exposure is more 
intermittent than it would be for LHTL under HH conditions (e.g., the number of daily shifts 
between altitudes was 7 vs. 2 in the NH and HH groups, respectively). Taken together, we 
assume that these intermittent characteristics cannot be ruled out as explanations for noted 
altitude training adaptations. In addition, Navarette-Opazo & Mitchell [35] demonstrated in a 
recent meta-analysis, that the number of cycles per day was one of the most relevant variable 
inversely correlated with the qualitative effect of intermittent exposures to hypoxia. 
Interestingly, in a similar way, Garvican et al. [22] described the “oscillating nature of 
LHTL,” the daily descents to sea level and the associated normoxic exposures as an 
explanation for the less dramatic fall in [EPO] compared to changes associated with 
continuous exposure to high altitudes. This observation may also explain the differences 
(almost twice as much in the HH group) in [EPO] decreases noted between the two groups.  
Night measurements also indicated that the two conditions were not similar. Night arterial 
oxygen saturations were higher in the NH group than in the HH group, while breathing 
frequencies were lower (Figure 4B). Such differences in ventilatory patterns may be 
explained by differences in the magnitude of alteration of pulmonary diffusion. Similarly, 
Savourey et al. [17] first demonstrated that HH induced greater respiratory frequencies, lower 
tidal volumes, and minute ventilation values over short time periods; thus, suggesting higher 
amounts of alveolar physiologic dead space, which is associated with ventilatory alkalosis and 
hypocapnia [14]. Later, similar conclusions have also been reported by Richard and Koehle 
[13] and Faiss et al. [18]. Changes in fluid balance have been shown as well with differences 
between the HH and NH conditions [15]. Additionally, barometric pressure (PB) modifies 
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fluid circulation and trans-alveoli-capillary membrane flux [36]. This may induce a stronger 
pulmonary vasoconstriction in the HH group and modify oxygen diffusion by decreasing the 
pressure gradient [14]. PB may also influence N2 and O2 concentrations in cerebrospinal fluid, 
as well as central regulation of ventilation [12]. Taken together, these alterations are the likely 
inducers of the lower mean sleeping SpO2 values reported in the HH group. It is interesting to 
note that these lower SpO2 values were maintained after subjects returned to 1150 m during 
the two nights period immediately following the camp. Several studies [17,37] have reported 
a more rapid blood desaturation under HH conditions, leading to a longer duration of 
hypoxemia. This is in line with the present results as we observed a larger decrease in SpO2 
from the first night under HH conditions and the maintenance of these lower values during the 
whole LHTL camp. Interestingly, the higher breathing frequencies while sleeping in HH 
conditions at 2250 m were also maintained during the two nights spent at 1150 m following 
the camp. This larger desaturation, which was most likely influenced by the higher breathing 
frequencies, potentially induced more severe hypoxemia in the HH group and delayed 
performance enhancement. 
Specific short-term post-hypoxic responses were observed immediately following the camps. 
These responses were noted primarily among haematological parameters and revealed 
differences between the groups that were clearly influenced by differences in both daily and 
total hypoxic exposures. To date, there is no consensus on neither the dose-response 
relationship between hypoxic stimulus and Hbmass increase nor on the recommendation in 
terms of total hypoxic exposure duration. For instance, Richalet and Gore have recommended 
an exposure of 216 h [20], Garvican et al. of 300 h [22], and Wilber at al. a minimum of 4 
weeks with at least 22 h.d-1 [25]. In the present study, the difference of 80 h (220 vs. 300 h for 
the NH and HH groups, respectively) is likely the primary cause of the larger increases in Hct, 
[Hb], and RET in the HH group. However, although the increase in Hbmass immediately 
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following camp was significant, the magnitude of the increase was the same in both groups 
(2.6 vs. 3.4% for the NH and HH groups, respectively). Our results are consistent with those 
of previous studies in which Hbmass was increased by 3-4% following several LHTL protocols 
[7,19,22,28,38] and illustrate an enhanced oxygen transport capacity as a result of an 
erythropoietic response. These findings are also consistent with the dose-response relationship 
and correspond to an average rise of 1% per 100 h of exposure [1,38]. Gore et al. [38] also 
suggested that the amount of the hypoxic dose or the level of altitude should be higher in 
cases involving the use of simulated altitudes to produce equivalent results at real altitudes 
(i.e. 3000m in NH with LHTL corresponding to 2320 m in HH with classical altitude 
training). Further, our results showed a 5-6% increase in VO2max in both groups following 
LHTL, an increase that is commonly observed under HH conditions [19] as well as NH 
conditions [26,39], although the phenomenon is more common in the former [40,41].  
We also reported differences in plasma and blood volume changes during the study period 
between the NH and HH groups. Of interest, is that diuresis and changes in fluid balance have 
been shown to be different between HH and NH (i.e. larger diuresis for NH and larger fluid 
retention for HH) [15,42]. The influence of PV changes (e.g., expansion and reduction) on 
performance enhancement are well-known [43]. It is known that plasma volume may increase 
until at least 16 days following an altitude training camp [44]. One may speculate that the 
non-significant difference in plasma volume observed at Post- between the two groups would 
not occur anymore at Post-21, suggesting a potential larger increase in PV for the HH group 
during these 3 weeks. This potential hemodynamic enhancement would partially explain the 
longer delay in performance enhancement compared to the NH group. However, based on the 
existing contradictory literature, it is difficult to speculate on the maintenance of the Hbmass 
gains at Post-21. Garvican-Lewis et al. [45] reported a 4% increase two weeks after 11 days 
of LHTL under NH conditions at 3000 m (14 h.d-1). However, a persistent increase in Hbmass 
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post-exposure does not mean that it did not decrease from the initial elevation during the days 
following the exposure. Several studies show a relatively linear decrease in Hb and Hct 
starting as soon as hypoxic stimulus is removed. For example, Gough et al. [46], reported a 
drop from post to post-14; and Garvican et al. [22], demonstrated that Hbmass had started to 
drop off by Post-4 and was no different from control after 10 days at sea level. Similarly, elite 
altitude-native Kenyan runners showed a significant 20 g decrease at 21 days at sea level 
(Figure 2A in [47]). 
 
One of the most important findings of the present study is the performance enhancement 
noted in the HH group three weeks after camp. Our results are consistent with those of the 
meta-analysis by Bonetti and Hopkins [27], which described a “terrestrial” LHTL protocol 
that induced additional benefits relative to the performances of elite athletes as estimated by 
power output increases of 4.0% under HH conditions and 0.6% under NH conditions.  
Delayed (in our case, three weeks after LHTL) performance enhancement has been observed 
in several [7,26] but not all studies [39]. The following mechanisms have been proposed: 
enhanced stroke volume compensating for the reduction in heart rate [48], enhanced 
efficiency [42], and increased VO2 and power output at the lactic threshold [26]. Recently, 
Chapman et al. [49] described the following three components, which may influence 
performance changes following altitude training: the timing of the decay of red cell mass, the 
consequences of ventilatory acclimatisation, and the alterations in the biomechanical and 
neuromuscular factors associated with force production. Regarding the first component, we 
cannot determine if the unknown decay of Hbmass (see above) in the present study influenced 
the difference in performance enhancement between groups at Post-21. The observed 
differences in the ventilatory pattern, as evidenced by the higher night breathing frequency in 
the HH group, could have influenced the delayed performance difference between groups. 
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Katayama et al. reported that the ventilatory adaptations upon returning to sea level were 
maintained for at least 4 weeks, after prior high altitude acclimatization, as these 
acclimatization benefits were observed during a new subsequent altitude exposition [50]. 
Finally, it is unlikely that there was any biomechanical alteration in either group who trained 
“low” at 1100-1200 m, as suggested by the preliminary results of Laymon et al. [51]. 
Therefore, a hypoxic-induced alteration in running style was probably not involved in the 
observed difference at Post-21.  
Strengths and limitations. Our primary aim was to compare LHTL training camps under real 
and simulated altitude in an ecological setting (e.g., by reproducing “real life” conditions of 
daily exposures and camp durations as described in previous LHTL studies under NH and HH 
conditions, respectively) rather than investigating the efficiency of LHTL, which has 
previously been documented. For this reason, we did not include a sea level control group. To 
the best of our knowledge, our study is the first to report differences in performance 
enhancement following direct comparisons of prolonged altitude training under NH and HH 
conditions. The athletes were well trained as shown by their training loads, VO2max, and 
performance levels. The groups were matched according to the VO2max values. Additionally, 
the athletes’ training load and content were quantified and matched during the 6-month period 
before the study, which included a suitable lead-in period. To our knowledge, this study is the 
first where training loads and altitude levels were entirely matched on a daily basis during the 
entire LHTL period. The current study emphasizes the importance of well-controlled studies 
to achieve a better understanding of the mechanisms and potential benefits of altitude training 
[52].  
The primary limitation of this study was that no measurements of total haemoglobin mass or 
other haematological parameters were completed at one or three weeks following LHTL due 
to logistical constraints. In addition, since our aim was to compare two typical 18-d LHTL 
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camps in “real” conditions, the hypoxic doses were different. One cannot rule out that the 
physiological and performance responses would be less dissimilar between NH and HH with 
a close matching of hypoxic doses. 
Perspectives. This study questions the relationship between modes of prolonged hypoxic 
exposure and subsequent performance improvement. Real altitude conditions (HH) were more 
demanding than the simulated altitude (NH) utilised in training camps of the same duration. 
However, in general, hypoxic chambers make adjustments possible and continue to attract 
interest because of their practicality. Chapman [53] emphasises that the response to training 
and competition at high altitudes is individual, and that timing the return to competition after 
altitude training must also be individualised to obtain optimal sea level performance [49]. 
Normobaric hypoxia devices offer these individualisation possibilities in terms of hypoxic 
doses and altitude adjustments. Finally, further studies are necessary to assess the 
physiological responses of these hypoxic training methods to equivalent hypoxic doses. 
This study highlights the different physiological adaptations noted in the HH and NH LHTL 
camps. Our results suggest that future investigations should increase the altitude of the 
normobaric hypoxia group to reach the same level of desaturation as that experienced under 
hypobaric hypoxic conditions and lengthen the durations of the camps to obtain hypoxic 
doses similar to those experienced under hypobaric hypoxic conditions.  
Conclusion. The primary finding of the study is that there were significant differences in the 
responses to a LHTL training camp in NH compared to HH. Specifically, our results included 
greater performance enhancements in the HH group three weeks after LHTL, greater 
significance in haematological changes within the HH group following camp, greater night 
desaturation levels, and higher breathing frequencies in the HH group, with similar increases 
in Hbmass and VO2max following LHTL in both NH and HH. Additionally, one cannot rule out 
other factors, including differences in sleep quality, desaturation level, breathing patterns, 
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fewer transitions between high and low altitudes (e.g., intermittence) or different responses 
relative to plasma volumes and [EPO] following camp. 
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Chapter Six 
Article 2 - Cycling time trial is more altered in hypobaric than 
normobaric hypoxia. 
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Abstract 
Purpose: Slight physiological differences between acute exposure in normobaric hypoxia 
(NH) and hypobaric hypoxia (HH) have been reported. Taken together, these differences 
suggest different physiological responses to hypoxic exposure to a simulated altitude (NH) 
versus a terrestrial altitude (HH). For this purpose, in the present study, we aimed to directly 
compare the time-trial performance after acute hypoxia exposure (26 h, 3450 m) by the same 
subjects under three different conditions: normobaric hypoxia (NH), hypobaric hypoxia (HH) 
and normobaric normoxia (NN). Based on all of the preceding studies examining the 
differences among these hypoxic conditions, we hypothesized greater performance 
impairment in HH than in NH. Methods: The experimental design consisted of three 
sessions: NN (Sion, FiO2 20.93); NH (Sion, hypoxic room, FiO2 13.6%, PB 716 mm Hg); and 
HH (Jungfraujoch, FiO2 20.93, PB 481 mm Hg). The performance was evaluated at the end of 
each session with a cycle time-trial of 250 kilojoules. Results: The mean TT duration in NN 
was significantly shorter than under the two hypoxic conditions (P<0.001). In addition, the 
mean duration in NH was significantly shorter than in HH (P<0.01). The mean SpO2 during 
the TT was significantly lower for HH than for NH (P<0.05), and it was significantly higher 
in NN than for the two other sessions (P<0.001). Conclusion: As previously suggested, HH 
seems to be a more stressful stimulus, and NH and HH should not be used interchangeability 
when endurance performance is the main objective. The principal factor in this performance 
difference between hypoxic conditions seemed to be the lower peripheral oxygen saturation in 
HH at rest, as well as during exercise. Key words: normobaric hypoxia, hypobaric hypoxia, 
performance, exercise. 
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Introduction 
The use of altitude training is now very common among elite athletes, and several altitude-
training methods have been developed to optimize training in both endurance (30) and team 
sports (28). Recent research has focused on the potential differences between normobaric 
(NH) and hypobaric hypoxia (HH), i.e., simulated and terrestrial altitudes (13). Slight 
physiological differences between acute exposure to NH and HH have been reported (29, 39): 
minute ventilation was higher in NH than in HH, with a combination of a higher tidal volume 
and lower respiratory frequency (12). AMS symptoms have been shown to be less severe in 
NH than in HH (27), and pre-acclimatization at a ‘terrestrial’ altitude (HH) resulted in a 
significant decrease in the severity of AMS when traveling to HH conditions, while this 
change did not occur with NH pre-acclimatization (18). Differences in fluid balance have also 
been observed, with higher diuresis and a larger decrease in plasma volume for NH, while HH 
induced greater fluid retention (12, 27). The nitric oxide (NO) in exhaled air or in plasma and 
oxidative stress markers were also shown to be lower in NH than in HH (16). Taken together, 
these differences suggest larger physiological responses to hypoxic exposure in ‘terrestrial’ 
(HH) versus ‘simulated’ altitudes (NH) (35). These results suggest the hypothesis that the 
type of hypoxia (e.g., normobaric or hypobaric hypoxia) could influence performance at 
different altitudes, even with exposure durations or ambient oxygen pressures strictly matched 
between the two conditions.  
Currently, many athletes or teams playing different sports integrate altitude or hypoxic 
training into their programs to improve performance through several physiological 
adaptations. Moreover, hypoxia could be applied for many therapeutic uses in cardiovascular 
diseases or in obese populations. These uses suggest that hypoxia could be of prime 
importance to understanding better the extent to which NH and HH differ from each other. 
However, surprisingly, only one study to our knowledge compared endurance performance 
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after short exposure to HH versus NH (5). In this study, two different groups were exposed to 
either NH or HH and then performed a 720-kJ time trial (TT). Compared to sea level, the TT 
performance decreased by less (-36 ± 14%) in NH (simulated altitude of 4300 m) than in HH 
(-65 ± 24%); however, we cannot exclude the possibility that the hypoxia sensitivity might 
have been different between the two groups. Accordingly, we designed an experimental 
protocol to compare for the first time TT endurance performance in NH versus HH versus 
control (normobaric normoxia, NN) conditions with the same subjects and the same acute 
exposure durations. We tested the hypothesis that greater performance impairment would 
occur in HH than in NH, compared to NN. 
 Methods 
Subjects 
Sixteen trained male subjects volunteered for this study, but three of them did not finish all of 
the experiments. Therefore, thirteen trained males subjects were included in the analyses 
(mean ± SD; age 34.7 ± 9.5 years old, body weight 75.2 ± 7.2 kg, height 179.7 ± 5.7 cm, fat 
mass 13.2 ± 5.9%, peak oxygen consumption [VO2max] 60.2 ± 9.9 mL.kg-1.min-1 [range: 43-75 
mL.kg-1.min-1]. All of the subjects provided written, voluntary informed consent before 
participation. The subjects were all non-smokers and were neither acclimatized nor recently 
exposed to significant altitudes for at least the month before the beginning of the experiment. 
In addition, all of the subjects were born and lived at altitudes of less than 700 m. The 
experiment was conducted according to the Declaration of Helsinki, and the study was 
approved by the local Ethical Committee (Commission Cantonale Valaisanne d’Ethique 
Médicale, CCVEM; Agreement 051/09). 
Experimental Design 
The experimental design consisted of three testing sessions preceded by a preliminary visit. 
For this preliminary visit, the subjects came to the laboratory for baseline anthropological 
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measurements, including body composition analysis by air plethysmography (BodPod®, Life 
Measurement, Concord, CA, USA). They completed a consent form and preliminary 
questionnaires, and they performed: (a) a maximal incremental exercise test (FiO2: 20.93%; 
60 W + 30 W.min-1) on a magnetic braked cycle ergometer equipped with a power meter 
(Cycleops IC 400 Pro, Madison, WI, USA) for the determination of maximal aerobic power 
output and VO2max; and (b) a preliminary 250-kJ TT on the same cycle ergocycle.  
The study then consisted of three sessions separated by at least 12 days and a maximum of 20 
days in a randomized order. The subjects were asked to maintain their usual training and 
physical activities during the whole experimental protocol to avoid fitness changes between 
sessions. Two sessions were completed in a hypoxic chamber (ATS Altitude, Sydney, 
Australia) built in our laboratory at an altitude of 485 m (Sion, Switzerland), and a third 
session was performed at a terrestrial altitude. The hypoxic chamber is a well-ventilated 30 
cu. m room (2.4 × 5.0 × 2.5 m) with transparent glass panels. The system consists of a 
compressor storing air in pressurized tanks with serial connection to air filters, allowing for 
oxygen reduction in the air input flow to the chamber (altitude simulation by lowering the 
inspired fraction of O2, FiO2). The temperature inside the chamber was maintained constant at 
23°C on average using an internal air conditioning system. The NN session was performed in 
the hypoxic chamber with a FiO2 of 20.93%, a measured barometric pressure (PB) of 718.1 ± 
3.3 mm Hg, an inspired pressure of oxygen (PiO2) of 140.5 ± 0.6 mmHg, a temperature of 23 
± 1°C and a humidity of 42.8 ± 4.4%. The NH session, corresponding to a simulated altitude 
of 3450 m, was performed with a FiO2 of 13.6%, PB of 715.8 ± 3.8 mmHg, PiO2 of 91.0 ± 0.6 
mm Hg, a temperature of 22.7 ± 0.8°C and a humidity of 41.0 ± 4.8%. FiO2, PB and the 
temperature were measured regularly with an electronic oximeter (GOX 100 oximeter, 
Greisinger, Regenstauf, Germany) and a barometer (GPB 2300, Greisinger). 
For blinding, the system also ran normoxic airflow into the chamber during the NN sessions. 
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The HH session was performed at the Altitude Research Station, Jungfraujoch, Switzerland 
(3450 m, FiO2 of 20.93%, PB of 481.8 ± 4.7 mm Hg, PiO2 of 90.9 ± 1.0 mm Hg, temperature 
of 21.3 ± 0.6°C, humidity of 45.1 ± 8.3%). The progressive increase in altitude to access the 
Jungfraujoch by train during the HH sessions was simulated during the NH and NN sessions. 
For 45 min before entering the hypoxic chamber, the subjects breathed either room air (for 
NN) or hypoxic air (for NH) in a blinded fashion, using a mask connected to a three-way 
valve to an altitude simulation device (Altitrainer, SMTech, Nyon, Switzerland). The subjects 
remained in the hypoxic chamber during the whole protocol (including the sleeping period 
and for meals). Similar standardized meals were provided at the same time under each 
condition. The same nitrate- and nitrite-free meals and drinks, standardized for nutritional and 
caloric content, were provided to the subjects at H+0, H+7 and H+19 to control nitrate intake, 
which can influence oxidative stress levels (see (16) for further details) and performance. The 
subjects ate in the hypoxic chamber or in the kitchen of the HH laboratory. They were asked 
to use the restrooms before entering the hypoxic chamber and had a second opportunity to go 
after the night for a limited time (less than 2 minutes). The schedule and activities were 
exactly the same for all the conditions. The subjects completed the same diary, which was 
precisely controlled. They performed preliminary tests of respiration patterns, balance, and 
baroreflexes. The sleep hours and conditions were also controlled. The bedding was similar 
among conditions. In addition, the subjects were equipped with earplugs and eye masks 
during the night. The subjective sleep quality was assessed by a validated questionnaire 
(Groeningen questionnaire for sleep assessment (22)), and sleep scores for sleep quality and 
waking state were measured with two visual analogue scales.  
Sleep quality was not different between HH and NH (6.6 ± 3.5 vs. 6.5 ± 4.1 for NH vs. HH, 
respectively, in sleep score; 4.2 ± 1.8 vs. 4.4 ± 2.4 for NH and HH, respectively, in sleep 
quality; 4.9 ± 2.1 vs. 5.0 ± 2.4 for NH vs. HH, respectively, for waking state). 
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The sessions consisted of 26 h of exposure to each condition (NN, NH, HH) in a randomized 
order. Of interest was that a double-blinded protocol was applied between the NN and NH 
conditions so that neither the subjects nor the experimenters in the hypoxic chamber were 
informed of the FiO2. In each session, the subjects completed the Lake Louise questionnaire 
(LL) after 10 and 20 h of exposure to assess acute mountain sickness (AMS). The perceived 
altitude was asked after 20 (H+20) and 26 h (H+26). Blood samples were obtained before and 
at H+20 during each session. Pulse oxygen saturation (SpO2) was recorded continuously with 
a finger pulse oximeter (WristOx2™, Model 3150, Nonin Medical, Inc., Plymouth, MN, 
USA). A 250-kJ TT was performed after 24 h of exposure using the same cycle ergometer as 
in the preliminary session. The TT was preceded by a resting period of 5 min, followed by a 
3-min warm-up at 70 W. The subjects were then instructed to complete the 250 kJ as rapidly 
as possible, and they were free to increase/decrease the resistance to adjust the workload as 
they became familiar with it in the preliminary session. The only visual feedback available for 
the subjects during the TT was the work performed (from 0 to 250 kJ). The time trial was 
performed at the same time (i.e., between 1 p.m. and 2 p.m.) of the day in each condition. 
Measurements 
 Gas exchange, heart rate, SpO2 and perceptual feeling. Ventilation and pulmonary gas 
exchange were measured breath by breath at rest and during TT using a portable gas analyzer 
(MetaMax 3B, Cortex, Leipzig, Germany) with an oronasal mask (Vmask™, 7500 series; 
Hans Rudolph Inc., Shawnee, KS, USA; dead space, 41 mL). This device measures volume 
using a bidirectional digital turbine. Oxygen uptake and carbon dioxide production are then 
determined in inspired and expired air successively by an electrochemical cell and an infrared 
analyzer, respectively, from the air drawn through a Nafion® sampling tube attached to the 
turbine at the output of the mask. The heart rate and pulse oxygen saturation were 
continuously recorded during the TT by an additional device, which was the same as that used 
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for the continuous 26 h recording presented previously (Radical-7®, Masimo Corporation, 
Irvine, CA, USA) and were stored for offline analyses with commercially available software 
(Labchart software, AD Instrument, Colorado Springs, CO, USA). At the end of the TT, the 
subjects were asked to quantify their leg and respiratory discomfort using a visual analogue 
scale (VAS, 1-10), as well as the rate of perceived exertion (RPE, Borg Scale, 6-20). 
Blood lactate. Blood lactate concentration (La) was measured at rest before exercise and 
immediately after exercise from a capillary finger blood sample (LactatePro, Arkay SAS, 
Paris, France). 
Venous blood sample. Antecubital vein blood samples (4.9 mL EDTA tube, Sarstedt, 
Nümbrecht, Germany) were obtained before (baseline, bl) each session and at H+20. The 
blood was subsequently analyzed via fluorescent flow cytometry and hydrodynamic focusing 
(XT-2000i, Sysmex Europe, Norderstedt, Germany), and the following primary hematological 
parameters were quantified: red blood cells (RBCs), hemoglobin (Hb), hematocrit (Htc), and 
reticulocyte percentage (RET%). The Sysmex XT-2000i underwent regular internal quality 
control procedures as required by the standards of laboratory medicine. During the period of 
our study, the coefficients of variations (CVs), which were determined using internal quality 
controls, were far less than 1.5% for Hb and 15% for RET% (within CV limits accepted by 
the manufacturer of the instrument). Changes in the plasma volume (∆PV in %) between the 
bl and H+20 were calculated using the Dill and Costill equation (14) as follows: 
∆!" % =  100× !"!"!"!!!" × 100− !"#!!!"100− !"#!" − 1 , 
where Htc is in %, and Hb is in g/dL. 
Power, workload and cadence. The power output, total workload and cadence were 
continuously recorded at 1 Hz during the TT by the cycle ergometer (Cycleops IC 400 Pro, 
Madison, WI, USA). 
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Electromyographic recordings. Electromyographic signals (EMG) of the right vastus 
lateralis (VL) were recorded using bipolar silver chloride surface electrodes 10 mm in 
diameter (Kendall Meditrace 100) during the whole exercise. The recording electrodes were 
taped lengthwise on the skin over the muscle of the belly following SENIAM 
recommendations, with an inter-electrode distance of 20 mm. The position of the electrodes 
was marked on the skin so that they could be fixed at the same place for the two other 
sessions. The reference electrode was attached to the patella. Low impedance (<5 kΩ) at the 
skin electrode was obtained by shaving and abrading the skin with an abrasive sponge and 
cleaning it with alcohol. EMG data were recorded with a Biopac system (MP150, Biopac 
System, Goleta, CA, USA) and were amplified (gain=1000) with a bandwidth frequency 
ranging from 10 to 500 Hz, digitized at a sampling frequency of 2 kHz, and recorded by the 
AD conversion system (common mode rejection ratio: 90 dB; input impedance: 100 MΩ; 
gain: 1000). For data analysis, the integral of the whole EMG activity was calculated using 
the following formula: 
 !"#$ ! ! =  !(!)  !"!! , 
where m is the raw EMG signal. For each condition and each subject, the iEMG value during 
TT was normalized to the total duration time of exercise (in s) to obtain an activation ratio per 
time unit during the time trial.  
Data analysis and Statistics. Data are reported as the mean ± standard deviation in the text, 
tables and figures. The data were tested for homogeneity of variances (Levene’s test) and for 
normality (Shapiro-Wilk test). One-way ANOVA with repeated measures and Tukey’s post-
hoc tests were used to identify differences among conditions (NN, NH, HH) in the mean 
values for each parameter during the resting period and during the TT. Two-way ANOVA 
was performed on repeated measures for each condition to determine the time effect for 
variables measured on several occasions during the sessions with pairwise multiple 
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comparison procedures (Holm-Sidak method). The correlations between SpO2 and TT 
performances were calculated with Pearson’s product moment correlation. The null 
hypothesis was rejected at P<0.05. All of the analyses were performed using Sigmaplot 
software, version 11.0 (Systat Software, San Jose, CA, USA).  
Results 
Acute mountain sickness and perceived altitudes. No AMS symptoms were observed after 
10 h of exposure, and the LL scores were not different between conditions (1.2 ± 0.9, 1.5 ± 
2.2 and 2.1 ± 2.1 for NN, NH and HH, respectively; P=0.391, ns). After 20 h of exposure, we 
reported a positive LL score (i.e., > 3) only for HH but without any significant difference for 
the other conditions (1.6 ± 1.3, 2.3 ± 2.8 and 3.1 ± 2.6 for NN, NH and HH, respectively; 
P=0.229, ns). The perceived altitude immediately before the TT (H+20) was not different 
between NN and NH (1138 ± 922 and 1864 ± 1017 m, for NN and NH, respectively; P=0.09, 
ns). After the TT (H+26), the perceived altitude was higher for NH and HH than for NN 
(2752 ± 870 and 3493 ± 27 vs. 1005 ± 702 m, for NH, HH and NN, respectively, P<0.001). 
Resting values. The SpO2 at rest was lower in the two hypoxic conditions than in NN 
(P<0.001). In addition, SpO2 was lower in HH than in NH (P<0.01). The heart rate was higher 
in the two hypoxic conditions (P<0.001), as was the PETO2 (P<0.001), with no difference 
between HH and NH. The PETCO2 was lower in NH than in the other conditions (P<0.001 and 
P<0.01 compared to NN and HH, respectively). All of the resting values are presented in 
Table 1. 
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Table 1 Mean cardiorespiratory and metabolic values while subjects were resting on the 
ergocycle before the time trial, after 24 h in normobaric normoxia (NN), normobaric hypoxia 
(NH) and hypobaric hypoxia (HH). 
 
 
 
 
 
 
 
 
 
SpO2 pulse oxygen saturation; HR heart rate; !E minute ventilation (BTPS); VT tidal volume; f breathing 
frequency; PETO2 end-tidal O2 pressure; PETCO2 end-tidal CO2 pressure; !O2 oxygen uptake; !CO2 carbon 
dioxide produced. Data are mean ± SD; *P<0.05 and ***P<0.001 for differences with NN; ##P<0.01 for 
differences between HH and NH. 
  
 NN NH HH 
Lactate [mmol. L-1] 2.53 ± 0.65 2.35 ± 0.71 2.7 ± 1.01 
SpO2 [%] 98 ± 1 92 ± 2*** 90 ± 2***## 
HR [bpm] 69 ± 11 77 ± 12*** 81 ± 8*** !E [L.min-1] 12.7 ± 4.1 15.7 ± 5.2* 14.1 ± 2.8 
VT [L.min-1] 1.1 ± 0.3 1.2 ± 0.3 1.2 ± 0.3 
f [L.min-1] 12.8 ± 3.3 13.6 ± 3.1 13.1 ± 3.3 
PETO2 [mm Hg] 99.9 ± 13.5 70.1 ± 17.8*** 58.2 ± 3.2*** 
PETCO2 [mm Hg] 30.6 ± 3.3 26.8 ± 2.9*** 30.0 ± 2.5## !O2 [L.min-1] 0.37 ± 0.09 0.41 ± 0.1 0.39 ± 0.06 !CO2 [L.min-1] 0.31 ± 0.12 0.34 ± 0.11 0.35 ± 0.05 
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Blood sample. Differences between the baseline and H+20 were observed in most of the 
blood parameters for both hypoxic sessions. Plasma volume also decreased to a greater extent 
for NH and HH than for NN, but this decrease was not different among the hypoxic 
conditions. All of the values are presented in Table 2. 
Time trial performance. Performance time in seconds is presented in Figure 1. Compared to 
NN (i.e., 1041 ± 151 s), the mean time was 24.1 ± 9.6% and 33.2 ± 12.4% higher for NH and 
HH, respectively (with both P<0.001). The mean time was 7.5 ± 7.5% higher in HH than in 
NH (P<0.01). 
 
Figure 1. Mean time trial performance in normobaric normoxia (NN), normobaric hypoxia (NH) and hypobaric 
hypoxia (HH). Data, expressed in seconds (s) are mean ± standard errors. **P<0.01 and ***P<0.001 for 
differences between conditions. 
Pulse oxygen saturation. Mean SpO2 during the TT was significantly higher in NH than in 
HH (79.2 ± 3.4 vs. 75.9 ± 5.9%; P<0.05; Figure 2). As expected, SpO2 was higher in NN 
(95.3 ± 3.0%) than in the two hypoxic conditions (both P<0.001). 
NN
***
***
**
NH HH
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Figure 2. Mean pulse oxygen saturation (SpO2) during the time trial in normobaric normoxia (NN), normobaric 
hypoxia (NH) and hypobaric hypoxia (HH). Data are mean ± standard errors. *P<0.05 and ***P<0.001 for 
differences between conditions. 
Cadence. The mean cadence during exercise was lower in HH than in NH (88.4 ± 6.2 vs. 92.5 
± 8.7 rpm; P<0.01) and NN (94.7 ± 6.8 rpm; P<0.001). 
Electromyographic activity. The iEMG/time activity was higher in NN than in the two 
hypoxic conditions (NN>NH, P<0.05 and NN>HH, P<0.001), and it was higher for NH than 
for HH (P<0.05). The values are presented in Table 3. 
Correlations. Negative correlations were observed between VO2max and the performance 
times in NN (r=-0.56, P=0.06), NH (r=-0.67; P<0.05) and HH (r=-0.58; P<0.05). However, 
we did not find any correlation between VO2max and the change in performance among 
conditions. A positive correlation was found between the NN SpO2 and the TT time (in 
seconds) in NN (r=0.65; P<0.05), NH (r=0.59; P<0.05) and HH (r=0.56; P<0.05). No 
correlations were found between the NH or HH SpO2 and performance or between the 
changes in SpO2 (from NN to NH, from NN to HH or from NH to HH) and the change in 
performance (NN-NH, NN-HH or NH-HH in %).  
NN NH HH
***
***
*
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However, correlations were observed between performance time (in seconds) under all 
conditions: between NN and NH (r=0.83; P=0.001), between NN and HH (r=0.80; P=0.002) 
and between NH and HH (r=0.87; P<0.001). In addition, positive correlations were found 
between the changes in performance time from NN to NH (NN-NH) and from NN to HH 
(NN-HH) (r=0.64; P=0.03), as well as between the changes from NN to HH (NN-HH) and 
from NH to HH (NH-HH) (r=0.59; P=0.04) but not between NN-NH and NH-HH (r=-0.24; 
P=0.46) (Figure 3). 
 
Figure 2. Correlations between the increase (in %) in time to perform the 250 kJ time trial (TT) from 
normobaric normoxia (NN) to hypobaric hypoxia (HH) with the increases (%) in time to perform the 250 kJ TT 
either from NN to normobaric hypoxia (NH) or from NH to HH.  
 
Other physiological and subjective feelings parameters. All parameters measured during the 
time trial are presented in Table 3. The subjective criteria of exhaustion (Borg scale) and 
perceived exertion were similar among the three conditions. Significant differences in 
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ventilatory parameters were observed between NN and the two hypoxic conditions (P<0.05 to 
P<0.001, see Table 3) but with no difference between NH and HH. 
  
T
able 2 M
ean hem
atologic values m
easured before the sessions (bl) and after 20 h (H
+20) in norm
obaric norm
oxia (N
N
), norm
obaric hypoxia 
(N
H
) and hypobaric hypoxia (H
H
). 
        R
B
C
 red blood cells; R
ET reticulocytes; H
tc haem
atocrit; H
b haem
oglobin; EPO
 erythropoietin; ∆ PV
 delta plasm
a volum
e betw
een H
+20 and bl; bl baseline 
values; H
+
20 values after 20 hours of exposition. D
ata are m
ean ± SD
; *P<0.05 and
 ***P<0.001 for differences w
ith N
N
; #P<0.01 for differences w
ith N
H
; 
$P<0.05 and $$$P<0.001 for differences w
ith baseline. 
 
N
N
 
N
H
 
H
H
 
 
bl 
H
+20 
bl 
H
+20 
bl 
H
+20 
R
B
C
 [u.µl -1] 
4.98 ± 0.35 
4.98 ± 0.28 
4.88 ± 0.36 
5.09 ± 0.39
$ 
5.02 ± 0.36 
5.33 ± 0.30
*#$ 
R
E
T
 [%
] 
1.02 ± 0.24 
1.05 ± 0.19 
1.01 ± 0.39 
0.97 ± 0.23 
1.07 ± 0.29 
1.02 ± 0.30 
H
tc [%
] 
43.90 ± 2.54 
43.64 ± 1.93 
43.28 ± 3.24 
44.56 ± 3.27
$ 
44.30 ± 2.76 
46.02 ± 2.00
*#$ 
H
b [g.dl -1] 
15.16 ± 0.99 
15.22 ± 0.88 
14.95 ± 1.20 
15.57 ± 1.27 
15.33 ± 1.05
$ 
16.23 ± 0.67
*#$ 
E
PO
 [m
U
.m
l -1] 
3.52 ± 2.25 
4.46 ± 1.92 
3.74 ± 2.10 
9.24 ± 3.69
***$$$ 
3.66 ± 2.25 
9.44 ± 3.63
***$$$ 
Ferritin [ng.m
L
-1] 
181.7 ± 111.6 
175.9 ± 134.8 
251.1 ± 148.4 
199.1 ± 136.4
$ 
206.1 ± 154.1 
171.5 ± 116.5
$ 
∆ PV
 [%
] 
- 
-2.9 ± 5.6 
- 
-8.8 ± 7.5
* 
- 
-8.8 ± 5.3
* 
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Table 3 Mean cardiorespiratory, and electromyographic responses during the time trial and 
metabolic and perceptual responses at the end of exercise in normobaric normoxia (NN), 
normobaric hypoxia (NH) and hypobaric hypoxia (HH). 
 
 
 
 
 
 
 
 
 
 
 
 
 
HR heart rate; !!  minute ventilation; VT tidal volume; f breathing frequency; PETO2 end-tidal O2 pressure; 
PETCO2 end-tidal CO2 pressure; !O!  relative oxygen uptake; ! CO2 relative carbon dioxide produced; 
iEMG/time integrated electromyography per total time for the vastus lateralis (VL); RPE rate of perceived 
exertion; VAS visual analogue scale. Data are mean ± SD; *P<0.05; **P<0.01 and ***P<0.001 for differences 
with NN. #P<0.05 for differences with NH. 
  
 NN NH HH 
HR [bpm] 161 ± 8 163 ± 7 163 ± 7 !E [L.min-1] 115.1 ± 30.7 121.3 ± 25.7 120.1 ± 24.1 
VT [L.min-1] 2.87 ± 0.32 2.97 ± 0.35 2.90 ± 0.40 
f [1.min-1] 40.0 ± 10.6 41.1 ± 8.8 42.6 ± 11.2 
PETO2 [mmHg] 101.5 ± 12.6 73.6 ± 16.1*** 64.7 ± 4.0*** 
PETCO2 [mmHg] 31.6 ± 3.7 25.9 ± 4.2*** 27.4 ± 4.0** !O2 [L.min-1] 3.5 ± 0.7 3.1 ± 0.4*** 2.9 ± 0.2* !CO2 [L.min-1] 3.3 ± 0.6 2.9 ± 0.4** 3.1 ± 0.4 !E/!O2  32.1 ± 7.3 37.8 ± 5.6* 40.4 ± 7.0*** !E/!CO2 33.1 ± 3.8 41.1 ± 6.4*** 37.8 ± 6.0** 
iEMG/time VL  0.048 ± 0.01 0.040 ± 0.01** 0.032 ± 0.0***## 
End Lactate [mmol. L-1] 13.3 ± 2.9 10.6 ± 3.0* 10.4 ± 2.3** 
Final RPE [6-20] 18 ± 2 19 ± 1 19 ± 1 
Final VAS legs [1-10] 8.3 ± 1.6 8.5 ± 2.4 8.2 ± 2.6 
Final VAS breath [1-10] 8.7 ± 1.4 9.5 ± 1.2 9.3 ± 1.5 
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Discussion 
The major finding of the present study was that the TT performance decrease from normoxia 
to hypoxia was 8% greater in HH than in NH for a terrestrial/simulated altitude of 3450 m. A 
lower SpO2 value was also observed in HH than in NH. However, there were no relationships 
between the decrease in saturation and the change in performance from normoxia to either 
normobaric or hypobaric hypoxia. 
Several authors have already compared the performance between NN and either NH or HH. 
Whereas some have compared them separately (9, 25), only one study (5) has compared 
performance in normobaric versus hypobaric hypoxic conditions, but the study was neither a 
direct comparison of the same subjects nor of the same protocol. The large inter-individual 
differences in hypoxia sensitivity might weaken such protocols when a decrease in 
performance has been observed even at very low altitudes, such as 580 m above sea level 
(20). This decrease was reported to be between 10% and 20% at 3000 m (10% (23); 18% 
(17); 20% (44)) in NH versus 10% at 2100 m in HH (9). At higher altitudes, the performance 
decrease was approximately 30% (6) in NH versus 40% in HH (41% (19); 44% (37)).  
Performance impairment with altitude. Based on several studies conducted at various 
altitudes, the main mechanism for endurance performance impairment in hypoxia might be 
the decrease in VO2max with a mean decrease of 7.7% per 1000 m increase in altitude (-4% at 
1000 m (8, 31, 46); -7.2% per 1000 m from 200 to 3200 m (11); -10% (31) to -15% (33, 46) 
at 2500 m; or -30% (31) at 4500 m, all in NH). All of these studies demonstrated that the 
reduced maximal oxygen uptake was induced by a decrease in arterial oxyhemoglobin 
saturation, leading to aerobic performance impairment. Obviously, the maximal oxygen 
uptake was strongly linked to SpO2 levels also tainted by altitude (7, 29). Indeed, in the 
present study, SpO2 was lower in the two hypoxic conditions compared to NN during both the 
resting period and the TT. The VO2 was also lower in hypoxia but only during exercise, while 
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the minute ventilation did not differ between normoxia and hypoxia during exercise. These 
equivalent ventilation values could be explained by the high intensity of the trial, which was 
not the case in the study by Faiss et al. (16), for instance, in which submaximal exercise was 
considered so that differences in ventilation between normoxia and hypoxic conditions were 
found.  
Physiological mechanisms. The acute (at H+20) changes in hematologic parameters (i.e., red 
blood cells, hematocrit and hemoglobin) were greater in HH than in NH. However, the well-
known altitude-induced effect of hemoconcentration (21) was similar between the two 
conditions. Taken together, these latter results were likely of negligible importance to the 
difference in performance reported between NH and HH. However, the resting PETCO2 was 
lower for NH than for HH, as previously described (16, 26, 27), while the SpO2 was higher in 
NH than in HH. The PETCO2 has been described by Reeves et al. (36) as ‘a good indicator of 
acclimatization’. The ventilatory acclimatization is a key component of altitude 
acclimatization and is characterized by an increased hypoxic ventilatory response, resulting in 
a decreased PETCO2 associated with an increased SaO2 (18), in accordance with our results. 
Altogether, these results suggested that NH is a less demanding condition than HH or that 
ventilatory acclimatization might occur more rapidly during acute exposure (~24 h) in NH. 
However, these slight ventilatory differences observed at rest were no longer observed during 
the TT. These results were in agreement with those of previous studies that reported similar 
cardiac responses to both conditions, either at rest or during exercise (5, 39). In contrast, some 
studies have emphasized an influence of hypoxia type on heart rate (15, 16, 41, 42). These 
data confirmed that NH and HH cannot be used interchangeably, but their impact on cardiac 
responses remains up for debate. The cardiac response is influenced by several factors, such 
as exercise duration, exposure time and SpO2, and these influences are independent of each 
factor. In addition, these responses are very individual, and personal monitoring of heart rate 
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is needed to adjust other training and recovery parameters in hypoxia, whether in NH or HH 
(13, 15). 
Performance in NH versus HH. A greater decrease in endurance performance was noted for 
the first time in HH compared to NH by direct comparison with the same subjects. Because 
the mean heart rate and the plasma volume were not different between hypoxic conditions, 
one might speculate that the performance difference observed in the present study, therefore, 
should not be attributed to differences in cardiac output. However, a higher SpO2 was found in 
NH than in HH, unlike in some reported studies (5, 16, 26) but in agreement with others (40-
42). These values have been observed mainly at rest, and only a few recent studies have 
reported exercise measurements. Thus, the observed higher pulse oxygen saturation in the 
present study seemed to be one of the main causes of better TT performance in NH than in 
HH because it is well known that the ability to defend SaO2 is strongly linked to the ability to 
maintain performance in aerobic activities at altitudes (7). However, this was not the case for 
the SpO2 in NH and HH. In addition, we did not find any relationship between the delta SpO2 
and the delta performance in any of the conditions. Thus, unlike what Chapman et al. (7) 
demonstrated, the two hypoxic conditions did not have a greater impact on the most 
hypoxemic subjects. Nevertheless, it has been reported that hypocapnea can decrease cerebral 
blood flow and thus cerebral oxygenation (43) and therefore limit aerobic performance, 
especially when SaO2 decreases to less than 82% (1). The fluid circulation and trans-alveolar 
capillary membrane diffusion differences already cited before (12, 27) could explain the SpO2 
difference between the two hypoxic conditions (24). The barometric pressure might modify 
the fluid circulation and the trans-alveoli-capillary membrane flux, which might in turn 
induce greater pulmonary vasoconstriction in HH and then modify the oxygen diffusion by 
decreasing the pressure gradient between the alveoli and capillaries. In addition, the 
exaggerated oxidative stress reported in HH might affect NO bioavailability, which could 
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impair oxygen unloading to tissues (16). Because our SaO2 values were lower than the 
aforementioned threshold, one cannot exclude the possibility that a greater degree of 
hypocapnea was an additional mechanism of the greater performance impairment in HH.  
The differences in TT performance between the normoxic and the hypoxic conditions were 
not correlated with the VO2max measured in NN. Previous studies have reported that elite 
subjects experienced a greater decrease in VO2max in altitude than their lower level 
counterparts (23, 32). Despite these findings, we did not measure VO2max in altitude but TT 
performance, so our results did not support these findings, and none of our subjects was elite. 
Our results suggested that NH and HH would induce different performance responses across 
all athletic subjects. 
More interesting is that there was a strong correlation between changes in TT performance 
from NN to NH and from NN to HH, suggesting that the sensitivity to hypoxia determined by 
chemosensitivity (38), the ventilatory response (34) or cerebral deoxygenation (6) would be a 
stronger influence than the type of hypoxia per se. In other words, it is likely that being a 
good or a bad responder to altitude would remain similar independent of exposure to NH or 
HH. This concept developed by Chapman et al. (7, 10) supported that there are good and bad 
responders to hypoxic stimuli. However, the type of hypoxia did not seem to influence this 
categorization. This latter point is of great practical importance and indicates that the 
conclusions of the numerous studies that have examined performance outcomes in hypoxia 
using NH would likely still have value in HH. However, our results also showed that the 
severity of the hypoxic stimulus was higher in HH than in NH, and this point must be 
accounted for when considering the hypoxic dose or when estimating exercise intensities, 
velocities or power output for HH conditions (e.g., competition in terrestrial altitude) on the 
basis of NH data. 
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Muscle activity. Hypoxia per se is known to modify muscle activity during a 5-km cycling TT 
by decreasing the neural drive, as shown by the greater iEMG activity decrease in hypoxia 
than in normoxia (2). However, there was a large difference between studies in the 
modification of iEMG signals in normoxia or hypoxia (3), which might arise from the 
variability in the hypoxic stimulus, i.e., acute, chronic or severe hypobaric or normobaric 
hypoxia (45). Thus, both the hypoxic stimulus and the exercise intensity seemed to have 
impacts on muscle activity. The present study was in agreement with these statements because 
we found a lower mean iEMG per time in the vastus lateralis during the TT in HH compared 
to both NN and NH. Cerebral perturbations during exercise in hypoxia have been shown to 
affect motor output and performance deeply (45). Further analyses of cerebral blood flow and 
cerebral and muscle oxygenation during such the TT are recommended to understand better 
how much distinct central nervous system adaptations in NH and HH might explain part of 
the larger performance decrease in the latter.  
Subjective feelings. Hypoxia is known to exacerbate the rate of peripheral fatigue 
development and to increase sensations of difficulty in breathing and limb discomfort during 
endurance exercise (3). However, in the present study, at the end of the TT, the perceived 
effort scores, both for the legs and for breathing discomfort, were close to the maximum and 
were not different among conditions. These results support that the exercise was conducted up 
to near exhaustion under all of the conditions and that the differences observed were not 
induced by motivational factors.  
This study was conducted with double blinding for the sessions (NN and NH) performed in 
the hypoxic chamber, and the blinding was effective because we did not find any differences 
between the perceived altitude of NH and NN immediately before the TT (H+20). However, 
for obvious practical reasons, blinding was not possible in the HH session. Therefore, one 
cannot exclude a placebo-nocebo effect on performance. Nevertheless, the 8% difference in 
 -140- 
performance between the two hypoxic conditions was greater than the 1 to 5% significant 
placebo effect attributed to this kind of effort (4). 
Perspectives 
The present study confirmed that NH and HH did not have equivalent impacts on endurance 
performance. This result does not question all of the preceding altitude studies conducted only 
in NH, but it suggests that the results observed would have been more significant had these 
been conducted in HH. It is true that hypoxic chambers and the use of simulated altitude 
allow for much greater flexibility and more adjustment possibilities than terrestrial altitude. 
For athletes and coaches preparing for altitude competitions with NH, it is thus important to 
benefit from this flexibility and convenience. However, we believe that training intensities or 
saturation levels should be adjusted when transferred from one type of hypoxia (e.g., testing 
in NH) to another (e.g., competing in HH). These statements would help coaches and sport 
physiologists make more accurate recommendations for training intensities or durations at 
various altitude levels and types. 
Limitation 
Although our conclusions could, theoretically, be extended to all athletes, the present 
population remains recreational and does not include elite athletes. Additional studies are 
needed to confirm how much elite endurance performance may or may not be more affected 
in HH compared to NH conditions. Moreover, the performance could be influenced by the 
pacing strategy and, for logistical reasons, it was impossible to blind all the conditions (i.e., 
subjects and experimenters knew when they were in HH at the top of Jungfraujoch). 
Therefore, one cannot rule out that slight environmental differences (e.g., during sleep or 
exercise) might have influenced to a small extent the behavior of the subjects. 
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Conclusion.  
This study showed greater performance impairment during a cycle time trial in hypobaric 
conditions, compared to normobaric hypoxia. As previously suggested, HH seemed to be a 
more stressful stimulus, and NH and HH were not interchangeable with endurance 
performance as the main objective. The main factor of this performance difference between 
hypoxic conditions seemed to be the lower arterial oxygen saturation in HH at rest, as well as 
during exercise. Further research is needed to better understand the physiological mechanisms 
responsible for these differences and for their impacts on muscle and brain function and 
pacing strategies. 
 
Acknowledgements 
This study was funded by grants from Bundes Amt für Sport (BASPO; Switzerland). The 
authors thank Prof. Olivier Dériaz and the staff at the Clinique romande de réadaptation (Sion, 
Switzerland) as well as Claudine Frieden and the custodians from the High Alpine Research 
Station of Jungfraujoch (Jungfraujoch, Switzerland) for their invaluable assistance and access 
to facilities. The authors have no conflict of interest, source of funding or financial ties to 
disclose and no current or past relationship with companies or manufacturers who could 
benefit from the results of the present study. The results of the present study do not constitute 
endorsement by the American College of Sports Medicine. 
  
 -142- 
Bibliography 
 
1. Amann M, Calbet JA. Convective oxygen transport and fatigue. Journal of applied 
physiology. 2008;104(3):861-70. 
2. Amann M, Eldridge MW, Lovering AT, Stickland MK, Pegelow DF, Dempsey JA. 
Arterial oxygenation influences central motor output and exercise performance via 
effects on peripheral locomotor muscle fatigue in humans. The Journal of physiology. 
2006;575(Pt 3):937-52. 
3. Amann M, Romer LM, Pegelow DF, Jacques AJ, Hess CJ, Dempsey JA. Effects of 
arterial oxygen content on peripheral locomotor muscle fatigue. Journal of applied 
physiology. 2006;101(1):119-27. 
4. Beedie CJ, Foad AJ. The placebo effect in sports performance: a brief review. Sports 
medicine. 2009;39(4):313-29. 
5. Beidleman BA, Fulco CS, Staab JE, Andrew SP, Muza SR. Cycling performance 
decrement is greater in hypobaric versus normobaric hypoxia. Extreme physiology & 
medicine. 2014;3:8. 
6. Bourdillon N, Fan JL, Kayser B. Cerebral oxygenation during the Richalet hypoxia 
sensitivity test and cycling time-trial performance in severe hypoxia. European 
journal of applied physiology. 2014;114(5):1037-48. 
7. Chapman RF. The individual response to training and competition at altitude. British 
journal of sports medicine. 2013;47 Suppl 1:i40-4. 
8. Chapman RF, Emery M, Stager JM. Degree of arterial desaturation in normoxia 
influences VO2max decline in mild hypoxia. Medicine and science in sports and 
exercise. 1999;31(5):658-63. 
9. Chapman RF, Stager JM, Tanner DA, Stray-Gundersen J, Levine BD. Impairment of 
3000-m run time at altitude is influenced by arterial oxyhemoglobin saturation. 
Medicine and science in sports and exercise. 2011;43(9):1649-56. 
10. Chapman RF, Stray-Gundersen J, Levine BD. Individual variation in response to 
altitude training. Journal of applied physiology. 1998;85(4):1448-56. 
11. Clark SA, Bourdon PC, Schmidt W et al. The effect of acute simulated moderate 
altitude on power, performance and pacing strategies in well-trained cyclists. 
European journal of applied physiology. 2007;102(1):45-55. 
12. Conkin J, Wessel JH, 3rd. Critique of the equivalent air altitude model. Aviation, 
space, and environmental medicine. 2008;79(10):975-82. 
 -143- 
13. Coppel J, Hennis P, Gilbert-Kawai E, Grocott MP. The physiological effects of 
hypobaric hypoxia versus normobaric hypoxia: a systematic review of crossover trials. 
Extreme physiology & medicine. 2015;4:2. 
14. Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, 
and red cells in dehydration. J Appl Physiol. 1974;37(2):247-8. 
15. DiPasquale DM, Strangman GE, Harris NS, Muza SR. Acute Mountain Sickness, 
Hypoxia, Hypobaria and Exercise Duration each Affect Heart Rate. International 
journal of sports medicine. 2015;36(8):609-14. 
16. Faiss R, Pialoux V, Sartori C, Faes C, Deriaz O, Millet GP. Ventilation, oxidative 
stress, and nitric oxide in hypobaric versus normobaric hypoxia. Medicine and science 
in sports and exercise. 2013;45(2):253-60. 
17. Faiss R, von Orelli C, Deriaz O, Millet GP. Responses to Exercise in Normobaric 
Hypoxia: Comparison Between Elite and Recreational Ski-Mountaineers. 
International journal of sports physiology and performance. 2014;9(6):978-84. 
18. Fulco CS, Beidleman BA, Muza SR. Effectiveness of preacclimatization strategies for 
high-altitude exposure. Exercise and sport sciences reviews. 2013;41(1):55-63. 
19. Fulco CS, Muza SR, Beidleman BA et al. Effect of repeated normobaric hypoxia 
exposures during sleep on acute mountain sickness, exercise performance, and sleep 
during exposure to terrestrial altitude. American journal of physiology. Regulatory, 
integrative and comparative physiology. 2011;300(2):R428-36. 
20. Fulco CS, Rock PB, Cymerman A. Maximal and submaximal exercise performance at 
altitude. Aviation, space, and environmental medicine. 1998;69(8):793-801. 
21. Grover RF, Weil JV, Reeves JT. Cardiovascular adaptation to exercise at high altitude. 
Exercise and sport sciences reviews. 1986;14:269-302. 
22. Jafarian S, Gorouhi F, Taghva A, Lotfi J. High-altitude sleep disturbance: results of 
the Groningen Sleep Quality Questionnaire survey. Sleep Med. 2008;9(4):446-9. 
23. Lawler J, Powers SK, Thompson D. Linear relationship between VO2max and 
VO2max decrement during exposure to acute hypoxia. Journal of applied physiology. 
1988;64(4):1486-92. 
24. Levine BD, Kubo K, Kobayashi T, Fukushima M, Shibamoto T, Ueda G. Role of 
barometric pressure in pulmonary fluid balance and oxygen transport. Journal of 
applied physiology. 1988;64(1):419-28. 
25. Levine BD, Stray-Gundersen J, Mehta RD. Effect of altitude on football performance. 
Scandinavian journal of medicine & science in sports. 2008;18 Suppl 1:76-84. 
 -144- 
26. Loeppky JA, Icenogle M, Scotto P, Robergs R, Hinghofer-Szalkay H, Roach RC. 
Ventilation during simulated altitude, normobaric hypoxia and normoxic hypobaria. 
Respiration physiology. 1997;107(3):231-9. 
27. Loeppky JA, Roach RC, Maes D et al. Role of hypobaria in fluid balance response to 
hypoxia. High altitude medicine & biology. 2005;6(1):60-71. 
28. Millet GP, Faiss R, Brocherie F, Girard O. Hypoxic training and team sports: a 
challenge to traditional methods? British journal of sports medicine. 2013;47 Suppl 
1:i6-7. 
29. Millet GP, Faiss R, Pialoux V. Point: Hypobaric hypoxia induces different 
physiological responses from normobaric hypoxia. Journal of applied physiology. 
2012;112(10):1783-4. 
30. Millet GP, Roels B, Schmitt L, Woorons X, Richalet JP. Combining hypoxic methods 
for peak performance. Sports medicine. 2010;40(1):1-25. 
31. Mollard P, Woorons X, Letournel M et al. Role of maximal heart rate and arterial O2 
saturation on the decrement of VO2max in moderate acute hypoxia in trained and 
untrained men. International journal of sports medicine. 2007;28(3):186-92. 
32. Mollard P, Woorons X, Letournel M et al. Determinant factors of the decrease in 
aerobic performance in moderate acute hypoxia in women endurance athletes. 
Respiratory physiology & neurobiology. 2007;159(2):178-86. 
33. Peltonen JE, Tikkanen HO, Ritola JJ, Ahotupa M, Rusko HK. Oxygen uptake 
response during maximal cycling in hyperoxia, normoxia and hypoxia. Aviation, 
space, and environmental medicine. 2001;72(10):904-11. 
34. Poulin MJ, Robbins PA. Influence of cerebral blood flow on the ventilatory response 
to hypoxia in humans. Exp Physiol. 1998;83(1):95-106. 
35. Rasmussen P, Siebenmann C, Diaz V, Lundby C. Red cell volume expansion at 
altitude: a meta-analysis and Monte Carlo simulation. Medicine and science in sports 
and exercise. 2013;45(9):1767-72. 
36. Reeves JT, McCullough RE, Moore LG, Cymerman A, Weil JV. Sea-level PCO2 
relates to ventilatory acclimatization at 4,300 m. Journal of applied physiology. 
1993;75(3):1117-22. 
37. Richalet JP. Operation Everest III: COMEX '97. High altitude medicine & biology. 
2010;11(2):121-32. 
 -145- 
38. Richalet JP, Keromes A, Carillion A, Mehdioui H, Larmignat P, Rathat C. [Cardiac 
response to hypoxia and susceptibility to mountain sickness]. Arch Mal Coeur Vaiss. 
1989;82 Spec No 2:49-54. 
39. Richard NA, Koehle MS. Differences in cardio-ventilatory responses to hypobaric and 
normobaric hypoxia: a review. Aviation, space, and environmental medicine. 
2012;83(7):677-84. 
40. Saugy JJ, Schmitt L, Cejuela R et al. Comparison of "Live High-Train Low" in 
Normobaric versus Hypobaric Hypoxia. PloS one. 2014;9(12):e114418. 
41. Savourey G, Launay JC, Besnard Y, Guinet A, Travers S. Normo- and hypobaric 
hypoxia: are there any physiological differences? European journal of applied 
physiology. 2003;89(2):122-6. 
42. Savourey G, Launay JC, Besnard Y et al. Normo or hypobaric hypoxic tests: 
propositions for the determination of the individual susceptibility to altitude illnesses. 
European journal of applied physiology. 2007;100(2):193-205. 
43. Siebenmann C, Sorensen H, Jacobs RA, Haider T, Rasmussen P, Lundby C. 
Hypocapnia during hypoxic exercise and its impact on cerebral oxygenation, 
ventilation and maximal whole body O(2) uptake. Respiratory physiology & 
neurobiology. 2013;185(2):461-7. 
44. Ventura N, Hoppeler H, Seiler R, Binggeli A, Mullis P, Vogt M. The response of 
trained athletes to six weeks of endurance training in hypoxia or normoxia. 
International journal of sports medicine. 2003;24(3):166-72. 
45. Verges S, Rupp T, Jubeau M et al. Cerebral perturbations during exercise in hypoxia. 
American journal of physiology. Regulatory, integrative and comparative physiology. 
2012;302(8):R903-16. 
46. Wehrlin JP, Hallen J. Linear decrease in .VO2max and performance with increasing 
altitude in endurance athletes. European journal of applied physiology. 
2006;96(4):404-12. 
 
  
 -146- 
  
 -147- 
 
Chapter Seven 
Article 3 – Same performance changes after Live High-Train Low 
in normobaric versus hypobaric hypoxia. 
	 	
 -148- 
  
 -149- 
 Article 3 - Same performance changes after Live High-Train 7.
Low in normobaric versus hypobaric hypoxia. 
 
Jonas J. Saugy1,2, Laurent Schmitt3, Anna Hauser1,5, Guillaume Constantin1, Roberto Cejuela4, 
Raphael Faiss1,5, Jon P. Wehrlin5, Jérémie Rosset1, Neil Robinson6, and Grégoire P. Millet1,2 
Frontiers Physiol. 2016. In Press 
 
 
 
 
 
 
 
 
 
 
 
 
1 ISSUL, Institute of Sport Sciences, Faculty of Biology and Medicine, University of Lausanne, 
Switzerland 
2 Department of Physiology, Faculty of Biology and Medicine, University of Lausanne, 
Switzerland 
3 National School of Mountain Sports/National Ski-Nordic Centre, Prémanon, France 
4 Departmental Section of Physical Education and Sports, University of Alicante, Spain 
5 Swiss Federal Institute of Sport, Magglingen, Switzerland 
6 Swiss Laboratory for Doping Analyses, University of Lausanne, Switzerland.  
 -150- 
Abstract 
Purpose: We investigated the changes in physiological and performance parameters after a 
Live High-Train Low (LHTL) altitude camp in normobaric (NH) or hypobaric hypoxia (HH) 
to reproduce the actual training practices of endurance athletes using a crossover-designed 
study. Methods: Well-trained triathletes (n=16) were split into two groups and completed two 
18-day LTHL camps during which they trained at 1100-1200 m and lived at 2250 m (PiO2 = 
111.9 ± 0.6 vs. 111.6 ± 0.6 mmHg) under NH (hypoxic chamber; FiO2 18.05 ± 0.03%) or HH 
(real altitude; barometric pressure 580.2 ± 2.9 mmHg) conditions. The subjects completed the 
NH and HH camps with a one-year washout period. Measurements and protocol were 
identical for both phases of the crossover study. Oxygen saturation (SpO2) was constantly 
recorded nightly. PiO2 and training loads were matched daily. Blood samples and VO2max were 
measured before (Pre-) and 1 day after (Post-1) LHTL. A 3-km running-test was performed 
near sea level before and 1, 7, and 21 days after training camps. Results: Total hypoxic 
exposure was lower for NH than for HH during LHTL (230 vs. 310 h; P<0.001). Nocturnal 
SpO2 was higher in NH than in HH (92.4 ± 1.2 vs. 91.3 ± 1.0%, P<0.001). VO2max increased to 
the same extent for NH and HH (4.9 ± 5.6 vs. 3.2 ± 5.1%). No difference was found in 
hematological parameters. The 3-km run time was significantly faster in both conditions 21 
days after LHTL (4.5 ± 5.0 vs. 6.2 ± 6.4% for NH and HH), and no difference between 
conditions was found at any time. Conclusion: Increases in VO2max and performance 
enhancement were similar between NH and HH conditions. 
 
Key words: Aerobic exercise, altitude-training camp, crossover study, real altitude, simulated 
altitude 
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Introduction 
Endurance athletes commonly use altitude-training camps with several hypoxic methods to 
achieve maximal sea-level performance enhancement (Millet et al., 2010). The “Live High – 
Train Low” (LHTL) method, where athletes live and sleep at altitudes between 2200 and 
2500 m and train under 1200 m (Levine and Stray-Gundersen, 1997;Chapman, 2013), is 
recognized as an effective method that can improves performance in athletes, despite a large 
inter-subject variability in response (Lundby et al., 2012). More than 15 years of research 
have revealed that LHTL is an effective training method to enhance sea-level performance in 
endurance athletes, and it provided 1-3% additional benefit compared with similar normoxic 
training, although not confirmed by all studies (Siebenmann et al., 2012). These altitude-
training camps are conducted under “real” (i.e., hypobaric hypoxia, HH (Stray-Gundersen and 
Levine, 2008;Chapman et al., 2014;Saugy et al., 2014)) or simulated altitudes (i.e., 
normobaric hypoxia, NH (Dehnert et al., 2002;Clark et al., 2009;Garvican et al., 
2011;Schmitt and Millet, 2012)). Emerging evidence suggests different physiological 
responses between these two types of hypoxia (Millet et al., 2012), and it is now admitted that 
they cannot be used interchangeably (Fulco et al., 2011;Saugy et al., 2014;Coppel et al., 
2015;DiPasquale et al., 2015). Short-term exposure in HH seems to induce greater levels of 
hypoxemia, when compared to NH (Savourey et al., 2003). Likewise, reduced ventilatory 
responses (Loeppky et al., 1997;Faiss et al., 2013), but higher oxidative stress, combined with 
impaired nitric oxide bioavailability (Faiss et al., 2013) were reported in HH. Regarding all 
these differences, pre-acclimatization effectiveness (Fulco et al., 2013) and acute mountain 
sickness (AMS) scoring (DiPasquale et al., 2015) are logically higher in HH.  
Sea-level performance improvement following LHTL may also be different between NH and 
HH (Bonetti and Hopkins, 2009). Most LHTL studies in HH conditions have reported 
performance or haematological improvements (Wehrlin et al., 2006;Bonetti and Hopkins, 
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2009;Chapman et al., 2014;Saugy et al., 2014;Garvican-Lewis et al., 2015), and positive 
outcomes have been less frequent in NH conditions (Robach et al., 2006b;Bonetti and 
Hopkins, 2009;Clark et al., 2009;Robertson et al., 2010b), when compared with control (i.e. 
sea-level) group. However, there is not a sufficient body of knowledge to confirm whether 
NH or HH induces better performance enhancement after LHTL training camps. It is difficult 
to compare results from studies with different parameters, such as different hypoxic doses, 
training loads, temperatures and statistical analyses (Millet et al., 2012;Coppel et al., 2015). 
There are not any crossover experimental designs to reduce the influence of the confounding 
factors that influence post-altitude responses and directly compare altitude-induced 
adaptations and performance changes after LHTL in NH and HH conditions in the same 
subjects. Athletes and coaches generally consider both hypoxic conditions similar, and it is 
important to clarify within practical and ecological conditions whether these two types of 
LHTL training camps may be used interchangeably. Consequently, we designed a crossover 
study to assess physiological and performance responses in trained athletes during and after 
LHTL camps matched in the inspired pressure of oxygen (PiO2) in NH or HH conditions. The 
first phase of the crossover was published previously (Saugy et al., 2014), and results 
demonstrated better performance enhancement after the altitude training camp conducted 
under HH conditions. Groups in the present study were crossed to complete the crossover 
design and reduce an eventual group effect. We hypothesized that the LHTL intervention 
conducted under HH conditions would produce better performance improvement and greater 
physiological adaptations than under NH, which is consistent with the results of the first 
phase of the crossover. 
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Methods 
Subjects 
Twenty-four well-trained male triathletes participated in the first phase of this study, and 21 
male triathletes participated in the second phase. We pooled data across phases to obtain a 
crossover analysis of sixteen subjects who were included in both conditions (n=10 in 2013 
and n=6 in 2014 for NH condition, and n=6 in 2013 and n=10 in 2014 for HH condition). The 
main characteristics of all subjects in the analysis are presented as means ± standard 
deviation: age 24 ± 4 years, body height 179 ± 5 cm, body weight 70 ± 5 kg, BMI 21.8 ± 1.7 
kg.m2, VO2max 66.3 ± 7.5 mL.kg-1.min-1, and Pmax 380 ± 48 w. Subjects were included in the 
NH and HH group in the first phase and switched to the other hypoxia type for the second 
phase. The washout period between two phases was one year. The following inclusion criteria 
for participation and data analysis were used: 1) a minimum of 5 years of endurance training 
and frequent participation in endurance competitions; 2) initial ferritin levels >30 µg/l; 3) 
sufficient training loads during the lead-in period; and 4) participation in both parts of the 
study (i.e., NH and HH altitude camps). All athletes provided written informed consent to 
participate in the study. The local ethical committees approved the study (Commission 
Cantonale Valaisanne d’Ethique Médicale, CCVEM; Agreement 051/09 and French National 
Conference of Research Ethics Committees; N°CPP EST I: 2014/33; Dijon, France), which 
corresponded to the two training locations. All experimental procedures conformed to the 
standards set by the Declaration of Helsinki.  
Study design 
This study includes the first phase of a crossover design published previously (Saugy et al., 
2014). Therefore, values presented here are means of the two phases (i.e., 2013 and 2014) of 
the crossover study unless specified, and more precise details are provided in the statistics 
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section. Many methodological details are reported elsewhere (Saugy et al., 2014), but these 
details are also outlined here for the reader’s convenience. The experimental design was 
identical to the first phase of the crossover and consisted of a 33-week period divided into 
four different phases: 1) 24 weeks of training load quantification at sea level; 2) a 3-week 
lead-in period also at sea level, where the training loads were quantified, and the training 
sessions were supervised; 3) an 18-day LHTL training camp under NH or HH conditions; and 
4) a 3-week post-altitude period at sea level where the training sessions were also supervised 
and loads quantified (see Fig. 1). The two phases were performed exactly during the same 
period of the competitive season (July) for the two consecutive years, with athletes training in 
the same club under the supervision of the same coaches. Subjects were assigned to the 
opposite condition (NH or HH) of the condition they underwent during first phase of the 
study (i.e., in 2013). They were initially matched based on VO2max values that were measured 
during the Pre-test of the 2013 study. Both groups lived at an altitude of 2250 m under 
simulated (NH) or real (HH) hypoxic conditions. All subjects trained at an altitude between 
1100 and 1200 m. Subjects performed several physiological tests in a well-ventilated 
laboratory (Prémanon, France, 1150 m) before (Pre-) and immediately after (Post-1) the 
LHTL camp. Measurements included blood samples, anthropometric measurements, and 
maximal incremental tests on a cycle ergometer (VO2max). The Pre- and Post-1 tests were 
performed in the same order at the same time of day with the same materials for both phases 
of the crossover study. Subjects performed five 3-km running tests at the following times: 
prior to lead-in, before LHTL (Pre-), one day after LHTL (Post-1), seven days after LHTL 
(Post-7), and twenty-one days after LHTL (Post-21), in exactly the same manner for 2013 and 
2014. All 3-km running tests were performed near sea level (between 100 and 390 m). 
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Hypoxic exposure 
Subjects were exposed to a normobaric hypoxia equivalent to 2250 m during NH conditions, 
which was obtained by extracting oxygen (i.e. oxygen filtration) from ambient air in hypoxic 
chambers (inspired oxygen pressure (PiO2) 111.9 ± 0.6 mmHg; inspired oxygen fraction 
(FiO2) 18.05 ± 0.03%; Barometric pressure (BP) 666.6 ± 3.6 mmHg). The gas composition in 
each hypoxic chamber was continuously monitored using oxygen and carbon dioxide 
analysers (FIELDBROOK Ltd., London, UK) connected to a central station under the control 
of an independent and specialized physiologist. The hypoxic chambers were of medium size 
(15 ± 1 m2) and equipped with conventional beds. Two subjects were in each room, and they 
primarily spent their time sleeping or resting between training sessions. Subjects in NH 
conditions left chambers 5-6 times daily on average to eat and train. Daily hypoxic dose in 
NH was 12.7 ± 0.5 h for a total hypoxic exposure of 229.2 ± 5.9 h. The HH group lived in 
Fiescheralp, Switzerland (2250 m, PiO2 111.6 ± 0.6 mmHg; FiO2 20.9 ± 0.0%; BP 580.2 ± 2.9 
mmHg) and traveled twice daily to the valley (altitude < 1200 m) via cable car for training. 
The daily hypoxic dose in HH was 17.1 ± 1.7 h for a total hypoxic exposure of 309.9 ± 4.1 h. 
The hypoxia exposure was monitored daily and recorded manually for both conditions.  
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Figure 1. Overview of the whole protocol conducted in a crossover design in two consecutive years. In 
horizontal axis the protocol duration of each part in weeks (W) and in vertical axis the testing altitude, including: 
the six months before the lead-in period where the training loads were assessed, the lead-in, the LHTL camp and 
the lead-out period. With: 3-km test = the 3-km running tests on the track near sea level made on Pre-, Post-1, 
Post-7 and Post-21; LHTL = Live High Train Low training camp for normobaric hypoxia (NH) and hypobaric 
hypoxia (HH). The two dark grey slots before and after the LHTL period correspond to the 2 days of Pre- and 
Post-tests (i.e. Pre1, Pre2 and Post1, Post2, respectively) at 1150 m. 
 
Measurements 
Training loads. Training consisted of swimming, cycling and running. Two experienced 
certified coaches supervised and advised athletes during each training session during camps, 
and intensity and volume were matched for both groups. Training load quantification was 
performed using “Objective Load Scale” (ECOs) (Cejuela Anta and Esteve-Lanao, 2011), 
which was specially developed for training quantification in triathlons. Briefly, the ECOs 
were calculated by multiplying the total duration of a training session (in minutes) with a 
scoring value between 1 and 50, depending on the heart rate-based training zone (1 to 8) and 
by a factor of 1.0, 0.75 or 0.5 for running, swimming or biking, respectively. Daily and 
weekly training loads (ECOs) of each subject were quantified based on each subject’s 
physical characteristics and training program intensity. 
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Running and maximal oxygen uptake. Running performance was evaluated using 3-km 
running tests that were completed on a 400-m outdoor synthetic track near sea level. Starts 
were given individually in a time-trial mode (i.e., 30 s between each subjects) to avoid any 
group or pacing influences. VO2max was tested before and after LHTL (i.e. at Pre-1 or Pre-2 
and Post-1, see Fig. 1) using an incremental cycling performance test. Subjects were tested on 
their own bicycles, which were linked to a computerized ergometer system (Cyclus 2®, RBM 
elektronik automation GmbH, Leipzig, Germany). Workload was increased by 30 W.min-1 
after a 5-min warm-up period at a workload of 90 W until voluntary exhaustion was reached. 
Subjects were strongly encouraged to perform until they reached maximal exhaustion. They 
wore a nose clip and a mouthpiece for breath collection. Oxygen (O2) and carbon dioxide 
(CO2) levels were continuously measured and monitored as breath-by-breath values in 
expired gas (Ultima Cardio 2 gas exchange analysis system, MGC Diagnostics with 
Breezesuite software, Saint Paul, MN, USA). The flow meter and gas analyser were 
calibrated prior to each test. VO2max was determined as the highest 30 s average value and 
based on the standard criteria of maximal exhaustion (VO2 plateau, RER > 1.1 and incapacity 
to maintain the exercise load). Maximal power output (Pmax) was considered as the load of the 
last stage completed. 
Blood samples. Blood samples were taken from the antecubital vein (3 x 4.9 mL EDTA 
tube®, Sarstedt, Nümbrecht, Germany) either immediately after waking up or before 
breakfast, twice during each study phase on the first morning during the Pre- and Post-tests 
(i.e. before and after LHTL, see Fig. 1). Blood analyses were conducted using an XT-2000i 
analyser® (Sysmex Europe, Norderstedt, Germany) in a Lausanne WADA (World Anti-
Doping Agency) accredited laboratory (Lamon et al., 2010). All samples were analysed in 
duplicate, and mean values were used for the study. The following hematological parameters 
were quantified: red blood cells (RBCs), hemoglobin (Hb), hematocrit (Hct), mean cell 
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volume (MCV), mean cell hemoglobin (MCH), mean cell hemoglobin concentration 
(MCHC), reticulocyte percentage (RET%), and absolute number of reticulocytes (RET#). 
Regular quality control procedures were applied as required by the standards of WADA-
accredited laboratories, and the coefficient of variations (CV) was within the CV limits 
accepted by the manufacturer for the instrument. Plasma EPO was quantified using an ELISA 
kit® (Stemcell Technologies, Grenoble, France), and the lower limit of quantification was 
measured at 1.6 mU/mL. Baseline ferritin was quantified using standard laboratory 
procedures (Dimension EXL, Siemens Healthcare Diagnostics SA, Zürich, Switzerland) to 
evaluate subject’s iron stores. All athletes were tested for doping by the accredited laboratory 
according to the biological passport standards to avoid performance enhancement via doping. 
Determined CVs were always below 15%. 
Night assessment. SpO2 and HR were recorded nightly from Pre-1 to Post-2 at 0.25 Hz using 
a wrist oximeter connected to a finger sensor (Wristox 3150® with 8000SM-WO Sensor, 
Nonin, Plymouth, MN). The oxygen desaturation index (ODI 3%; i.e. the number of times per 
hour of sleep that the blood’s oxygen level drops by 3 percent or more) has been calculated 
throughout the periods. 
 
Data Analysis and Statistics. Subjects’ data were pooled for each condition from both 
phases of the study as follows: the NH condition values considered were the pooled values 
from the NH subjects in 2013 (n=10) and the NH subjects in 2014 (n=6); the same subjects 
were considered for the HH condition but reversed (n=6 in 2013 and n=10 in 2014; i.e., n=16 
for the whole analysis). Data are reported as means and standard deviations of the sixteen 
subjects considered for the crossover analysis. Data were tested for equality of variance 
(Fisher-Snedecor F-test) and normality (Shapiro-Wilk test). When both conditions were met, 
a two-way ANOVA was performed for repeated measures for each hypoxia condition (NH 
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and HH). To determine the time effects for variables measured on several occasions during 
camps, pairwise multiple comparison procedures was used (Holm-Sidak method, applied to 
the SpO2, HR and training loads). NH and HH were subsequently compared across time (Pre-, 
Post-1, Post-7, and Post-21) using a two-way ANOVA. When equality of variance or 
normality was not satisfied (differences in blood parameters tests from Pre- to Post-1 
conditions), variables were analysed for each condition using a Friedman test for repeated 
measures. To determine time effects, pairwise multiple comparison procedures was used 
(Bonferroni test). Differences in percentage changes between conditions were tested using a 
Wilcoxon signed rank sum test (applied to changes in performance and blood parameters). 
The statistical power of the performed tests concerning the 3000 m performance with alpha = 
0.05 was, for the time effect of 1.000, and for the group effect of 0.469. Differences between 
NH and HH condition at baseline (Pre-) were tested using a Mann-Whitney rank sum test 
(applied to incremental cycling test parameters and baseline blood sample parameters). Null 
hypotheses were rejected at P<0.05. All analyses were completed using Sigmaplot 11.0 
software (Systat Software, San Jose, CA). 
Results 
Hypoxic doses, PiO2, night peripheral oxygen saturation and heart rate. Daily hypoxic 
dose (12.7 ± 0.5 vs. 17.1 ± 1.7 h, P<0.001) and total hypoxic exposure (229.2 ± 5.9 vs. 309.9 
± 4.1 h, P<0.001) were lower in NH than in HH. The average PiO2 values were not different 
between conditions (111.9 ± 0.6 vs. 111.6 ± 0.6 mmHg, for NH and HH). The nightly average 
of HR was higher for NH than for HH (51 ± 1 vs. 48 ± 2 bpm for NH and HH, P<0.001), and 
these values stayed higher when returning to 1200 m in Prémanon during the two nights of 
post-test (51 ± 2 vs. 46 ± 2 bpm, for NH and HH, P<0.001). Nightly SpO2 values were similar 
between two groups during the control nights (i.e., the two nights at 1150 m before LHTL 
camps, Pre-1 and Pre-2), but values were higher in NH than in HH during the entire camp 
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(D1-D18; 92.4 ± 1.2 vs. 91.3 ± 1.0%, for NH and HH, P<0.001). These values remained 
higher (P<0.05) during the two nights at Post-1 (94.4 ± 0.9 vs. 93.6 ± 0.9%, for NH and HH, 
P<0.05). All values are presented in Fig. 2. In addition, the ODI 3% was significantly lower 
for NH than HH throughout the hypoxic nights (9.9 ± 1.6 vs. 15.1 ± 3.5, P<0.001). 
 
Figure 2. Mean values of night oxygen pulse saturation (SpO2) for the crossover data. Data are presented in 
mean ± standard error. Pre1-Pre2: measurements before the camps (1150 m, Prémanon, France); D01-D18: 
measurement during the camps (NH: hypoxic room in Prémanon, France; HH: Fiescheralp, Switzerland); Post1-
Post2: measurements after the camps (1150 m, Prémanon, France). #P<0.05, ###P<0.001 for differences 
between conditions. 
 
Training loads. No difference was found in daily training loads during the lead-in (3 weeks 
prior LHTL camps; 79.8 ± 22.7 vs. 87.4 ± 23.1 ECOs) or the lead-out (3 weeks following the 
LHTL camps; 164.4 ± 20.2 vs. 173.9 ± 24.1 ECOs; see fig. 1) periods between NH and HH, 
respectively. No difference was found in daily training loads (226.7 ± 56.5 vs. 214.5 ± 56.4 
ECOs for NH and HH groups) between the two groups during the 18-d LHTL camps in both 
conditions of the crossover. Finally, weekly training loads monitored during the 24 weeks 
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prior to the study were not different between groups (979 ± 207 vs. 1135 ± 98 ECOs for NH 
and HH group, respectively). Daily training loads during the LHTL in phase 2 were reduced 
compared to phase 1 (232.2 ± 27.2 vs. 220.3 ± 31.4 for NH and 217.3 ± 48.1 vs. 211.4 ± 21.0 
ECOs for HH, P<0.05). 
3-km performance test. The 3-km performance was significantly increased to a larger extent 
in the HH group than in the NH group at Post-21 in the first phase of the study (−1.2 ± 2.9 vs. 
−3.2 ± 3.8%, for NH and HH, P<0.05). Performance in the second phase (i.e., 2014) increased 
from Pre- to Post-1 (−3.3 ± 2.0 vs. −3.9 ± 2.9%, for NH and HH, P<0.01), Post-7 (−2.7 ± 3.1 
vs. −2.6 ± 3.6%, for NH and HH, P<0.05) and Post-21 (−8.4 ± 4.1 vs. −9.1 ± 6.1%, for NH 
and HH, P<0.01). Performance increased from Post-1 and Post-7 to Post-21 for both 
conditions. However, no difference was noted between NH and HH groups at any time. The 
crossover demonstrated that performance increased from Pre- to Post-1 (–1.92%, P<0.05) and 
Post-7 (–2.44%, P<0.05) for HH but not in NH (–0.97 and -2.27% from Pre- to Post-1 and 
Post-7 respectively, ns). And it increased from Pre- to Post-21 (P<0.001), Post-1 to Post-21 
(P<0.001) and Post-7 to Post-21 (P<0.001) for both conditions. However, no difference was 
noted between conditions at any time (Fig. 3). We found important inter-individual 
differences between both conditions, i.e. during two successive years. For example subject 
n°1 decreased his performance time at Post-21 by −3.6% in NH vs. −7.4% in HH. Subject n°6 
increased his performance time at Post-21 by 1.9% in NH and decreased it by −12.1% in HH. 
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Figure 3. Relative change in 3-km run time from Pre- to Post-1, Post-7, and Post-21 as determined on a running 
track near sea level for the normobaric hypoxia (NH) and hypobaric hypoxia (HH) conditions (in %) for the 
crossover (n = 16). Data are mean ± standard error *P<0.05, **P<0.01 and ***P<0.001 for differences with Pre-
; $$$P<0.001 for differences with Post-1; †††P<0.001 for differences with Post-7. 
 
Maximal test on cycle ergometer. Subjects increased their power output and maximal 
oxygen uptake values immediately after altitude training camps in both NH and HH, but 
without any difference between conditions. Table 1 presents all values. Ventilation and heart 
rate at the submaximal work rate of 190 ± 24 W corresponding to 50% PPO pre- values have 
been measured. HR decreased to the same extent from Pre- to Post-1 (−6 ± 3 vs. −6 ± 2 bpm) 
and ventilation did not change significantly (2.5 ± 2.2 vs. −1.7 ± 7.9 L.min-1) in NH vs. HH, 
respectively. 
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Table 1 Main parameters measured during the incremental test on ergocycle for normobaric 
hypoxia (NH) and hypobaric hypoxia (HH) group before (Pre-) and after (Post-) the camps. 
 
 
 
 
 
 
 
 
 
Physiological parameters during the incremental test on ergocycle; VO2max maximal oxygen uptake; HRmax 
maximal heart rate; Pmax maximal power output; VEmax maximal ventilation. Data are mean ± SD; **P<0.01 and 
***P<0.001 for differences between Pre- and Post-. 
 
Hematological parameters. EPO values decreased significantly to the same extent from Pre- 
to Post-1 in both conditions (−30 ± 25 and −36 ± 21% for NH and HH, P<0.001). No 
significant changes were observed in the other parameters. Table 2 presents all values. 
  
  
Pre- Post- Delta % 
VO2max 
[ml.O2.kg.min-1] 
NH 65.2 ± 6.3 68.3 ± 5.0 *** 4.9 ± 5.6 
HH 66.7 ± 8.5 68.8 ± 2.4 ** 3.2 ± 5.1 
HRmax 
[bpm.min-1] 
NH 191 ± 8 191 ± 6 0.4 ± 2.2 
HH 190 ± 7 189 ± 6 −0.5 ± 1.7 
Pmax 
[W] 
NH 362 ± 45 385 ± 33 *** 7.1 ± 6.6 
HH 397 ± 46 411 ± 39 *** 4.9 ± 5.1 
VEmax 
[l.min-1] 
NH 180.1 ± 17.4 185.4 ± 15.1 3.6 ± 10.5 
HH 192.3 ± 31.7 195.2 ± 21.7 2.3 ± 7.7 
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Table 2 Main parameters measured with blood analyses for normobaric hypoxia (NH) and 
hypobaric hypoxia (HH) group before (Pre-) and after (Post-) the camps. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Blood and hemoglobin parameters; EPO erythropoietin; RBC red blood cells; Hb hemoglobin; Htc hematocrit; 
MCV mean cell volume; MCH mean cell hemoglobin; MCHC mean cell hemoglobin concentration; RET 
reticulocytes. Data are mean ± SD; ***P<0.001 for differences between Pre- and Post-.  
  
  
Pre- Post- Delta % 
EPO 
[mU/mL] 
NH 5.12 ± 2.57 3.08 ± 1.55*** −33.6 ± 27.3 
HH 4.48 ± 1.45 3.02 ± 0.71*** −35.7 ± 19.7 
RBC [u/µl] 
NH 5.21 ± 0.49 5.29 ± 0.46 1.7 ± 7.3 
HH 5.24 ± 0.44 5.29 ± 0.38 1.1 ± 4.6 
Hb [g/dl] 
NH 15.38 ± 1.23 15.99 ± 1.05 4.3 ± 6.7 
HH 15.44 ± 1.08 15.75 ± 1.01 2.4 ± 5.1 
Hct [%] 
NH 45.52± 3.31 46.70 ± 3.10 2.9 ± 7.1 
HH 45.51 ± 3.16 46.44 ± 2.59 2.5 ± 3.7 
MCV [fl] 
NH 87.56 ± 4.10 88.53 ± 3.48 1.15 ± 1.3 
HH 87.19 ± 3.46 87.96 ± 3.30 0.9 ± 1.4 
MCH [pg] 
NH 29.56 ± 1.02 30.30 ± 1.22 2.5 ± 1.8 
HH 29.50 ± 1.12 29.84 ± 1.26 1.2 ± 1.8 
MCHC [g/dl] 
NH 33.78 ± 0.81 34.25 ± 0.92 1.4 ± 1.7 
HH 33.83 ± 0.85 33.92 ± 0.91 0.3 ± 2.1 
RET [%] 
NH 1.14 ± 0.53 1.13 ± 0.27 6.3 ± 31.1 
HH 1.09 ± 0.28 1.09 ± 0.36 3.8 ± 31.8 
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Discussion 
This study is the first crossover study to compare physiological and performance responses 
during and after an 18-d LHTL altitude camp conducted in NH or HH conditions. The 
crossover design incontestably increased the statistical power of the present analysis 
compared with the first phase of this study (Saugy et al., 2014). Lower peripheral oxygen 
saturation levels during the night and longer hypoxic exposure were noted in HH than in NH. 
However, no differences in blood parameters, maximal power output or VO2max were 
observed between hypoxic conditions. Both conditions directly induced performance 
enhancement seven or twenty-one days after the camps. However, no differences were 
observed between NH and HH in sea level performances. 
The second phase (i.e., 2014) and crossover 3-km running performances were not different 
between conditions at any measurement point (Fig. 3), which is unlike the first phase of the 
study. Both conditions induced performance enhancements Post-1, Post-7 and Post-21 in 
2014 and at Post-21 when considering the crossover. VO2max and performance increased to the 
same extent for NH and HH conditions. So the VO2max increase itself could explain at least 
partly the enhanced performance. Moreover, there is currently a large debate about running 
economy and efficiency when returning from altitude camps (Schmitt et al., 2006;Lundby et 
al., 2007;Chapman, 2013). In the present study VO2 and ventilation were unchanged while 
HR decreased to the same extent during a submaximal cycling test in both groups. These later 
results show that cycling efficiency was not modified. It is therefore likely that running 
economy did not change significantly and did not influence the running performance 
enhancement. This evolution is consistent with the established insight for the development of 
performance after altitude training camps described by Sinex et al. (Sinex and Chapman, 
2015) and drawn from Millet et al. (Millet et al., 2010). These studies have demonstrated 
initial improvements in performance (days 1-7) and a higher plateau in performance (days 18-
20 or more). The result that improvements were significant for only HH at Post-1 and Post-7 
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in the crossover was clearly influenced by NH data of 2013. A group effect was observed in 
the first phase, and NH subjects in 2013 did not assimilate the combination of training load 
and hypoxic dose as well as the other group. The training content and load were strictly 
similar between the two groups during each phase but were adjusted from phase 1 to phase 2 
by coaches (probably from their experience of phase 1). The main change consisted in a 
reduced training load in phase 2 (232.2 ± 27.2 vs. 220.3 ± 31.4 for NH and 217.3 ± 48.1 vs. 
211.4 ± 21.0 ECOs for HH, in phase 1 vs. phase 2) and a different periodization. Of interest is 
that a similar training adjustment has been performed between successive studies conducted 
in a chronological order at the same location; i.e. with elite Nordic skiers (Robach et al., 
2006a), swimmers (Robach et al., 2006b) and distance runners (Brugniaux et al., 2006). The 
crossover design tone down this tendency, but it highlights the considerable importance of 
inter-individual variations in responses to altitude training (Friedmann et al., 2005;Garvican 
et al., 2010;Chapman, 2013;Sinex and Chapman, 2015). Of interest is the observed intra-
individual variability between successive years, in line with a previous case study (Garvican 
et al., 2007). This inter- or intra-subjects variability between the two phases raises questions 
about the physiological basis of highly variables findings from previous published LHTL 
studies (Pialoux et al., 2009;Robertson et al., 2010a;Nordsborg et al., 2012;Robach et al., 
2012;Siebenmann et al., 2012;Garvican-Lewis et al., 2013). With small effects and sample 
sizes, added to the large among of confounding factors (i.e. training loads, subjects training 
level, food supplies, sleep…), the probability of type 2 errors has been often under-
considered.  
The daily exposures are consistent with previous studies in normobaric or hypobaric hypoxia 
with 8-12 h.d-1 (Roberts et al., 2003;Saunders et al., 2004) and 18 h.d-1 (Levine and Stray-
Gundersen, 1997;Wehrlin and Marti, 2006) in NH and HH, respectively. Night peripheral 
oxygen saturation was lower for HH than for NH from the beginning to the end of the camps, 
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and it remained lower after returning to Prémanon (1150 m) for the Post-tests (Fig. 2). This 
result confirmed the results of the first phase of the crossover, and it is consistent with 
previous studies (Savourey et al., 2003;Savourey et al., 2007;Self et al., 2011) using short 
exposures and higher altitudes (less than 1 h, 4500 to 7620 m). No difference was reported in 
longer exposure (up to 24 h, from 3000 m to 4564 m) studies (Roach et al., 1996;Loeppky et 
al., 2005;Miyagawa et al., 2011;Faiss et al., 2013). However, the hypoxic exposure was 
always shorter than in the present study. To our knowledge, no study has directly compared 
NH and HH conditions in LHTL camps using a crossover design. Potential mechanisms 
underlying this difference in the nocturnal SpO2 found in the present study were reported 
previously (Saugy et al., 2014). Briefly, a stronger pulmonary vasoconstriction in HH, which 
was induced by the modified fluid circulation and trans-alveoli-capillary membrane flux 
under the influence of barometric pressure, may lead to decreased pressure gradient and 
oxygen diffusion (Levine et al., 1988;Loeppky et al., 2005;Millet et al., 2012). In addition, 
the ODI 3%, a reliable indicator of apnea/hypopneas index was calculated throughout all 
nights and indicated larger sleep disordered breathing in HH than NH. This is in line with 
previous results from Heinzer et al. (Heinzer et al., 2013) who has reported more hypopneas 
with polysomnography analyses in HH compared to NH. However, the present difference in 
ODI 3% seems not clinically relevant (much lower than reported values in clinical groups) for 
inducing difference in performance enhancement between conditions. Moreover, Goodall et 
al. (Goodall et al., 2014) recently found that the integrity of the corticospinal system is 
modified after 2 weeks at 5260 m, which potentially reduces fatigue level observed in acute 
hypoxia and might be a contributor to increased performance following acclimatization. 
Moreover, adaptive changes have been observed after 3 h of NH exposure (Rupp et al., 2012). 
Thus, it seems that a time-dependent effect on the central nervous system exists. These central 
nervous system adaptations are likely influencing the observed changes in performance. 
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However, these mechanisms have not been investigated in the present study conducted under 
lower altitudes. 
 
Differences in daily and total hypoxic exposures were found between conditions (13 vs. 17 
h.d-1 and 230 vs. 310 h for NH and HH), but our aim was to compare the two LHTL camps in 
“real conditions” in ecological ways. Moreover, this hypoxic doses difference is not the main 
factor for the SpO2 difference between NH and HH since SpO2 was lower for HH from the first 
night of exposure and remained stable throughout the camps (see Fig. 2). 
 
Hematological parameters evolved to the same extent in both conditions, which is consistent 
with recent studies using natural (Garvican et al., 2012;Garvican-Lewis et al., 2013;Saugy et 
al., 2014;Garvican-Lewis et al., 2015) or simulated altitudes (Wehrlin et al., 2006;Gore et al., 
2013;Saugy et al., 2014) in LHTL protocols, but none of these studies have directly compared 
NH and HH. Interestingly, most of the studies on “altitude acclimatization” (e.g. conducted 
with untrained lowlanders) failed to demonstrate altered erythrocyte volume for up to 3 weeks 
below 4000 m (Sawka et al., 2000). These authors reported that “physical activity modulates 
the erythrocyte volume expansion during altitude acclimatization” and that elite athletes 
engaged in aerobic training, despite a large inter-individual variability, might have larger 
benefits from the same hypoxic dose, due to genetically inherited factors that may modulate 
the hypoxic ventilatory drive, Hb P50, or erythropoietin responsiveness to hypoxia. Most of 
these points remain unresolved and were beyond the scope of the present study. Nevertheless, 
the LHTL camps in NH or HH did not affect hematological parameters, except serum EPO 
concentrations (table 2). However, the higher the Hbmass value at the start of the hypoxic 
exposure, the lower the Hbmass increase (Robach and Lundby, 2012). This result is consistent 
with previous studies from Dehnert et al. (Dehnert et al., 2002) and Robach et al. (Robach et 
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al., 2006b), who have observed no changes in primary hematological parameters. EPO 
concentrations significantly fell when the subjects returned to 1150 m for the Post-tests, but 
this drop was not different between conditions in the crossover, unlike the first phase of the 
study. A drop in EPO after return to normoxia following continuous hypoxic exposure was 
reported previously (Milledge and Cotes, 1985;Savourey et al., 1996;Savourey et al., 
2004;Risso et al., 2007;MacNutt et al., 2013). The lower serum EPO concentration found 
after the camp in the present study may be explained by the oscillating nature of LHTL, 
which was suggested by Garvican et al. (Garvican et al., 2012), but the underlying 
mechanisms are not clear. However, MacNutt et al. (MacNutt et al., 2013) has provided 
indirect evidence of neocytoloysis and an assumption of the mechanisms in a study with mice: 
a decrease in EPO mRNA within 1 h of hypoxia cessation combined with neocytolysis, 
whereby the most recently formed erythrocytes are targeted for destruction and phagocytized 
by macrophages in the spleen. 
Strength and limitations 
The use of a crossover design increases statistical power, and it is of great importance because 
of the large inter-subject variations due to hypoxia (Coppel et al., 2015). It is even more 
important when comparing normobaric and hypobaric hypoxia because of the slight nature of 
their physiological differences. However, considering the statistical power (i.e. 0.469) for the 
group effect on the 3000 m performances, we cannot exclude the presence of type-2 error. 
Thus, there is still a possibility of performance difference between NH and HH, despite the 
crossover-designed protocol. This study is the first crossover study to compare prolonged 
altitude training in NH and HH. The present study compared the physiological and 
performance differences between NH and HH during and after a three-week LHTL conducted 
under “real” conditions (i.e., daily exposures based on the literature and real training sessions 
supervised by coaches). The aim of this study was not to test the effectiveness of LHTL 
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training alternatives. It is likely that the large performance enhancement following the LHTL 
period was due to the intensified training during both LHTL and lead-out periods. The high 
training loads during the LHTL camp could be the main stimulus leading to performance gain 
during the lead-out period. Given the increase in training loads and the lack of a control 
group, we cannot evaluate whether hypoxic exposure/acclimatization actually contributed to 
the performance enhancement. Moreover, considering the fact that there was no control 
group, we cannot rule out that there is a strong placebo effect that would influence partly the 
performance enhancement in the athletes. It is a serious limitation in the present study since 
we cannot appreciate the magnitude of this placebo effect and if it was different between NH 
and HH conditions. In addition, considering the statistical power above-mentioned, further 
studies are needed with larger sample sizes to completely answer the research question. 
Athletes were well trained, and training loads were not different between conditions. Training 
loads were quantified six months prior the study and supervised during the whole protocols 
for both phases of the crossover. The “real life” parameters of this study induced significant 
hypoxic dose differences between conditions. One cannot exclude that the slight physiological 
differences found between NH and HH would also appear with same hypoxic doses. On the 
other hand, we have to consider that simulated vs. real altitude might have produced different 
results if we had compared them at equal hypoxemia doses. Since the condition x time 
interaction was not significant, one cannot report from a statistical point of view that a 
condition was more efficient than the other one. However, from a practical and coaching point 
of view, the 0.95, 0.17 and 0.58% larger performance improvement in HH compared to NH 
(from Pre- to Post-1, Post-7 and Post-21, respectively) are not negligible. Nevertheless the 
aim of the present study was not a true comparison between these two hypoxic conditions, 
which would have requires equal stimulus levels. This crossover study confirmed that NH and 
HH involve different physiological adaptations but elicit similar performance improvements 
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when using LHTLs of the same duration. The hypoxic dose and/or the altitude level should be 
adjusted to individual athlete responses, e.g., the night SpO2, to achieve the highest 
performance improvements. Obviously, the NH condition is more convenient for this purpose. 
Further investigations should focus on the individualization of the training and hypoxic 
exposure. Nevertheless, it is important to take into consideration that the group effect from the 
larger NH cohort in 2013 could be driving the results. Since the crossover is not perfectly 
balanced (with 10 and 6 instead of 8 and 8) the crossover design could not “cancel” this 
tendency. 
Conclusion 
The present crossover study provided a further step to compare normobaric and hypobaric 
hypoxia. The results confirmed that NH and HH are definitely not interchangeable when 
several physiological responses are considered, as suggested previously (Fulco et al., 
2011;Millet et al., 2012;Saugy et al., 2014;Coppel et al., 2015). Despite differences in the 
stimulus that occur when using these two different methods in real life, we report no 
observable differences in responses to NH vs. HH. 
 However, the hematological responses and performance improvements post-LHTL were 
similar. Each hypoxic condition has advantages and drawbacks from a practical point of view. 
The HH condition leads to longer hypoxic doses for a given training period (i.e., 18 d in this 
study), which may fit easier into a complex training plan with elite athletes, but the logistical 
constraints, and the cost may be detrimental. In contrast, NH condition allows athletes and 
trainers to individualize the hypoxic stimulus. It may be interesting to adjust the hypoxic dose 
by modifying the time spent in the room or the altitude setting to athletes’ physiological 
responses and training level. However, training camps conducted under normobaric hypoxia 
require longer periods of time to achieve sufficient hypoxic doses because of the lower 
amount of time spent in hypoxia than under HH. 
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Abstract 
 
Study objectives: Hypoxia is known to generate sleep disordered-breathing but there is a 
debate about the pathophysiological responses to two different types of hypoxic exposure: 
normobaric hypoxia (NH) and hypobaric hypoxia (HH), which have never been directly 
compared. Our aim was to compare sleep disorders induced by these two types of altitude. 
Design/Setting: Subjects were exposed to 26h of simulated (NH) or real altitude (HH) 
corresponding to 3450m and a control condition (NN) in a randomized order. The sleep 
assessments were performed with nocturnal polysomnography (PSG) and questionnaires.  
Subjects: Thirteen healthy trained males subjects volunteered for this study (mean±SD; age 
34±9 yrs, body weight 76.2±6.8 kg, height 179.7±4.2 cm). 
Results: Mean nocturnal oxygen saturation was further decreased during HH than in NH 
(81.2±3.1 vs. 83.6±1.9%; P<0.01) when compared to NN (95.5±0.9%; P<0.001). Heart rate 
was higher in HH than in NH (61±10 vs. 55±6 bpm; P<0.05) and NN (48±5 bpm; P<0.001). 
Total sleep time was longer in HH than in NH (351±63 vs. 317±65 min, P<0.05), and both 
were shorter compared to NN (388±50 min, P<0.05). Breathing frequency did not differ 
between conditions. Apnea-hypopnea index was higher in HH than in NH (20.5[15.8-57.4] 
vs. 11.4[5.0-65.4]; P<0.01) and NN (8.2[3.9-8.8]; P<0.001). Subjective sleep-quality was 
similar between hypoxic conditions but lower than in NN. 
Conclusions: Our results suggest that HH has a greater impact on nocturnal breathing and 
sleep structure than NH. In HH, we observed more periodic breathing, which might arise from 
the lower saturation due to hypobaria, which needs to be confirmed. 
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Introduction 
Sleep has been recognized as an essential component for athlete preparation and has been 
suggested to be the single best recovery strategy available to an athlete 1, 2. On the opposite, 
sleep impairment has been shown to negatively influence the athletes’ performance 3, mainly 
through an impairment of their aerobic performance, which was shown to be directly related 
to sleep quantity and quality 4, 5. A drawback of altitude training might be a lower sleep 
quality since high-altitude exposure is known for altering the sleep quality: West et al. 6 
reported significant sleep impairment at high altitude based on climbers subjective account 
and objectively through polysomnography (PSG) recordings. Szymczak et al. used two 
standardized scales (the Pittsburgh Sleep Quality Index and the Athens Insomnia Scale) to 
assess the subjective sleep quality alterations at high altitude and found significant 
impairments in general sleep quality and sleep induction 7. However, the precise mechanisms 
causing sleep disturbances at high altitude remain unclear.  
Recreational mountain sports in altitude such as trekking, ski touring or alpinism are 
becoming increasingly popular. Altitude/Hypoxic training is also commonly used by athletes 
for enhancing their sea-level performance through an improved oxygen transport capacity as a 
result of a hypoxia-induced erythropoietic response 8. Hypoxia can be produced by a 
combination of reduced barometric pressure (PB) and/or a reduced inspired fraction of 
oxygen (FIO2) resulting in an inspired partial pressure of oxygen (PIO2) less than 150 mmHg 
9. There is currently a large debate on the patho-physiological responses to hypoxia in two 
different types of exposure: hypobaric hypoxia (HH; FIO2 = 20.9%; PB < 760 mmHg) or 
normobaric hypoxia (NH; FIO2 < 20.9%; PB = 760 mmHg) 10. These two types of hypoxia 
seem to trigger different physiological responses with, for instance a greater increase in 
oxidative stress markers 11 and a decrease in the nitric oxide (NO) bioavailability in HH, 
compared to NH condition 12, 13. In addition, breathing pattern has been shown to be affected 
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in a different way between HH and NH with a lower tidal volume, lower minute ventilation, a 
higher physiological dead space and a higher respiratory frequency during HH exposure 9, 14, 
15. Several previous studies have also demonstrated that the severity of acute mountain 
sickness (AMS) is higher in HH compared to NH 16-18.  
 
During sleep, altitude also seems to have an impact on respiratory physiology in both HH and 
NH: Oxygen transport has been shown reduced in continuous 19 and intermittent NH 20 as 
well as in HH 21. Moreover, Nespoulet et al. showed that O2 and CO2 chemosensitivity are 
closely related to ventilation during NH22. Kinsman et al. largely studied the respiratory and 
sleep disturbances during sleep in NH and observed periodic breathing (irregular respiratory 
pattern marked by alternating periods of rapid and slow respirations and by apneic periods 
lasting 15 sec or less) at a simulated altitude of 2650 m23-25.  In addition, they also determined 
that the rate of rapid eye-movement sleep (%REM) increased with simulated hypoxic 
exposure compared to normoxia and that longer exposure time was associated with worse 
sleep quality. In HH conditions, several authors observed the development of periodic 
nocturnal breathing with increasing altitude. Moreover, Sargent et al. and Roach et al. 26, 27 
reported a reduction of REM sleep and the presence of periodic breathing during sleep in 
young athletes after rapid ascent to 3600 m. This occurrence of nocturnal periodic breathing 
with accompanying cyclical intermittent hypoxia (IH 19, 28) means that the sleeping athlete 
would experience varying severities of cyclical, intermittent arterial hypoxemia, that contain 
many of the features of maladaptive IH associated in sleep apneas (e.g., reactive oxygen 
species producing cyclical HbO2 desaturation/resaturation, transient arousals, repeated swings 
in cerebral vascular resistance and blood flow and intra-thoracic pressures coinciding with 
apneic/hyperpneic phases of the periodic cycles) 29. Furthermore, it was speculated 30 that 
these maladaptive effects of the altitude-induced nocturnal IH would persist during the 
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athlete’s daily training sessions and negatively impact exercise performance even in normoxia 
through elevated sympathetic vasoconstrictor outflow and pulmonary vascular remodeling 
reduced plasma volume or high ventilatory drive. Thus, sleeping in altitude would lead to 
alterations in breathing physiology during sleep and/or subsequently to maladaptive effects 
altering directly exercise performance even at sea level. On the other hand, recent studies also 
suggest that periodic breathing at altitude may be a protective/adaptive mechanism: It has 
been shown that for a given stimulus (either normobaric or hypobaric) mean nocturnal SpO2 
mean can be higher in subjects exhibiting a large amount of apneas compared to those who 
don’t 22. In addition, periodic breathing seems not to play a predominant role in the 
pathogenesis of acute mountain sickness 31 and may even have a protective role 22. This 
supposes a possible disconnection between sleep quality (high number of apneas would be 
deleterious) and adaptive efficiency (high number of apneas could be positive despite a poor 
sleep quality). This was recently shown in heart failure patients in whom treatment of Cheyne 
stokes breathing with adaptive servoventilation increased significantly cardiovascular 
mortality 32. To date, sleep pattern has been observed in either NH or HH, but never directly 
compared between one another. The purpose of the present study was therefore to compare 
the magnitude of sleep and breathing disturbances between these two hypoxic conditions in 
order to better understand the underlying pathophysiological mechanisms.  
Methods 
Participants 
Thirteen healthy trained males subjects volunteered for this study (mean ± SD; age 34 ± 9 yrs, 
body weight 76.2 ± 6.8 kg, height 179.7 ± 4.2 cm). All subjects provided a written informed 
consent before participation. The experiment was approved by a Medical Ethics Committee 
(Commission Cantonale Valaisanne d’Ethique Médicale, CCVEM; Agreement 051/09) and 
performed in accordance with the Declaration of Helsinki.  
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Protocol 
After a first visit to the sleep laboratory, the participants were asked to sleep under three 
different conditions in random order, 12 to 20 days apart. Two nights were spent in a hypoxic 
chamber (ATS Altitude, Sydney, Australia) at an altitude of 485 m (Sion, Switzerland). One 
night recording was performed in the chamber under normobaric normoxia (NN) conditions 
with a FIO2 of 20.9% (control night, PB of 718.1 ± 3.8, mmHg PIO2 140.5 ± 0.6 mmHg, a 
temperature of 23 ± 1°C and a humidity of 42.8 ± 4.4%), and a second night in the chamber 
under normobaric hypoxia (NH) with a FIO2 of 13.6% to simulate an altitude of 3450 m (PB 
of 715.8 ± 3.8 mmHg, PIO2 of 91.0 ± 0.6 mmHg, a temperature of 22.7 ± 0.8°C and a 
humidity of 41.0 ± 4.8%). Oxygen level was controlled with an electronic oximeter (GOX 
100 oximeter, Greisinger, Regenstauf, Germany). In order to blind the subjects to normobaric 
hypoxic or normoxic condition, the hypoxic system was also running during the NN night but 
normoxic airflow was spread into the chamber. The third nocturnal recording was performed 
in hypobaric hypoxia (HH) at the Jungfraujoch  High Altitude Research Station (3450 m, FIO2 
of 20.9%, PB of 481.8 ± 4.7 mm Hg, PIO2 of 90.9 ± 1.0 mmHg, temperature of 21.3 ± 0.6°C, 
humidity of 45.1 ± 8.3%). Each session consisted in a 26-h exposure to each condition (NN, 
NH, HH) in a randomized order. The schedule and activities during the whole sessions were 
exactly the same for each condition. The bedding conditions were similar among conditions. 
Sleep hours and conditions were very well controlled. Subjects were equipped with the PSG 
and then directly went to bed at 10 pm. The light were turned off at this moment for the whole 
night and turned on at 6 am. Thus the time spent in bed and the night duration were exactly 
the same among conditions. Moreover, subjects were wearing earplugs and eye masks during 
the nights, to avoid any external (i.e. noise and/or light) perturbations. The travel duration to 
access the Jungfraujoch by train during the HH sessions was approximately 50 minutes. This 
gradual gain in altitude was simulated during the NH and NN sessions. For 45 min before 
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entering the chamber, subjects breathed either hypoxic air (for NH) or room air (for NN) in a 
blinded fashion, using a mask connected to a three-way valve to an altitude simulation device 
(Altitrainer, SMTech, Nyon, Switzerland).  
The hypoxic chamber is a well-ventilated 30 m3 room (2.4 m×5.0 m×2.5 m) with transparent 
glass panels. The system consists in a compressor storing air in pressurized tanks with serial 
connection to air filters allowing oxygen reduction (altitude simulation) in the chamber. 
Temperature inside the chamber was maintained at 23° (23 and 22.7° for NN and NH 
respectively) in average by an internal air conditioning system.  
During each session, participants were asked to fill three questionnaires upon waking-up in 
the morning including 1) The ESQ (Environmental Symptoms Questionnaire, divided in two 
parts: ESQ C for cerebral symptoms and ESQ R for respiratory symptoms out of 67 
questions33) developed to help researchers quantifying symptoms experienced by individuals 
exposed to extreme environmental conditions, 2) the Lake Louise score questionnaire (LLS), 
a scoring system developed by the 1991 International Hypoxia Symposium consensus 
committee, which is widely used today to assess the severity of AMS 34 and 3) the Groningen 
Sleep Quality Scale (GSQS)35, which was used to evaluate high altitude sleep (HAS) 
disturbances. 
Twice per session, 4 hours before sleep and 4 hours after waking up, the Eupneic end-tidal 
CO2 pressure (PETCO2) was recorded on a breath-by-breath basis at the mouth with a Pitot 
tube (Medgraphics CPX, Loma Linda, USA). This parameter is a good indicator of arterial 
pressure in CO2 (PaCO2).  
Sleep was recorded using polysomnography (PSG). A trained sleep technician equipped the 
subjects with the PSG recorder (Titanium, Embla® Flaga, Reykjavik, Iceland) between 7 and 
9 PM. All sleep recordings included six electroencephalography, two electrooculography, 
three surface electromyography (one submental, two for right and left anterior tibialis 
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muscles) channels, electrocardiogram (composed of two electrodes), nasal pressure, thoracic 
and abdominal belts, body position, oxygen saturation and pulse rate. 
All PSG recordings were scored by a trained sleep technicians (NT) using Somnologica 
software (Version 5.1.1, by Embla® Flaga, Reykjavik, Iceland) and reviewed by certified 
sleep physicians. Sleep stages, leg movements and arousals were scored according to the 2007 
AASM criteria 36. Apneas/hypopneas were scored according to the AASM 2012 rules 37. The 
average number of apneas/hypopneas per hour of sleep (apnea-hypopnea index [AHI]) was 
calculated. The oxygen desaturation indexes represent the number of oxygen saturation drops 
(≥ 3% and ≥ 4% for ODI 3% and ODI 4%, respectively) per hour of sleep. 
Statistic 
Data are reported as means and standard deviation for all parameters except for AHI and ODI 
where the medians and the 1st and 3rd quartile are reported. Data were tested for equality of 
variance (Levene's Test for Equality of Variances) and for normality (Shapiro-Wilk test). 
One-way ANOVAs with Student-Newman-Keuls post-hoc tests for all pairwise comparisons 
were used to identify differences between conditions (NN, NH, HH) in all respiratory, sleep 
and questionnaires data. AHI and ODI were not normally distributed, so ANOVAs were done 
on log-transformed data and values are presented with medians and confidence intervals. Null 
hypothesis was rejected at P<0.05. A two-ways ANOVA with repeated measures (condition x 
time) was used to identify differences in PETCO2 between before and after the night as well as 
between conditions; Holm-Sidak post-hoc test was used for all pairwise comparisons to 
identify differences between conditions (NN, NH, HH). Pearson correlation was used to 
determine correlations between SpO2, hypopneas and LLS. All analyses were made using 
Sigmaplot 11.0 software (Systat Software, San Jose, CA). We estimated that 13 subjects were 
needed to have a 90% power with and alpha of 0.05 to detect 10±10 respiratory events per 
hour of sleep between the different conditions. 
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Results   
Sleep variables in the three different conditions are presented in table 1. Total sleep duration 
was decreased under both hypoxic conditions compared with the normoxic condition. The 
time spent in deep sleep (N3) and in REM sleep was also reduced in both hypoxic conditions 
(ANOVA P<0.05 and P<0.001 respectively), with an additional reduction in HH compared to 
NH (P<0.05 for both).  
 
Table 1: sleep indexes and indicators measured with night polysomnography 
Indices Unity NN NH HH ANOVA P 
TST   [min] 388 ± 50 317 ± 65** 351 ± 63*# 0.031 
Sleep efficiency  [%] 92.8 ± 4.8 85.3 ± 12.5 84.4 ± 12.2 0.094 
WASO [min] 29 ± 19 55 ± 45 63 ± 48 0.083 
AI   [1.min-1] 17.3 ± 6.8 26.2 ± 14.3 24.6 ± 13.9 0.150 
SOL  [min] 7.4 ± 7.1 9.4 ± 9.7 5.6 ± 3.6 0.407 
NREM 1  [min] 28.5 ± 11.3 26.9 ± 16.0 32.01 ± 12.8 0.620 
NREM 1 [%] 7.4 ± 2.8 8.6 ± 4.9 9.2 ± 4.1 0.502 
NREM 2 [min] 217.9 ± 38.0 192.2 ± 40.8 207.7 ± 41.7 0.271 
NREM 2 [%] 56.3 ± 7.5 61.1 ± 7.1 59.1 ± 6.5 0.235 
NREM 3 [min] 66.7 ± 17.5 55.8 ± 18.5* 49.2 ± 15.1*# 0.043 
NREM 3 [%] 17.1 ± 3.4 17.6 ± 4.6 14.3 ± 4.2 0.098 
REM [min] 75.0 ± 19.9 42.2 ± 20.9** 62.4 ± 27.1*# 0.003 
REM [%] 19.2 ± 4.0 12.7 ± 4.9*** 17.4 ± 5.8*# 0.006 
Position 
transition  
[n] 26.0 ± 26.6 26.7 ± 15.3 34.9 ± 22.6 0.522 
 
With NN: Normobaric normoxia, NH: normobaric hypoxia and HH: hypobaric hypoxia. TST total sleep time; 
Sleep efficiency is the ration of time spent asleep (i.e. TST) to the amount of time spent in bed; WASO 
wakefulness after sleep onset; AI total arousal index; SOL sleep onset latency; NREM non rapid eyes 
movements during sleep in different stages of sleep (1, 2, 3); REM rapid eyes movements. Data are mean ± SD. 
*P<0.05, **P<0.01, ***P<0.001 for differences with NN; #P<0.05 for differences with NH. 
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Respiratory parameters during sleep are displayed in table 2.  
Table 2: respiration indexes and indicators measured with the night polysomnography. 
Indices Unity NN NH HH 
ANOVA 
P 
AHI  [n] 8.2 [3.9-8.8] 11.4 [5.0-65.4]* 20.5 [15.8-57.4]*# 0.006  
AHI in REM  [n] 0 [0-6.8] 1.2 [0-17.0] 6.5 [0.6-11.5] 0.291 
AHI NREM [n] 6.9 [3.2-8.2] 10.2 [5.4-69.1]* 20.9 [12.2-58.9]*# 0.010 
AHI Supine [n] 9.4 [2.4-18.1] 17.9 [7.9-61-7]* 40.7 [17.5-76.2]*# 0.003 
AHI Non-supine [n] 5.2 [3.1-7.0] 11.9 [2.8-51.0] 23.5 [7.3-40.4] 0.116 
ODI 3% [n] 4.4 [2.2-4.8] 22.7 [13.1-73.8]* 47.6 [22.1-82.2]*# <0.001 
ODI 4% [n] 0.9 [0.5-1.2] 9.1 [5.7-59.2]* 29.2 [8.8-57.1]*# <0.001 
RAI [n] 5.3 ± 3.9 14.2 ± 17.8 13.1 ± 13.4 0.185 
Hypopnea [n] 7.2 ± 2.4  18.3 ± 15.9* 25.3 ± 18.8**# 0.005 
Mean SpO2  [%] 95.5 ± 0.9 83.6 ± 1.9*** 81.2 ± 3.1***## <0.001 
Min SpO2 [%] 92.0 ± 1.5 74.7 ± 7.0*** 72.6 ± 4.2***# <0.001 
Heart rate [beat.min-1] 48 ± 5 55 ± 6* 61 ± 10***# <0.001 
%TST SpO2 < 90% [%] 0.2 ± 0.7 99.79 ± 0.3*** 99.84 ± 0.6***# <0.001 
Breathing freq [breath.min-1] 9.7 ± 3.2 10.5 ± 3.4 10.9 ± 3.7 0.748 
 
With NN: Normobaric normoxia, NH: normobaric hypoxia and HH: hypobaric hypoxia. AHI apnea/hypopnea 
index; AHI in REM apnea/hypopnea index in rapid eyes movements; AHI NREM apnea/hypopnea index in non-
rapid eyes movements; AHI Supine apnea/hypopnea index in supine position; AHI Non-Supine apnea/hypopnea 
index in Non-Supine position; ODI 3% oxygen desaturation index of 3%; ODI 4% oxygen desaturation index of 
4%; RAI respiratory arousal index; Mean SpO2 mean of oxygen saturation level; Min SpO2 minimal oxygen 
saturation level; %SpO2<90% % of oxygen saturation under 90%; f breathing frequency. Data are median ± IC 
for all AHI and ODI and mean ± SD for RAI, HI, Mean SpO2, Min SpO2, HR and %SpO2 < 90%. *P<0.05, 
**P<0.01 and ***P<0.001 for differences with NN; #P<0.05 and ##P<0.01 for differences with NH. 
 
In HH and NH, there was a decrease in mean nocturnal SpO2 (P<0.001) and an increase in 
ODI 3% or ODI 4% compared to NN condition (P<0.001). We also observed a further 
significant alteration in these parameters in HH compared to NH (P<0.05 for all). In the same 
line, the frequency of respiratory events (AHI), increased in NH compared to NN and was 
even significantly higher in HH compared to NH (P<0.05). These differences in AHI were 
however absent in REM sleep. The type of respiratory events observed included a great 
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majority of hypopneas, which were almost exclusively of central type. There was no 
significant difference in the types of apnea (central, obstructive or mixed) events between the 
three conditions, which were almost exclusively of central type. Breathing frequency did not 
differ between the 3 conditions. 
The LLS were not statistically different between conditions (1.6 ± 1.3, 2.3 ± 2.8 and 3.1 ± 2.6 
for NN, NH and HH, respectively), but showed mild AMS (score > 3) only in HH.   
The results of the questionnaires assessing subjective sleep quality and sleep related 
complaints are displayed on table 3. Only the Goeningen questionnaire showed a significant 
decrease in sleep quality in NH and HH compared to NN, without difference between the two 
hypoxic conditions.  
 
Table 3: questionnaires scores 
Questionnaire Score NN NH HH ANOVA P 
LLS [0-15] 1.6 ± 1.3 2.3 ± 2.8 3.1 ± 2.6 0.229 
ESQ C [0-5] 0.1 ± 0.1 0.3 ± 0.5 0.5 ± 0.6 0.096 
ESQ R [0-5] 0.2 ± 0.2 0.2 ± 0.3 0.3 ± 0.4 0.268 
SLS [0-14] 3.8 ± 3.4 6.6 ± 3.5* 6.5 ± 4.1* 0.016 
VAS SQ [0-10] 5.5 ± 2.1 4.0 ± 2.1 4.7 ± 2.2 0.194 
VAS WS [0-10] 5.9 ± 1.8 4.9 ± 2.1 5.0 ± 2.4 0.329 
 
Questionnaires filled in the morning after each night in normobaric normoxia (NN), normobaric hypoxia (NH) or 
hypobaric hypoxia (HH). LLS Lake Louise score; ESQ C environmental syndrome questionnaire for cerebral 
symptoms of acute mountain sickness; ESQ R environmental syndrome questionnaire for respiratory symptoms 
of acute mountain sickness; SLS sleep score (Groeningen); VAS SQ visual analogic scale for sleep quality; VAS 
WS visual analogic scale for waking state. Data are mean ± standard deviations. *P<0.05 for differences with 
NN. 
 
The PETCO2 before sleep was not different between HH and NH (34.9 ± 5.5 vs. 35.1 ± 2.7 
mmHg for HH and NH respectively) but they were both significantly lower compared to NN 
(38.7 ± 3.2 mmHg, P<0.05). After the sleep the PETCO2 remained higher for NN (39.3 ± 3.1 
mmHg, P<0.001) compared to the hypoxic conditions (33.2 ± 2.2 and 33.5 ± 4.8 mmHg for 
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NH and HH, respectively) with both hypoxic conditions being similar (condition by time 
interaction F = 2.003, P = 0.167). 
A negative correlation was noted between SpO2 and the hypopneas (r = -0.442, P = 0.024; NH 
and HH data pooled). When considering the conditions separately, the relationship was 
significant only in NH (r = -0.555, P = 0.049 vs. R = -0.326, P = 0.277, for NH and HH 
respectively).  Another correlation was observed between SpO2 and the LLS (r = -0.416, P = 
0.035; NH and HH data pooled) but was significant only in HH (r = 0.006, P = 0.984 vs. r = -
0.659, P = 0.014; for NH and HH respectively). 
 
Discussion 
To our knowledge, this is the first study comparing directly the effects of normobaric vs. 
hypobaric hypoxia with matched inspired pressure of oxygen on sleep structure and sleep 
disordered breathing in the same group of subjects. Our results show that both hypoxic 
conditions are associated with decreased sleep quality and increased nocturnal breathing 
disturbances. The major finding is that the addition of hypobaria to hypoxia (i.e. HH) further 
alters nocturnal breathing and sleep quality compared to hypoxia alone (i.e. NH). 
 
The decrease in mean SpO2 found in both hypoxic conditions were expected but we observed 
a further decrease in HH compared to NH despite a similar oxygen pressure level (PIO2 91.0 ± 
0.6 mmHg vs. 90.9 ± 1.0 for NH and HH). These data are in line with previous ones 15, 18, 38. 
Although differences in physiological dead space between NH and HH have been previously 
suggested14, this mechanism remains highly speculative. In the present study, breathing 
frequency was not significantly higher in HH than in NH, but differences in breathing pattern 
between the two hypoxic conditions have been already reported15, 39 with a higher breathing 
frequency in HH, even if this point is still debated 39.  
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The lower SpO2 in HH compare to NH could also be due to a decrease in NO bioavailability, 
yielding a pulmonary capillary vasoconstriction and impaired alveolar/capillary gas exchange 
and modifying O2 diffusion by decreasing the pressure gradient 9, 40, 41.  Barometric pressure 
per se can modify the fluid circulation (e.g. pulmonary lymph) and the trans- alveoli-capillary 
membrane flux 40. It may also influence the N2 and O2 concentration in the cerebrospinal fluid 
and therefore partly change the central regulation of ventilation 9. Moreover, it has been 
speculated that apnea/hypopneas have a protective effect during sleep at altitude by 
preserving a better oxygenation, probably due to a more pronounced hyperventilation 
following apnoeic events 22. It was not the case in the present study: the lower the SpO2, the 
higher the number of hypopneas. In addition, the relationship between SpO2 and hypopneas 
was significant only in NH, suggesting that the difference in mean nocturnal SpO2 between 
NH and HH was not only due to the difference in the ventilatory events. 
 
The increase in respiratory events (central apneas and hypopneas) found in both hypoxic 
conditions are believed to be related to a hypoxia-induced increase in chemoreceptor 
sensitivity (higher loop gain)42. When loop gain increases, the ventilatory response to mild 
increases in arterial CO2 level generated by hypopneas or apneas tends to be excessive during 
sleep. This ventilatory “overshoot” at the end of the respiratory events will in turn generate a 
drop in PaCO2 level (and re-increase SpO2) in the following seconds. During sleep, ventilation 
drive is highly dependent on the blood CO2 level: when PaCO2 drops below a certain level 
called the “apnea threshold”, breathing slows down or stops generating a hypopnea or an 
apnea until PaCO2 builds up and stimulates breathing again, and so on.  
Another factor influencing the increase in respiratory events could be the decreased mean 
SpO2 which increases the amplitude of the oxygen desaturations (ODI 3% and ODI 4%) for a 
given decrease in PaO2, since the hemoglobin dissociation curve is much steeper for the SaO2 
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values of 81%-84% that we observed in hypoxic conditions. A decrease in arousal threshold 
(increased arousability) associated with hypoxia could also induce respiratory instability and 
increase the frequency of nocturnal respiratory events. However, we do not believe that this 
was a major factor since the arousal index was only mildly increased in hypoxic conditions 
compared with normoxia.  
 
The decrease in respiratory events found during REM sleep is a well-known phenomenon 
occurring at low and high altitude due to a lesser CO2 sensitivity in this sleep stage. The 
increase in sleep disordered breathing observed in HH compared to NH is however more 
difficult to explain. The possible increase in physiological dead space in HH is probably not 
the only cause since previous studies by our group and others showed that an increase in dead 
space (using a face mask) could significantly decrease altitude-induced central respiratory 
events 43, 44 (even though this experimental increase in dead space was probably much larger). 
Altered environmental conditions (comfort, temperature…) at high altitude compared with 
simulated altitude could play a role but the arousal index was not different between both 
conditions. Of importance was that the environmental factors were strictly controlled, with the 
particular attention to humidity, temperature and sleep conditions (bedtime and rise, noise and 
light conditions…) and, obviously, inspired oxygen fractions. A measurement of end-tidal 
CO2 during sleep in both conditions could help to better understand these differences. 
 
We also found decreased sleep duration and a lower proportion of deep sleep (N3) and REM 
sleep in both hypoxic conditions compared with normoxic condition. These sleep structure 
alterations have been reported before in young athletes at high altitude (3600 m) with a 
resumption of after two weeks except for lower deep sleep 26. The same pattern was also 
reported in mountaineers at higher altitude (4559 m) with an early improvement after 3 nights 
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already31. The most likely explanation for these sleep structure alterations is the increase in 
sleep-disordered breathing, which increases sympathetic nervous system activity. Our results 
do however not support direct impact of environmental conditions such as temperature or 
discomfort of the bed since we saw the same decrease in REM sleep, SWS and TST in both 
hypoxic conditions whereas NN recordings took place in the exact same chamber as NH; with 
FIO2 being the only difference.  Surprisingly, the sleep duration was more impaired in NH 
condition than in HH condition despite a lower AHI in NH. We could speculate that 
hypobaric conditions (HH) may be more exhausting for the brain and could thus generate a 
greater sleep need than in NH but this hypothesis would need to be confirmed in a specific 
study.   
Despite the fact that no statistical difference in LLS was reported between conditions, a score 
> 3 was only present in HH, showing a mild AMS in this condition only. Hypobaric hypoxia 
seems to induce more severe acute mountain sickness than normobaric hypoxia, which is in 
line with a recent study from DiPasquale et al. 18. Moreover the relationship between SpO2 and 
LLS was significant in the pooled data of NH and HH, but only in HH and not in NH. The 
lower the SpO2, the higher the AMS, in line with previous studies.  
The larger “maladaptive response” 30 of sleeping in HH (i.e. induced by lower SpO2 and 
positive LLS), when compared to NH, is of practical importance for altitude training in 
athletes. First, it confirms that the severity of hypoxia is higher in HH. Secondly it might 
explain that these detrimental effects may counteract partly the expected positive ones: 
recently, we reported that the increase in hemoglobin mass 45 and the performance 
enhancement 46 were similar following 18 days of “Live High Train Low” in NH or HH, 
despite a more severe hypoxic stimulus (larger sleeping desaturation) and longer hypoxic dose 
(300 vs. 220 h) in HH. However, the present study was performed at real and simulated 
altitude of 3450 m and it is likely that the physiological consequences of various degrees of 
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hypoxia might differ. Therefore, the conclusions from the current study might not apply to 
studies performed at lower or higher altitudes. Further studies at different altitudes are needed 
to assess the potential sleep differences between NH and HH. Many fields are concerned by 
the differences between normobaric and hypobaric hypoxia: national and international teams 
and athletes are now using altitude or hypoxic training to improve their preparation47; several 
military forces are also using pre-acclimatization strategies to prepare for high altitude 
missions or assess the impact of hypobaric vs. normobaric hypoxia for space and aviation 
applications48, 49. 
 
Conclusion 
Our results demonstrate for the first time that hypobaric hypoxia (e.g. “real altitude”) has a 
greater impact on nocturnal breathing and sleep structure than normobaric hypoxia (e.g. 
“simulated altitude”) conditions. Primarily, hypobaric hypoxia induces lower nocturnal 
oxygen saturation and more AHI compared to normobaric hypoxia. The main differences 
between these conditions could be NO metabolism altering pulmonary capillaries vasodilation 
or an increased physiological dead space due to hypobaria, but these hypotheses will need to 
be confirmed in further studies. Further researches are required to determine individually the 
duration and severity of inspired PO2 (i.e. the degree of hypoxia) for achieving an optimal 
combination of positive (erythropoietic and peripheral) effects without significantly inducing 
maladaptive consequences for recovery and performance. However, the present study 
explores only one (the first) night. A valuable perspective would be to extend the comparison 
between conditions over longer duration, in order to assess the different adaptations during 
and after the acclimatization period. Another perspective would be to extend the comparison 
at lower or higher altitudes, as the present results are only applicable at the tested altitude of 
3450 m. 
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Abstract 
The present study aimed to compare sleep disordered breathing during Live High-Train Low 
(LHTL) altitude camp using normobaric (NH) and hypobaric (HH) hypoxia. Sixteen highly 
trained triathletes completed two 18-d LHTL camps in a crossover-designed study. They 
trained at 1100-1200 m while they slept either in NH at a simulated altitude of 2250 m or in 
HH. Breathing frequency and oxygen saturation (SpO2) were recorded continuously during 
all nights and oxygen desaturation index (ODI 3%) calculated. Breathing frequency was 
lower for NH than HH during the camps (14.6 ± 3.1 vs. 17.2 ± 3.4 breath.min-1, P<0.001). 
SpO2 was lower for HH than NH (90.8 ± 0.3 vs. 91.9 ± 0.2, P<0.001) and the number of ODI 
3% was higher for HH than NH (15.1 ± 3.5 vs. 9.9 ± 1.6, P<0.001). Sleep in moderate 
hypobaric hypoxia is more altered than in normobaric hypoxia during a LHTL camp.  
Keywords: Exercise, hypobaric hypoxia, normobaric hypoxia, sleep quality. 
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Introduction 
The “Live High-Train Low” (LHTL) training method, introduced in the 1990s (Levine and 
Stray-Gundersen 1997), where athletes sleep at moderate altitude while training at lower 
altitudes or near sea-level, is now used successfully by many endurance athletes. 
Nevertheless, it involves sleeping at altitude, which has been shown to impair sleep quality 
both at high (Sargent et al., 2013) and moderate altitude (Latshang et al., 2013). Furthermore, 
sleep was recognized as an essential component for athletes’ preparation and is suggested to 
be the best recovery strategy available (Halson 2008). In addition, lower sleep quantity and 
quality impairment were shown to negatively influence athletes’ performance (Cook et al., 
2011), mainly through a decrease in their aerobic performance (Davenne 2008; Oliver et al., 
2009).  
Several possibilities to induce hypoxia could currently be used for LHTL. Simulated altitude, 
called normobaric hypoxia (NH), with reduction of the inspired fraction of oxygen (FiO2) can 
be used instead of the natural and terrestrial altitude, so called hypobaric hypoxia (e.g., a 
lower barometric pressure inducing a lower oxygen partial pressure, HH). Several slight 
physiological differences between NH and HH exposure have been reported (Millet et al., 
2012; Richard and Koehle 2012). Indeed, the minute ventilation (VE) is higher in NH than in 
HH with a combination of a higher tidal volume and lower respiratory frequency (Conkin and 
Wessel 2008; Savourey et al., 2003). Acute mountain sickness (AMS) symptoms have been 
shown to be less severe in NH than in HH (Loeppky et al., 2005) and the pre-acclimatization 
in ‘real’ altitude (HH) resulted in significant decrease in severity of AMS when traveling to 
HH conditions, while it was not the case with NH pre-acclimatization (Fulco et al., 2013). 
Differences in fluids balance have also been observed with a higher diuresis and larger 
decrease in plasma volume for NH, while HH induced larger fluid retention (Conkin and 
Wessel 2008; Loeppky et al., 2005). The nitric oxide (NO) in exhaled air or in plasma and the 
 -210- 
oxidative stress markers were also shown to be lower in NH than in HH after 10h of exposure 
(Ribon et al., 2016), 24h of exposure (Faiss et al., 2013) or 18-d of LHTL training (Debevec 
et al., 2015). Taken together, these differences suggest different physiological responses to 
hypoxic exposure in ‘simulated’ (NH) versus ‘real’ altitude (HH) given similar inspired 
oxygen partial pressure (PIO2). Therefore, we can then speculate that the type of hypoxia (e.g. 
normobaric or hypobaric hypoxia) could influence the sleep in altitude in a different way 
between conditions, even with PIO2 strictly matched. Which could be the potential 
mechanisms underlying differences between sleep in normobaric and hypobaric hypoxia and 
their influence on the athletes’ recovery? Several protocols have already studied the sleep 
disturbances either with NH (Fulco et al., 2011; Hoshikawa et al., 2013; Nespoulet et al., 
2012) or HH (Latshang et al., 2013; Roach et al., 2013; Sargent et al., 2013) but never with a 
direct comparison on the same subjects. The purpose of the present study was then to 
compare the sleep disordered breathing during a LHTL altitude training camp of 18 days 
either in NH or HH, with a crossover design including a one-year washout period between the 
two campaigns. Regarding all precedents studies on the differences between the two types of 
hypoxia, we hypothesized that HH would impair sleep breathing to a greater extent than NH.  
 
Methods 
Ethics statement. The study was approved by the regional medical ethics committee 
(Commission Cantonale Valaisanne d’Ethique Médicale, CCVEM; Agreement 051/09 and 
French National Conference of Research Ethics Committees; N°CPP EST I: 2014/33; Dijon, 
France). All experimental procedures conformed to the standards set by the declaration of 
Helsinki. This study was part of a comprehensive research program investigating 
physiological, psychological and performance adaptions of endurance athletes to normobaric 
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and hypobaric LHTL protocol. Many methodological details are reported elsewhere (Saugy et 
al., 2014), but are also outlined here for the convenience of the reader.  
 
Participants. Sixteen subjects participated to the study (data are mean ± SD: age 24 ± 4 years, 
body height 179 ± 5 cm, body weight 70 ± 5 kg, BMI 21.8 ± 1.7 kg.m2, VO2max 66.3 ± 7.5 
mL.kg-1.min-1, and Pmax 380 ± 48 w). All participants were informed about the experimental 
procedures and gave a written informed consent prior start of the study. The participants were 
non-smokers, sea near sea-level residents (< 600 m) and were not exposed to altitudes above 
2000 m for at last one month prior to the study.  
 
Study design. This crossover designed study comprised of two main experimental campaigns. 
Before the first campaign the participants were equally assigned to either the NH or the HH 
LHTL protocol. A one-year washout period was implemented between the campaigns to 
avoid any carry-over effect from the first intervention. During the second campaign the 
participants’ conditions were crossed in order to complete the study crossover design. The 
intervention consisted of an 18-day LHTL phase performed in either NH or HH preceded by 
Pre-test and ending with Post-test. During the LHTL phase all participants performed 
supervised training sessions at altitudes between 1100 – 1200 m and resided at natural or 
simulated altitude of ~ 2250 m. Peripheral oxygen saturation (SpO2) was measured during 
each night throughout the LHTL phase using a fingertip portable oximeter. During the LHTL 
phase, the participants were asked to spend a minimum of 12 hrs·day-1 in 1-3 person hypoxic 
rooms with conventional beds. The reduction of the O2 fraction (FIO2) was achieved and 
maintained using an oxygen extraction system (OBS, Husøysund, Norway) that delivered the 
oxygen-depleted air to the designated rooms. The system was calibrated before the start of the 
study using precision calibration gases. The levels of O2 and carbon dioxide were 
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continuously monitored using designated probes in each room (OBS, Husøysund, Norway). 
The simulated altitude in the rooms was kept constant throughout the protocol in order to 
maintain a simulated altitude of 2250 m (FIO2 = 18.05 ± 0.03%; Barometric pressure (PB) = 
666.6 ± 3.6 mmHg; PIO2 = 111.9 ± 0.6 mmHg; simulated altitude ~ 2250 m). The HH 
participants resided in a ski resort in the Swiss Alps (FIO2 = 20.9 ± 0.0%; PB = 580.2 ± 2.9 
mmHg; PIO2 = 111.6 ± 0.6 mmHg; altitude = 2250 m) throughout the terrestrial LHTL phase 
in 1-5 person rooms equipped with conventional beds (similar as in the NH rooms).  
 
Measurements 
Anthropometrics values. Athletes’ body weight and height were measured in the morning 
before the breakfast and main body composition parameters were measured during Pre- and 
Post-tests and twice per week during the LHTL camp. 
Questionnaire. Daily Lake Louise questionnaires were filled directly after waking up in 
rooms (hypoxic rooms for NH and normal room in HH, but all in hypoxia) during the whole 
protocol.  
Sleep breathing assessment. SpO2 and HR were recorded during all nights at 0.25 Hz with a 
wrist oximeter connected to a finger sensor (Wristox 3150 with 8000SM-WO Sensor, Nonin, 
Plymouth, MN). In addition, the number of times per hour of sleep that SpO2 level drops by 3 
percent or more has been calculated throughout these nights recordings (i.e. oxygen 
desaturation index = ODI 3%). Subjects were wearing an instrumented t-shirt (model SEW, 
CSEM, Neuchâtel, Switzerland) during all nights (including the 2 Pre- and Post- nights). This 
device made of comfortable fabric measured the breathing frequency with an elastic sensor 
included in the textile and the sleeping position with accelerometers.  
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Data Analysis and Statistics. Data are reported as means and standard deviations. Data were 
tested for equality of variance (Fisher-Snedecor F-test) and for normality (Shapiro-Wilk test). 
When both conditions were met, a two-way ANOVA for repeated measures was performed 
with the two conditions (NH and HH). To determine the time effect for variables measured 
several times during the camps, all pairwise multiple comparison procedures was used (Holm-
Sidak method). Differences between means in NH and HH were then compared using a paired 
t-test. Null hypothesis was rejected at P<0.05. All analyses were made using Sigmaplot 11.0 
software (Systat Software, San Jose, CA).  
Results 
Peripheral oxygen saturation. The peripheral oxygen saturation was higher for NH than HH 
during the whole camps (91.9 ± 0.2 vs. 90.8 ± 0.3, P<0.001) and remained higher at Post 
(94.4 ± 0.1 vs. 93.6 ± 0.2, P<0.05). ODI 3% mean was significantly higher for HH than NH 
throughout the hypoxic nights (15.1 ± 3.5 vs. 9.9 ± 1.6, P<0.001). The nightly ODI 3% was 
significantly higher in HH than NH from D2 to D14. No difference was found before and 
after the camp. The evolution of the ODI 3% during the camps is presented in Figure 1.   
Heart rate. The mean nocturnal heart rate during the whole camp was higher for NH than HH 
(51 ± 1 vs. 48 ± 2 bpm, P<0.001). 
Night breathing frequency. Although the night breathing frequencies were similar between 
the conditions during the two nights prior the camps (14.4 ± 2.4 vs. 15.1 ± 2.9 breath.min-1 for 
NH and HH, respectively), they were lower for NH than HH (14.6 ± 3.1 vs. 17.2 ± 3.4 
breath.min-1, P<0.001) during the camps (D1-D18), and stayed lower the two nights following 
the camps (14.2 ± 3.4 vs. 15.6 ± 3.1 breath.min-1, P<0.01). These data are presented in Figure 
2. 
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Lake Louise Questionnaire 
No positive Lake Louise score and no difference between conditions were found (1.2 ± 1.4 vs. 
1.2 ± 1.6 for NH and HH, respectively). 
 
Figure 1. Values (mean ± standard error) of night oxygen desaturation index larger than 3% ≥per hour (ODI > 
3%). Pre1-Pre2: measurements before the camps (1150 m); D01-D18: measurement during the camps (NH: 
hypoxic room; HH: ski resort). #P<0.05 for differences between conditions. 
Oxygen desatura!on index ≥ 3%
#
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Figure 2. Values (mean ± standard error) of breathing frequency (f) measured during the night with 
instrumented t-shirts for NH and HH groups. Pre1-Pre2: measurements before the camps (1150 m); D01-D18: 
measurement during the camps (NH: hypoxic room; HH: ski resort). ##P<0.01, ###P<0.001 for differences 
between conditions. 
Discussion 
To our knowledge, this is the first crossover study comparing the sleep breathing during an 
18-d LHTL altitude camp conducted either in NH or HH conditions. Lower night peripheral 
oxygen saturation levels and HR were noted in HH compared to NH. Moreover, a higher ODI 
3% has been observed during the nights in HH. In addition, a lower nocturnal breathing 
frequency has been shown in NH compared to HH.  
 
As stated before, sleep quality is known to be disturbed in hypoxia either with NH (Fulco et 
al., 2011; Hoshikawa et al., 2013; Kinsman et al., 2003; Nespoulet et al., 2012) or HH 
(Kinsman et al., 2003; Latshang et al., 2013; Roach et al., 2013; Sargent et al., 2013). The 
decreased oxygen fraction leads to hypoxemia, which is known to induce sleep perturbations 
(Fulco et al., 2011). In addition, Fulco et al. (Fulco et al., 2011) stated that sleep either in NH 
or HH characterized the altitude acclimatization as a result from numerous inter-related 
### ##
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physiological adjustments that compensate hypoxemia. The progressive decrease in the end-
tidal PCO2 (PETCO2) leads to an increase in peripheral oxygen level (SpO2) during the first 
days of moderate altitude residence in HH (Young and Reeves 2002). A comparable degree of 
acclimatization was induced in NH with daily exposure to hypoxia (Muza 2007).  
Logically, SpO2 was lower in hypoxia than in the two control nights. Of interest is that SpO2 
remained lower in HH compared to NH during and after the camps. These differences were 
also found at higher altitude with shorter expositions (Saugy et al., 2015). The reasons of this 
lower peripheral oxygen saturation in HH are still unclear. However, one may speculate that 
the barometric pressure modifies the fluid circulation and the transalveoli–capillary 
membrane flux, which might in turn induce greater pulmonary vasoconstriction in HH and 
then modify the oxygen diffusion by decreasing the pressure gradient between the alveoli and 
capillaries. In addition, the exaggerated oxidative stress generally reported in HH might affect 
nitric oxide bioavailability, which could impair oxygen unloading to tissues (Faiss et al., 
2013; Ribon et al., 2016).  
The oxygen desaturation index (ODI 3%) was significantly higher for HH compared to NH 
(Figure 1) denoting a more disturbed sleep breathing than in NH. ODI 3% is considered as a 
reliable indicator of sleep apnea (Hang et al., 2015). This episodic breathing observed in HH 
might lead to intermittent hypoxia and consequently have clinical consequences: the 
desaturation-reoxygenation sequence is a typical pattern coupled with the majority of 
respiratory events defining intermittent hypoxia leading to oxidative stress with production of 
reactive oxygen species (ROS) (Lavie 2003). This increase in ROS could generate vascular 
endothelial damage and dysfunction (Lavie 2008). Altered baroreflex activity, increased 
pulmonary arterial pressure, changes in heart structure are also potential deleterious causes of 
sleep disordered breathing induced by episodic breathing in intermittent hypoxia (Lavie 
2008).  
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The increase in ventilation is one of the first physiological adaptations when exposed to either 
normobaric or hypobaric hypoxia (Dempsey and Morgan 2015; Fulco et al., 2011). This rise 
counteracts partly the reduction in oxygen transport induced by hypoxic environments. 
Ventilation and its associated parameters (i.e. PETO2, PETCO2, breathing frequency and 
physiological alveolar dead space) have already been shown different between NH and HH 
(Conkin and Wessel 2008; Loeppky et al., 2005; Savourey et al., 2003). In the present study, 
the breathing frequency was higher in NH compared to HH from the first to the last night in 
hypoxia and remained higher during the two following nights (14.6 ± 3.1 vs. 17.2 ± 3.4 
breath.min-1 for NH and HH, respectively, P<0.001). These later findings confirmed that “NH 
is not a surrogate to HH” (Conkin 2016) and that NH and HH cannot be used 
interchangeably (Coppel et al., 2015; DiPasquale et al., 2015; Fulco et al., 2011; Saugy et al., 
2015; Saugy et al., 2014). 
It can be assumed that these differences in nocturnal SpO2 and ventilation should have an 
influence on acute mountain sickness, but no AMS has been reported. It is well known that 
AMS is not a problem for the majority of athletes between 2000 and 2500 m (Schommer et 
al., 2012) and that under 3000 m the risk of developing acute altitude illness is very low 
(Luks et al., 2010). 
The present study is unique: In a “real-word” setting, well-trained endurance athletes slept for 
2 phases of 18-days in different hypoxia conditions, with a finger oximeter and an 
instrumented t-shirt in order to measure saturation and breathing frequency without disturbing 
the sleep quality and the training program. By signal analysis, ODI 3% were extracted. The 
use of polysomnography is not possible in these conditions because it would disturb the 
recovery of the athletes.  Of interest is that the present results at a moderate altitude and with 
prolonged exposure confirm our results measured with polysomnography at higher altitude 
(3450 m) during one night where lower SpO2 and higher amount of ODI 3% were observed 
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for HH compared to NH (Heinzer et al., 2016) 
Conclusion 
Our results demonstrate for the first time with a crossover study that sleeping in moderate 
altitude during LHTL altitude camp involved different physiological adaptations between NH 
and HH. First, HH induces lower nocturnal oxygen saturation compared to NH, and a larger 
amount of ODI 3%. The present study adds elements to the growing body of evidences stating 
that NH and HH cannot be used interchangeably (Coppel et al., 2015; Fulco et al., 2011; 
Millet et al., 2012; Saugy et al., 2015; Saugy et al., 2014). However, results should be handle 
with care considering the very individual side of altitude exposures responses (Chapman 
2013). Moreover, the oxygen desaturation index used is calculated from the raw SpO2 
measurements and is an indicator of sleep apneas, but not as relevant as the parameters 
measured by polysomnography analysis.   
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Abstract 
Hypoxia is one major environmental factor, which is supposed to mediate central motor 
command as well as afferent feedbacks at rest and during exercise. We examined the potential 
differences between normobaric and hypobaric hypoxia on the pacing strategies during a self-
paced aerobic exercise. Sixteen healthy subjects performed three cycling time trials (250 
kilojoules) in three different conditions: hypobaric hypoxia (HH), normobaric hypoxia (NH) 
and normobaric normoxia (NN) after 24 h of exposure. Cerebral and muscular oxygenation 
was assessed by near infrared spectroscopy. Power output and peripheral oxygen saturation 
were also measured during the time trial. The tests were divided in 25 slices of 10 kilojoules 
to assess the pacing strategies.  
 
Running title: Self-paced exercise at simulated and terrestrial altitude.  
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Introduction 
Prolonged self-paced exercise, i.e. time trial, is more and more used in sport sciences for its 
relevance to real competitions (Periard & Racinais, 2016). With growing interest in the last 
decades, different models have been proposed to explain the complex regulation of such 
performances implying pacing – distribution of work or energy expenditure throughout a 
time- or distance-fixed exercise – based on several integrative and/or independent factors. 
Most of them refer to central and peripheral regulations through different sensitive feedbacks 
that could be selected by the central nervous system (St Clair Gibson et al., 2006; Edwards & 
Polman, 2013; Roelands et al., 2013; Renfree et al., 2014). One of the most known pacing 
theory has been established by Tucker (Tucker, 2009), called the anticipatory feedback rate of 
perceived exertion (RPE) model, in which the aim is to maintain the homeostasis of the 
athlete in order to finish exercise using the brain as a central governor. Even though 
discrepancies exist between authors, pacing is commonly accepted as a conscious process 
depending on anticipatory/feedforward components and informed by the balance between the 
central motor command (i.e., effort) and afferent feedbacks from multiple physiological 
systems (i.e., exertion). Hence, the RPE would drive behavioral adjustments in power output 
(Abbiss et al., 2015) to both promote optimal performance intensity and prevent catastrophic 
changes in the monitored physiological variables (bodily harm), what is particularly critical 
when external/environmental conditions are challenging. 
One major environmental factor, which is supposed to mediate central motor command as 
well as afferent feedbacks at rest and during exercise, is hypoxia. Cerebral perturbations when 
exercise is conducted under hypoxic conditions compared to normoxia have been reviewed 
recently (Verges et al., 2012; Goodall et al., 2014) and authors concluded that several aspects 
of the supraspinal function such as cerebral blood flow or central motor command play a 
significant role in the hypoxia-induced impaired performance. Particularly, a major role of the 
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prefrontal and/or motor cortex oxygenation trends has been underlined with near-infrared 
spectroscopy measurements during constant (Amann et al., 2007) or incremental (Subudhi et 
al., 2009) workload exercise to exhaustion in hypoxia.  
Besides, decreased arterial oxygenation has been supposed to influence motor output via an 
effect on peripheral locomotors muscles (Amann et al., 2006b; Amann et al., 2007; Amann & 
Calbet, 2008). Enhanced afferent feedbacks (i.e. peripheral fatigue) from respiratory muscles 
exercising in hypoxia are also likely to impact performance through brain integration (Verges 
et al., 2010; Walker et al., 2016). 
Overall, it is known that hypoxia acutely decreases peak oxygen consumption (VO2max) and 
aerobic performance, in particular with large muscular groups involved like in cycling 
activities (Verges et al., 2012), but how pacing may be affected remains uncertain. Only a few 
studies investigated self-paced exercise when arterial oxygenation is manipulated, suggesting 
marginal differences (Clark et al., 2007; Beidleman et al., 2014; Bourdillon et al., 2014) or 
similar trends (Amann et al., 2006b; Periard & Racinais, 2016) in pacing between normoxia 
and hypoxia, despite reduced average power output in the later. A major concern regarding 
these studies is that subjects where exposed to simulated altitude for only 5 to 40 minutes 
before time trials. As oxygen delivery to the tissues (e.g. muscle, brain) progressively evolves 
in the first hours of exposition to hypoxia (e.g. time delay in changes between arterial and 
cerebral oxygenation, (Rupp et al., 2013c), pacing strategies adopted after a 24-h period may 
strongly differ from what has been observed in artificially acute models of exposition.  
Discrepancies in the literature regarding altered pacing in hypoxia may result from differences 
in time trial duration targets (e.g., 5 min for (Clark et al., 2007) versus 50-60 min for (Periard 
& Racinais, 2016)) but also from the type of hypoxia used in these models (hypobaric versus 
normobaric, respectively). Indeed, there is now a large debate on the use of diverse methods 
to induce hypoxia (Millet et al., 2012) as numerous differences have been recently found in 
 -229- 
subjects resting and exercising at a given pressure of inspired oxygen (PiO2), but among 
normobaric (NH) or hypobaric (HH) hypoxic conditions (Coppel et al., 2015). For instance, a 
combination of a higher tidal volume and lower respiratory frequency leading to higher 
minute ventilation in NH compared to HH (Conkin & Wessel, 2008) has been reported and 
markers of oxidative stress have recently been shown lower in NH compared to HH (Faiss et 
al., 2013; Ribon et al., 2016). The mechanisms underlying these slight physiological 
differences are not so clear yet, but we have just shown that they are great enough to 
significantly emphasize performance impairment in HH compared to NH on a 250-kJ cycling 
time trial at 3450 m (Saugy et al., 2016b). A potential explanation of this greater decrement 
could be the lower arterial saturation (SpO2) found at rest and during exercise in HH, despite 
an iso-PiO2. However, the extent to which underlying physiological responses driving pacing 
strategies would be differentially affected in HH versus NH remains unknown. 
The influencing factors of pacing may provide insight into how or why performance 
becomes impaired. In this study, we therefore examined pacing strategies in relation to 
arterial saturation, muscle activity, cerebral hemodynamics and rate of perceived exertion (i.e. 
subjective feelings) during a 250-kJ cycling time trial conducted after 24 h in 1) normobaric 
hypoxia (NH) at a simulated altitude of 3450 m, 2) in hypobaric hypoxia (HH) at a terrestrial 
altitude of 3450 m and, 3) in normobaric normoxia as a control condition. It was hypothesized 
that a 24-h exposure to either normobaric or hypobaric hypoxia would affect pacing strategy 
as a way to avoid critical exercise-induced brain harm. It was also anticipated that SpO2 and 
cerebral hemodynamics would decline to a greater extent during time trial in HH, leading to 
suboptimal pace management and a greater performance loss compared to NH.  
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Methods 
Experimental design and part of the methods have already been presented in a previous paper 
(Saugy et al., 2016b) focusing on global exercise performance in HH versus NH but with no 
mention to the present interests (i.e. exercise-induced physiological adaptations and related 
pacing strategies). For the convenience of the reader, key methodological informations are 
redefined in the present paper.  
Subjects 
Sixteen healthy, trained males subjects volunteered to participate to this study (mean ± SD; 
age 34.7 ± 9.5 years, body weight 75.2 ± 7.2 kg, height 180 ± 6 cm, VO2max 60.2 ± 9.9 ml.kg-
1.min-1). Written informed consent was obtained from each participant before participation. 
Subjects were all non-smokers, and neither acclimatized nor recently exposed to altitude. All 
procedures conformed to the standards set by the Declaration of Helsinki and the study was 
approved by a Medical Ethics Committee (Commission Cantonale Valaisanne d’Ethique 
Médicale, CCVEM; Agreement 051/09). 
Experimental Design 
The experimental design consisted in a preliminary visit and three testing sessions. During the 
first meeting to the laboratory, subjects completed the baseline anthropological 
measurements, filled the consent form and the preliminary questionnaires.  Participants then 
performed (i) a maximal incremental exercise test (FiO2: 0.21; 60 W + 30 W.min-1) to 
determine VO2max and the peak workload on a braked cycle ergometer including a Powertap 
sensor (Cycleops IC 400 Pro, Madison, Wisconsin, USA); and (ii) a familiarization test with 
the 250-kilojoules time trial on the same ergocycle.  
The experimental design was then composed of three different sessions in a 
randomized order separated by at least 12 days. One session was performed in a hypobaric 
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hypoxia (HH) environment at the Altitude Research Station in Jungfraujoch (3450 m, FiO2: 
20.9%, BP: 478.5 ± 3.2 mmHg, PiO2: 100.2 ± 1.4 mmHg).  Two sessions were conducted in a 
hypoxic chamber (ATS Altitude, Sydney, Australia) built in our laboratory (Sion, 485 m, 
Switzerland). The hypoxic chamber is a well-ventilated 30-m3 room (2.4 m × 5.0 m × 2.5 m) 
with transparent glass panels. The system consists in a compressor storing air in pressurized 
tanks with serial connection to air filters allowing oxygen reduction (altitude simulation) in 
the air input flow to the chamber. Temperature inside the chamber was maintained at 22°C in 
average maintained by an internal air conditioning system. One of the two sessions completed 
in the chamber was performed in normobaric hypoxia (NH) with a FiO2 of 13.8% (BP: 716.5 
± 4.4 mmHg, PiO2: 100.3 ± 1.8 mmHg) corresponding to a simulated altitude of 3450 m. The 
other session was performed in normobaric normoxia (NN) with a FiO2 of 20.9% (BP: 719.1 
± 4.0 mmHg, PiO2: 150.5 ± 1.6 mmHg). These parameters were controlled regularly with an 
electronic device (GOX 100 oximeter, Greisinger, Regenstauf, Germany). In order to blind 
subjects to altitude, the system was also running normoxic airflow into the chamber during 
the NN sessions. To simulate the progressive rise in altitude to reach Jungfraujoch by train in 
HH sessions, subjects breathed either hypoxic air (for NH) or room air (for NN) provided via 
a mask connected with a three-way valve to an altitude simulation device (Altitrainer, 
SMTech, Nyon, Switzerland) before each session in the hypoxic chamber. It was done in a 
total blinded way.  
Each session consisted of 26 hours of exposure in each condition (NN, NH, HH) in a 
randomized blinded order. After 24 h of exposure, subjects completed a self-paced 250 kJ 
time trial, being free to set the resistance as they did it in the familiarization session. All trials 
were preceded by a rest period of 5 min, followed by 3 min warm-up period at 70W. Work 
completed from 0 to 250 kJ was the only information (visually) provided to subjects during 
the time trial. In order to mimic real world cycling environmental conditions and to prevent 
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excessive thermal stress, a fan providing a high wind speed was placed directly in front (~80 
cm) of the subjects during the trials. 
Measurements 
Gas exchanges, heart rate and SpO2. Breath-by-breath pulmonary gas exchange, minute 
ventilation (VE) and respiratory frequency (Rf) were measured at rest and throughout time 
trial using a portable gas analyzer (MetaMax 3B, Cortex, Leipzig, Germany) with an oronasal 
mask (Vmask™, 7500 seires; Hans Rudolph Inc., Shawnee, KS; dead space, 41 mL). The 
volumes were measured using a bidirectional digital turbine. Oxygen uptake (VO2), carbon 
dioxide production and end-tidal carbon dioxide partial pressure (PETCO2) were determined 
with an electrochemical cell and an infrared analyzer, respectively, from the air drawn 
through a Nafion® sampling tube attached to the turbine at the output of the mask. Heart rate 
(HR) and peripheral oxygen saturation (SpO2) were continuously recorded (Radical-7®, 
Masimo Corporation, Irvin, CA, USA) and stored for offline analyzes with commercially 
available software (Labchart software, AD Instrument, Colorado Springs, CO, USA).  
Power, workload and cadence. Power output, speed, cadence and total workload were 
continuously recorded during the time trial by the cycle ergometer (Cycleops IC 400 Pro, 
Madison, Wisconsin, USA). 
Electromyographic recordings. Quadriceps electromyography (EMG) was continuously 
recorded from the right vastus lateralis (VL) using bipolar silver chloride surface electrodes 
of 10-mm diameter (Kendall Meditrace 100). Recording electrodes were taped lengthwise on 
the skin over the muscle belly following SENIAM recommendations, with an interelectrode 
distance of 20 mm. Positions of the electrodes were marked on the skin so ensure precise 
replacement in other sessions. Reference electrode was attached on the patella. Low 
impedance (<10 kΩ) at the skin-electrode was obtained by shaving and abrading the skin with 
an abrasive sponge and cleaning with alcohol. EMG data were recorded with Biopac system 
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(MP150, Biopac System, Goleta, CA) and amplified (gain = 1000) with a bandwidth 
frequency ranging from 10 to 500 Hz, digitized at a sampling frequency of 2 kHz, and 
recorded by the AD conversion system (common mode rejection ratio: 90 dB, input 
impedance: 100 MΩ; gain: 1000). For the data analysis, the integral of the EMG activity was 
calculated over 10-kJ time-periods throughout time trial using the formula: 
 !"#$ ! ! =  !(!)  !"!! , 
where m is the raw EMG signal. 
Cerebrovascular variables. Mean middle cerebral artery blood flow velocities (MCAv) were 
measured bilaterally using a 2-MHz pulsed Doppler ultrasound system (ST3, Spencer 
technology, Seattle, USA). The Doppler ultrasound probes were positioned over right and left 
temporal windows and held firmly in place with an adjustable headband (Marc 600 
Headframe, Spencer technology, Seattle, USA). The signals were at depths ranging from 44 
to 58 mm. Signal quality was optimized using an M-mode screen shot and insonation depth, 
probes and headband locations were marked to ensure within-subject repeatability. Bilateral 
MCAv were averaged to represent an index of global cerebral blood flow at rest and during 
exercise. Cerebral O2 delivery (cDO2) before and during exercise was calculated using the 
equation: cDO2 = mean MCAv x CaO2, where CaO2 refers to the oxygen content of the 
arterial blood estimated as follows: CaO2 = [hemoglobin concentration assessed in each 
condition after 20 h of exposure x 1.36 x SpO2/100], oxygen dissolved in plasma being 
neglected. cDO2 was then expressed as a percentage of the resting normoxic (NN) pre-
exercise value. 
Near-infrared Spectroscopy measurements. Cerebral oxygenation in the left prefrontal (PFC) 
and motor (MC) cortex was assessed by monitoring changes in oxy- and deoxy- hemoglobin 
(O2Hb and HHb, respectively) obtained with spatially resolved, continuous wave near-
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infrared spectroscopy (NIRS) (Artinis, Oxymon MkIII, Zetten, The Netherlands). Theoretical 
and performance details of NIRS have been previously described (Perrey, 2008). PFC NIRS 
probes were centered between Fp1 and F3 locations according to the international 10-20 EEG 
system, with 3.5-cm interoptode distance. MC NIRS data were expressed as the average of a 
4-channel square setting (3-cm interoptode distance) fixed with headbands between Cz and 
C3 locations. Muscle oxygenation was assessed from the right vastus lateralis (at mid thigh) 
using a 4-cm interoptode distance. For PFC and muscle, probe holders were secured to the 
skin using double-sided adhesive tape to minimize any change in its relative position and all 
optodes were covered with black sweatbands for them to be shield from ambient light. Total 
hemoglobin changes (THb = O2Hb + HHb) were calculated to reflect the changes in tissue 
blood volume within the illuminated areas and difference in hemoglobin (HbDiff = HbO2 - 
HHb) was calculated as a reliable estimator of change in tissue (de-) oxygenation status 
(Hoshi et al., 2001; Rooks et al., 2010). NIRS data were recorded at 10 Hz, filtered with a 2-s 
moving Gaussian window smoothing algorithm and expressed as relative changes (∆µmol) 
from the stable baseline preceding each time trial. 
 
Diet and perceptual variables 
Diet was standardized for nutritional and caloric content. Same nitrate- and nitrite-free meals 
and drinks were provided to the subjects (at the same times of day in the 24 h preceding the 
tests for the three conditions) to control nitrate intake, which can influence performance and 
oxidative stress levels (see (Faiss et al., 2013; Ribon et al., 2016) for further details). Subjects 
ate in the hypoxic chamber or in the kitchen of the HH laboratory and were allowed to drink 
water ad libitum during the whole protocol. 
To evaluate acute mountain sickness (AMS) symptoms, subjects completed self-reported 
questionnaires in the morning before each time trial (after 20 h of exposure). These 
 -235- 
evaluations comprised 4 sections of the Lake Louise AMS questionnaire (LLS, i.e. 
“headache”, “gastrointestinal distress”, “fatigue/weakness”, “dizzy/light-headedness”) (Roach 
et al., 1993) and the neurologic part of the Environmental Symptom Questionnaire (ESQ-III 
ESQc, 11 items graded from 0 to 5 covering “lightheadedness” “faintness” “weakness” 
“nausea” “I feel hung-over” and so on) (Sampson et al., 1983). AMS is defined as a LLS 
score of more than 3 or an ESQc score ≥ 0.7. 
Finally, subjects were regularly asked to qualify their rate of perceived exertion (RPE, Borg 
Scale, 6-20) during the time trial. Legs and breathing feelings were also assessed with visual 
analog scales (VAS, 0-10), ranging from “no difficulty” to “extremely difficult”. 
 
Statistics. Data are reported as means and standard deviations with 95% confidence intervals. 
Data were tested for equality of variance (Fisher-Snedecor F-test) and for normality (Shapiro-
Wilk test). To investigate the pacing strategies we divided the time trial in 25 slices of 10 kJ 
(increments of 4% of the total work completed). One-way ANOVA were used to determine if 
systemic (SpO2, VO2), cerebrovascular (MCAv, cDO2) and AMS (LLS, ESQc) variables were 
different between conditions before the time trial (i.e., at baseline, BL). When significant 
interaction effects were found, Bonferroni post-hoc tests were used to localize differences 
between conditions (NN, NH, HH). Two-way ANOVA (time x condition) with repeated 
measures were used for each parameter during the time trial. When significant main or 
interaction effects were found, Bonferroni post-hoc tests were used to localize differences 
between conditions (NN, NH, HH) and/or time (each 10 kJ slice from 0 to 250 kJ). Null 
hypothesis was rejected at P<0.05. All analyses were made using Sigmaplot 11.0 software 
(Systat Software, San Jose, CA). 
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Results 
Time trial performance and pacing. Compared to NN (i.e., 1041 ± 151 [955.9-1126.9] s), the 
mean time required to complete 250 kJ was 24.1 ± 9.6 [18.7-29.5] % and 33.2 ± 12.4 [26.2-
40.2] % higher for NH and HH, respectively (with both P < 0.001). The mean time was 7.5 ± 
7.5 [3.2-11.7] % higher in HH than in NH (P < 0.01) (Saugy et al., 2016b). Compared to NN 
the whole time trial pace was reduced for both hypoxic conditions (Fig. 1A, P<0.001). The 
HH power output was significantly reduced compared to NH from 140 to 220 kJ (P<0.05). 
When expressed as a function of the average power sustained in each respective condition 
(Fig. 1B), an interaction effect was observed (P<0.05) showing inverse trends between NN 
and both NH and HH, despite a comparable range of variation (~30%, ~21% and ~23%, for 
NN, NH and HH, respectively). In HH, normalized power output followed a similar pattern to 
NH. 
Pulse oxygen saturation. As presented in Fig. 2A, SpO2 was significantly higher at baseline 
(97.7 ± 1.2 [97.1-98.4] %; P<0.001) and during cycling in NN compared to both hypoxic 
conditions (0-250 kJ; P<0.001) and SpO2 was significantly lower in HH compared to NH at 
rest (92.2 ± 2.1 [91.1-93.3] vs. 89.9 ± 1.9 [88.9-91.1] %; P<0.01) and during the first half of 
the time trial (0-140 kJ; P<0.05).  
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Figure 1. Power output (A) and normalized power output (B) during the self-paced 250-kJ time trial in 
normobaric normoxia (NN), normobaric hypoxia (NH) and hypobaric hypoxia (HH). *P<0.05, ***P<0.001 for 
difference between NN and both hypoxic conditions; #P<0.05 for difference between NH and HH. 
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Figure 2. Peripheral oxygen saturation (SpO2, panel A), middle cerebral artery blood flow mean velocity 
(MCAv, panel B) and cerebral oxygen delivery (cDO2, panel C) during the self-paced 250-kJ time trial in 
normobaric normoxia (NN), normobaric hypoxia (NH) and hypobaric hypoxia (HH). *P<0.05, ***P<0.001 for 
difference between NN and both hypoxic conditions; $P<0.05 for difference between NN and NH; #P<0.05 for 
difference between NH and HH. 
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Cerebrovascular variables. MCAv at rest was not different between conditions. MCAv was 
increased in the first quarter of the time trial in both NN, NH and HH (+ 31%, + 15% and 
+25%, respectively), the increase being lower in NH compared to HH (from 10 to 150 kJ, 
P<0.05) and NN (from 10 to 100 kJ, P<0.05) while no difference was found along time trial 
between HH and NN (Fig 2B), in which conditions MCAv decreased from 40 kJ onward. 
Rest cDO2 values were not different between conditions (Fig 2C). In contrast, during time 
trial cDO2 was lower in both NH and HH compared to NN (P<0.05), with no difference 
between NH and HH, in which conditions cDO2 decreased to near baseline values at ~100 kJ 
while it remained elevated in NN (P<0.05). 
Cardio-respiratory parameters. VO2 was higher for NN compared to both hypoxic conditions 
(from 70 to 250 kJ; P<0.001) and trend to be lower for HH compared to NH before the end-
spurt (from 70 to 210 kJ; P=0.08)(Fig. 3A). No difference was observed between conditions 
in VO2 relative to VO2max (Fig. 3B). Heart rate was higher at rest for both hypoxic conditions 
(78 ± 12 [71-84] and 81 ± 8 [76-85] bpm for NH and HH, respectively) compared to NN (69 
± 11 [62-75] bpm) but no difference was observed during the time trial (Fig. 3C). PETCO2 was 
lower for NH (26.8 ± 2.9 [25.1-28.4] mmHg) than NN (30.6 ± 3.3 [28.7-32.5] mmHg; 
P<0.05) and HH (29.9 ± 2.5 [28.5-31.4] mmHg; P<0.05) at rest but no statistical difference 
was reached during the time trial (Fig. 3D). VE was higher in NH than NN at rest (15.8 ± 5.2 
[12.8-18.8] and 12.8 ± 4.2 [10.4-15.1] L.min-1, respectively, P<0.05) but no difference was 
found between NH and HH at rest or between conditions during exercise (Fig. 3E). No 
difference was found neither at rest nor during the exercise for Rf (Fig. 3F). 
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Figure 3. Absolute oxygen uptake (VO2, panel A), oxygen uptake relative to VO2max (panel B), heart rate (panel 
C), end-tidal CO2 pressure (PETCO2, panel D), minute ventilation (VE, panel E) and respiratory frequency (Rf, 
panel F) during the self-paced 250-kj time trial in normobaric normoxia (NN), normobaric hypoxia (NH) and 
hypobaric hypoxia (HH). *P<0.05; ***P<0.001 for difference between NN and both hypoxic conditions; 
$P<0.05 for difference between NN and NH; (#)P=0.08; #P<0.05 for difference between NH and HH. 
Cerebral oxygenation. These results are presented in Figure 4A-F. PFC and MC HbDiff were 
higher for NN than for the two hypoxic sessions throughout the time trial (P<0.001, fig. 4A 
and 4B). Lower values were found in HH compared to NH in PFC HbDiff at the beginning of 
the time trial (20-120 kJ, P<0.05, fig. 4A), while higher values were observed in HH 
compared to NH in MC HbDiff in the second part of the time trial (160-240 kJ, P<0.05, fig. 
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4B). Cerebral HHb exercise-induced increase was lower for NN than the two hypoxic 
conditions in both PFC and MC (P<0.001, fig. 4C and 4D), this increase being particularly 
limited during the first half of the time trial. MC HHb was also slightly lower for HH 
compared to NH in the last part of exercise (P<0.05). Increase in cerebral THb along exercise 
was similar in the three conditions in PFC (Fig. 4E) but was higher for NN in MC during the 
second half of the time trial (from 100 kJ onward, P<0.001, fig. 4F).  
 
Figure 3. Mean changes in cerebral hemoglobin difference (HbDiff = O2Hb-HHb), deoxy-(HHb), and total-
hemoglobin (THb), during the self-paced 250-kJ time trial in normobaric normoxia (NN), normobaric hypoxia 
(NH) and hypobaric hypoxia (HH). Data are shown for the prefrontal cortex (PFC, panels A to C) and for the 
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motor cortex (MC, panels D to F). ***P<0.001 for difference between NN and both hypoxic conditions; #P<0.05 
for difference between NH and HH. 
Muscle oxygenation. Muscle HbDiff was lower for NN compared to NH from 20 to 210 kJ 
(P<0.05) and lower for HH compared to NN from 190 to 240 kJ (P<0.05)(Figure 5A). HbDiff 
was also lower in NH compared to HH from 50 kJ onward (P<0.05). No difference has been 
found in muscle HHb increase during time trials between conditions (Figure 5B). Muscle THb 
were higher in HH compared to both NN and NH conditions from 90 kJ onward (P<0.05) 
(Figure 5C) with no difference between NN and NH.  
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Figure 5. Mean changes in muscle hemoglobin 
difference (HbDiff = O2Hb-HHb, panel A), 
deoxy-(HHb, panel B), and total-hemoglobin 
(THb, panel C), during the self-paced 250-kJ 
time trial in normobaric normoxia (NN), 
normobaric hypoxia (NH) and hypobaric 
hypoxia (HH) for the vastus lateralis. $P<0.05 
for difference between NN and NH; £P<0.05 
for difference between NN and HH; #P<0.05 
for difference between NH and HH. 
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Electromyographic activity. EMG activity was higher for NN compared to both hypoxic 
conditions from 60 kJ onward (Fig 6, P<0.001) and it was lower for HH compared to NH 
from 130 to 210 kJ (P<0.05). 
 
Figure 6. Electromyographic activity (iEMG) measured for the vastus lateralis during the self-paced 250-kJ 
time trial in normobaric normoxia (NN), normobaric hypoxia (NH) and hypobaric hypoxia (HH). ***P<0.001 
for difference between NN and both hypoxic conditions; #P<0.05 for difference between NH and HH. 
 
Subjective feelings. The LLS was not statistically different between conditions (1.6 ± 1.4 
[0.9-2.4], 2.3 ± 2.8 [0.8-3.8] and 3.2 ± 2.7 [1.8-4.7] for NN, NH and HH, respectively), but 
showed mild AMS (score > 3) only in HH. ESQc was also higher in HH only (0.48 ± 0.65 
[0.13-0.84]) compared NN (0.06 ± 0.07 [0.02-0.01], P<0.05), with no difference versus NH 
(0.27 ± 0.53 [0-0.56], P>0.05). 
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conditions along cycling. However, breathing discomfort (Fig 7C) was higher for both 
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hypoxic conditions from the beginning to the end of the time trial (P<0.001), with no 
difference between NH and HH. In addition, a biphasic evolution from 0 to 70 kJ and from 70 
to 250 kJ was observed with a time effect on both legs and breathing discomfort (both 
P<0.001, fig. 7B-C). 
 
Discussion 
The major findings of the present study was that, after a 24-h exposure, decreased time 
trial performance was observed in both normobaric or hypobaric hypoxia with an inverse and 
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Figure 7. Rate of perceived 
exertion (RPE, panel A) and 
visual analog scale score 
(VAS) for legs feelings (panel 
B) and breathing difficulty 
(panel C) during the self-paced 
250-kJ time trial in normobaric 
normoxia (NN), normobaric 
hypoxia (NH) and hypobaric 
hypoxia (HH). VAS, visual 
analog scale. ***P<0.001 for 
difference between NN and 
both hypoxic conditions. 
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more variable pacing pattern compared to normoxia, in conjunction with depressed 
cerebrovascular function for a same relative intensity of exercise (i.e., %VO2max, RPE).  The 
present study also demonstrates for the first time that, despite lower power output during time 
trial in HH versus NH, similar pacing pattern and relative exercise intensity were observed for 
very distinctive physiological adaptations, emphasizing, and explaining at least in part, subtle 
differences between HH and NH at exercise, which have been suggested in the past. 
 
Pacing in hypoxia. Hypoxia-induced impairments of aerobic performance have been 
extensively studied by the past but much fewer studies have described how pacing (i.e., 
distribution of power output or energetic reserves) or pacing strategy (i.e., self-selected tactic 
adopted by the athlete) may help to understand why we fatigue when oxygen availability 
becomes challenging.  
Previous reports examined exclusively time trials performed after very short exposure 
to hypoxia, ranging from only 3-40 min (Amann et al., 2006a; Clark et al., 2007; Fan & 
Kayser, 2013; Van Cutsem et al., 2015; Periard & Racinais, 2016) up to 2 h (Beidleman et al., 
2014). Sudden and acute hypoxic exposure provides an interesting model that stresses oxygen 
transport systems but in real-world training/competing (particularly at terrestrial altitude), 
exposure time preceding exercise is usually longer and is prone to deeply influence how pace 
would be regulated (Tucker, 2009). Indeed we previously showed that the first hours at 
altitude progressively affect motor cortical excitability (Rupp et al., 2013a) or muscle and 
cerebral oxygenation (Rupp et al., 2013c) for instance. In the present experiment, the 
prooxidant/antioxidant balance became impaired from 10 h in hypoxia (Ribon et al., 2016), 
hematologic parameters were affected after 20 h in hypoxia (Saugy et al., 2016b) and sleep 
quality was significantly disturbed in hypoxia the night before time trial (Heinzer & Saugy, 
2016). This might, at least partly explain why available evidence suggests that the acute 
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reduction in both maximal aerobic power and endurance performance is maximal within 16–
24 h of exposure (2300 m, (Schuler et al., 2007)), and resorbs progressively thereafter.  
To our knowledge this is the first study to investigate time trial performance in 
conjunction with systemic, muscle and cerebrovascular variables after a 24-h exposure to 
hypoxia. However, for duration longer than ~5 min, the strategy most commonly displayed in 
literature consist in an initial fast start over the first 10–15 % of the trial, followed by a slight 
reduction in power output with an even pace until the final 10-15 % of the time trial, where 
there is an end-spurt in which the power output returns to the initial values (Roelands et al., 
2013). Our results show that subjects started exercise at the same workload (~226 W) in 
normoxia and hypoxia but acutely reduced power output until end-spurt in hypoxia whereas a 
slightly positive trend was seen in normoxia over the same period. Variation in power outputs 
(as a function of mean power during the trial) from the start to 85% of time trial was twice 
higher in hypoxia compared to normoxia (~22% and ~11%, respectively). Hence, the pacing 
pattern adopted during ~17-23 min time trials was significantly different in NN versus after 
24 h in either NH or HH. This observation is supported by a previous experiment examining 
comparable time trial duration (15-km cycling, 25-35 min) but at higher acute altitude 
(~5000m, NH; (Fan & Kayser, 2013; Bourdillon et al., 2014)). However most of the studies 
reporting self-paced exercise performance at lower but acute altitude for shorter (5-min or 5-
km cycling, ~3200 m in HH or  ~2700 m in NH; (Clark et al., 2007) and (Amann et al., 
2006a), respectively), similar (30-min cycling, 3800 m, HH; (Van Cutsem et al., 2015)) or 
longer (750-kJ cycling, ~3000 m, NH; (Periard & Racinais, 2016)) time trial durations failed 
to demonstrate any difference between normoxic and hypoxic pacing profiles. These 
discrepancies may suggest an effect of hypoxic dose (higher altitude or longer pre-exposure 
duration) on the ability to regulate efficiently power output along exercise. Yet, it should be 
stressed that comparisons with the cited studies are questionable because i) time trials <7-8 
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min may follow a particular trend compared to longer exercises (Roelands et al., 2013), ii) 
some of the studies were time-delimited rather than total work-delimited and compel to a 
predefined initial power output with the risk to affect subsequent pacing (Van Cutsem et al., 
2015), and iii) some results relate to remarkably well-trained subjects (e.g., VO2max >4.5 
L/min in NN; (Periard & Racinais, 2016)) what is not the case in our study (VO2max = 4.2 
L/min in NN). 
Moreover, the distinct regulation of the pace in normoxia and hypoxia was associated 
with distinct systemic, cerebrovascular and muscle adaptations but for a similar RPE and 
similar normalized (relative) VO2 throughout time trials. It has been proposed that at the onset 
of time trial exercise, afferent information from various physiological systems and 
external/environmental cues is used by the brain to generate a conscious RPE and then to 
regulate work rate to ensure that this conscious RPE does not increase excessively at any 
stage during exercise, reaching maximal tolerable RPE at the moment exercise is completed 
(mandatory for optimal performance), but not before. The concept of “teleoanticipation” 
refers to both a conscious and unconscious prediction of a pacing pattern, whereby the rate of 
energy expenditure is regulated in a way that allows the performer to complete a task as fast 
as possible while controlling the magnitude of homeostatic disturbance (Tucker et al., 2004; 
Tucker, 2009; Tucker & Noakes, 2009). This concept also relies on the existence of an 
anticipatory component (i.e., “exercise template” dependent from the previous experience and 
expected endpoint) and the constant interplay between afferent feedbacks from the periphery 
and a thin regulation/modulation of the central drive (i.e., active neural calculations in the 
brain) (St Clair Gibson & Noakes, 2004). 
 
Initial phase. Athletes are supposed to self-select an initial exercise intensity, which is 
anticipated to be optimal for the expected exercise format, but this was not the case in 
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hypoxia as expressed from the rapid decrease in power output over that period, with a -15% 
variation in normalized power output compared to a +3% variation only in normoxia (Fig. 
1A).  Interestingly, similar low levels and high rate of increase in RPE were observed in all 
conditions in the present study in the first 30% of completed work (0-70 kJ). These RPE were 
however generated from a very different balance between central drive and afferent feedbacks 
(physiological adaptations) in normoxia and hypoxia. A wide range of variables can influence 
pacing but recently, tactical adaptations in the chosen pacing strategies have been incredibly 
manipulated with the use of central nervous system drugs and selective block of the central 
projection of ascending sensory pathways (e.g., fentanyl, opioid analgesic) (Amann et al., 
2009; Roelands & Meeusen, 2010), so that the role of neurophysiological processes has 
grown.  
Cortical representation of muscle involved in cycling is served dominantly by MCA 
(Jorgensen et al., 1992) and transcranial Doppler as we used can provide quantitative 
information on cerebral hemodynamic changes at the macrovascular level (i.e., cerebral 
arteries) but is unable to assess directly the qualitative repercussions of such changes for the 
tissue at the microvascular level. How much reductions in SpO2 and cDO2 translate into 
changes in cerebral tissue oxygenation when self-paced exercise is performed in hypoxia 
remains largely unknown. In this way, NIRS is increasingly used to measure the (mis)balance 
between oxygen supply and utilization directly in tissue microvessels (venules, arterioles and 
capillaries), with a predominant venous contribution (70-80%) (Hamaoka et al., 2007; Wolf et 
al., 2007).  
Interestingly, we found that the cerebrovascular responses in NN over the first part of 
exercise appeared appropriate (e.g., cDO2 maintained at ~125% from baseline value, 
preserved brain oxygenation), while it is likely that the brain function was threatened in 
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hypoxia over that period from a rapid decrease in SpO2, cDO2 (Fig. 2) and cerebral 
oxygenation towards low levels (Fig. 3). 
 
Main phase. From 30 to 85% of the time trial mean power output difference between NN and 
both hypoxic conditions continued to grow (Fig. 1A), still without any difference in RPE and 
relative exercise intensity as expressed from %VO2max, HR or ventilation parameters (Fig. 7). 
RPE as an expression of the somatosensory experience (Hampson et al., 2001), is 
supposed to be a key component of a regulatory system that protects against bodily harm 
(Tucker, 2009) and it achieves the regulation of the physiological perturbations occurring 
during exercise. The lower work-rate in hypoxia was achieved by the alteration in the degree 
of skeletal muscle recruitment (i.e., lower iEMG) in accordance with Peltonen et al. (Peltonen 
et al., 1997). This is corroborated for the first time by a significant cerebral hypoperfusion at 
the micro-vascular level (from THb with NIRS, Fig. 3F) over the motor cortex, which directly 
drives the muscles. 
With growing interest in the last decade, NIRS is now widely used as a suitable tool 
for studying muscle and cerebral hemodynamics and oxygenation responses to exercise with 
challenging environmental conditions as altitude (Verges et al., 2012), but previous research 
almost exclusively considered the prefrontal cortex (PFC). PFC synthesizes information from 
a wide range of brain systems and exerts control over cognitive and executive behavior (e.g. 
task-related memory, sensory information integration, decision-making, movement planning, 
pacing strategies and motivation), so that these associative areas play a central role in the 
orchestration of thoughts and actions in accordance with internal goals (Miller & Cohen, 
2001; Ramnani & Owen, 2004). PFC is of particular interest in our study but the central 
motor drive is ultimately conducted from the premotor and primary motor areas, which have 
never been investigated during self-paced exercise before. From the study of Subudhi et al. 
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(Subudhi et al., 2009) it has been often argued that there is a good correlation between 
prefrontal, premotor and motor cortices oxygenation measurements during exercise. However, 
this has been shown during a short, maximal incremental exercise, where pacing strategy was 
minimal as power output was compelled throughout the test. We recently demonstrated that 
PFC and MC oxygenation profiles can differ during submaximal fatiguing exercise (Rupp et 
al., 2013b) and to our knowledge the present study is the first to present simultaneous macro-
circulation in MCA and both PFC and MC micro-hemodynamics and oxygenation during a 
self-paced exercise. 
In the present study, PFC and MC oxygenation were both markedly depressed in 
hypoxia in the first part of the time trial (Fig. 4), confirming what has been reported before 
almost exclusively during progressive maximal exercises in hypoxia and in the PFC (Subudhi 
et al., 2009; Vogiatzis et al., 2011). Presumably, exercise-induced increased in cerebral cortex 
oxygenation reflects progressive increase in oxygen metabolic demand (Secher et al., 2008) 
with increased neuronal networks activation. Despite lower central drive and muscle activity 
during time trial in hypoxia, it is likely that the challenging environmental conditions (cf., low 
FiO2) blunted the ability of the neurovascular coupling to increase or even maintain cerebral 
oxygenation to habitual levels aiming at preserving a positive balance between oxygen supply 
and consumption. An hypothesis might be that power output is steadily decreased in hypoxia 
to prevent the body to be exposed to unacceptable levels of SpO2, cDO2 and cerebral 
oxygenation or, at least, to values which would be considered as incompatible with the 
remaining expected time before exercise completion. The diminished power output certainly 
allowed cDO2 and cerebral hemodynamics not to decrease further (cf. baseline values for 
cDO2). On the other hand it is important to stress that PFC and MC oxygenation would be 
only one of many afferent signals influencing complex regulation of motor drive during self-
paced exercise (St Clair Gibson & Noakes, 2004).  
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 In the present study, CBF declined during the second part of time trial in both NN and 
HH despite increased versus decreased power output, respectively. This adaptation mirror the 
PETCO2 decrease over the same period and might thus be triggered by hyperventilation-
induced hypocapnia (breathing fatigue increase). This assumption is corroborated by the 
results from Periard & Racinais (Periard & Racinais, 2016) who observed a similar decrease 
in MCAv during a 750-kJ time trial in normoxia. Conversely, other results demonstrated a 
maintain MCAv (in normoxia) or an increased MCAv (and almost maintained cDO2 in 
hypoxia) during a 15-km time trial (Fan & Kayser, 2013). To explain these results, authors 
underlined a higher RPE during the time trial in hypoxia (5000 m) and suggested a greater 
sensori-motor activation compared to normoxia. 
 
End-spurt. In accordance with well-known field observations and as previously described in 
the literature (Albertus et al., 2005; Roelands et al., 2013) our results indicated a 
characteristic end-spurt phenomenon in the last 10-15% of the time trial. Indeed, it is assumed 
that energetic resources would be efficiently used in the case all energy stores are used before 
finishing race, but not so far from the end to avoid any meaningful slowdown to occur (Foster 
et al., 1993; Roelands et al., 2013). The level of uncertainty becoming smaller when endpoint 
approaches, protective motor unit and metabolic reserve throughout exercise can be delivered. 
The distance (work load) that remains is a crucial “anchor” against which the RPE is 
interpreted. This might explain why linear increase in RPE was not affected by the end-spurt 
phenomenon (i.e., steep increase in power output and muscle activity but no steeper increase 
in RPE). This end-spurt was seen whatever the condition, even if it was delayed and reduced 
in NH. Our results further support the concept of a central governor, the subjects having the 
drive and/or motivation in normoxia but also in hypoxia to augment power output when 
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approaching the end-point (what is not the case anymore after administration of a serotonin 
reuptake inhibitor in normoxia, (Roelands et al., 2009)). 
 
Normobaric versus hypobaric hypoxia. As previously mentioned, several studies assessed 
performance and pacing in either normobaric (Bourdillon et al., 2014) or hypobaric (Richalet, 
2010; Fulco et al., 2011) hypoxia in comparison with normoxia, resulting in indirect 
comparisons between these conditions. However, to date only one study was conducted 
aiming to compare these two hypoxic conditions (Beidleman et al., 2014), but it has been 
done with independent groups and subjects with relatively low endurance ability during the 
baseline tests (even after a familiarization session, i.e. between 47.5 and 49.5 ml/min/kg). 
Moreover, due to the small sample size in each groups (i.e. n = 6) statistical power was not 
sufficient to reach significant difference in power output but only a trend (i.e. lower power 
output in HH, P=0.08). The short pre-exposure duration (i.e. 2h) might also be a potential 
reason. In another side, our study is the first to directly compare both hypoxic conditions in a 
controlled crossover design with the same subjects. Thus, similarly with Beidleman et al. 
(Beidleman et al., 2014) the trends were comparable between NH and HH, but with a 
significant lower power output at the end of the second part for hypobaric hypoxia, 
emphasizing different physiological adaptations. 
When comparing NH and HH, it should be noted that power output at the immediate 
onset of the time trial (0-20 kJ, 8%) was similar and also similar to NN, suggesting that the 
initial selection of work rate was more likely based on previous experience and expectations 
of exercise duration, rather than on an instantaneous (baseline) afferent input from hypoxemic 
or disturbed organ/tissue homeostasis (e.g., modified baseline HR, SpO2, PETCO2). Indeed, 
even higher AMS and the knowledge of the condition (no possibility to blind HH) had no 
influence on the initial power output. However, the tendency towards lower power output in 
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HH in the first part of the time trial appeared significant in the second part (from ~30% of 
total work onward). Trends and normalized variation in power output (Fig. 2A) were similar 
in NH and HH throughout the time trial, but for the first time we were able to identify subtle 
differences in physiological adaptations with a potential explanation to explain the greater 
mis-performance in HH. 
  From an initial “exercise template” similar power outputs were produced in the initial 
part of exercise but subsequent physiological adaptations progressively differed in NH and 
HH. Part of the explanation may arise from distinct baseline status in NH and HH after the 
24-h exposure. 
The 24-h exposure time-window adopted in the present study coincides for instance 
with the earliest symptoms of AMS encountered after several hours (i.e., 4-8h) of hypoxic 
exposure (Wilson et al., 2009; Subudhi et al., 2010) and which incidence is >40% above 3000 
m depending on the rate of ascent, the altitude reached and individual physiology (Hackett & 
Roach, 2001; Richalet & Herry, 2006). In our study, AMS was observed to be slightly higher 
in HH compared to NH (LLS > 3, and ESQc higher in HH only compared to NN). AMS 
degree has been correlated to degree of hypoxemia in the first hours of exposition (Fulco et 
al., 2011). Accordingly baseline SpO2 before the time trial was significantly lower in HH 
despite similar PiO2 (Saugy et al., 2016b). 
This might impact subjective feelings during exercise so that power output had to be 
reduced in HH compared to NH to match equivalent relative exercise intensity (%VO2max, 
HR, RPE, leg feelings…). Besides, underlying mechanisms associated with the same relative 
exercise intensity were different likely explaining lower power output in HH along time trial. 
 
Mass oxygen delivery to the brain is dependent on cerebral blood flow (cDO2 assessed 
from MCA in the present study) and on arterial content in oxygen, which is itself a function of 
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hemoglobin concentration and arterial saturation in oxygen. It seems consistent to think that 
the rate of cDO2 is important information integrated by the central nervous system to regulate 
central drive. We demonstrated that cDO2 was extremely reduced in both NH and HH 
compared to NN, already in the first part of the time trial. It is particularly interesting to see 
how the progressive decrease in power output mirrored the plateau in the decrease in cDO2, 
apparently preventing any further decrease under dramatically low (baseline) values in 
hypoxia.  
This was observed in a very similar extent in both NH and HH but we show here for 
the first time that the similar cDO2 levels achieved, resulted from distinct mechanisms in NH 
and HH and were seen in conjunction with significantly different cerebral oxygenation in both 
conditions. 
First SpO2 was significantly lower at rest and during the first half of the time trial in 
HH compared to NH, what may explain i) the higher hemoconcentration measured before 
exercise in HH (+6%, (Saugy et al., 2016b)) as a compensatory mechanism and, ii) the higher 
MCAv values in HH (+ 7.5% over 10-150 kJ) throughout exercise due to a higher hypoxic-
stimulus-induced cerebral vasodilation (Casey & Joyner, 2012).  
Diuresis is common during the first few days of exposure to even moderate hypoxia. 
Hence rapid increase in hemoglobin concentration has been reported (including after a single 
night, (Ashenden et al., 2000)) with the magnitude differing markedly between individuals. 
Hemoconcentration being triggered by hypoxemia, it serves an adaptive purpose by elevating 
arterial oxygen content, so that more O2 can be delivered to the tissues per liter of cardiac 
output. 
At the same time, exercise-induced decrease in PETCO2 was approximately the same in 
NN, NH and HH (-8 mmHg on average over 20-250 kJ with similar VE and Rf kinetics, Fig. 
3), but the latter started from a significant hypocapnic state only in HH. Accordingly, MCAv 
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appeared to be much more affected by hypocapnia-induced vasoconstriction in HH compared 
to NH (Fig. 2B). All together, cDO2 was maintained at comparable levels in NH and HH, but 
from significantly lower values of CaO2 (despite a slight hemoconcentration) and 
significantly higher values of MCAv in HH.  
However, impaired cDO2 is only part of the equation and explains (i.e. reduction in the 
ability of CNS to voluntarily activate skeletal muscle, (Goodall et al., 2014)) mainly the 
decreased performance in both NH and HH compared to NN. Cerebral oxygenation profiles 
described in the present study also help to understand how and why pacing might be down-
regulated in HH compared to NH. From our data, a comparable central drive was produced in 
HH and NH in the initial part of the time trial (e.g., same MC deoxygenation, iEMG, power 
output, muscle deoxygenation, absolute VO2). However PFC deoxygenation was significantly 
higher in HH (Fig. 4A) during that period. As cDO2 was the same in NH and HH along the 
time trial, the lower PFC oxygenation may result from higher extraction rate of oxygen (i.e., 
higher neuronal activity) in this part of the brain. Whatever the explanation (e.g., greater 
integrative process, higher planning activity) the fact is that lowering power output in HH 
allowed PFC HbDiff to progressively “restore” to NH levels. Finally these observations 
suggest similar PFC activity in the second part of the time trial for lower power output in HH 
than in NH. Consistently, the lower power output in HH was seen in conjunction with a lower 
degree of muscle recruitment (i.e., lower MC and muscle deoxygenation, lower iEMG). 
With simultaneous measurements of systemic parameters, cerebrovascular function, 
muscle activity and subjective feelings during time trial, this study provides new insight into 
the mechanisms underlying the distinctive magnitude of pacing down-regulation in HH versus 
NH. Hence, HH appears to be a more stressful stimulus (e.g., lower SpO2 and higher PFC 
deoxygenation for a given power output, higher “adaptive cost”) than NH and induces a 
subjective feeling that exercise is more difficult (same RPE, leg feelings and %VO2max for a 
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lower power output). As a consequence, the system was more “protective” in HH and the end-
spurt was greater (starting earlier and reaching same absolute power output than in NH). 
 
Methodological considerations. 
Although the results of the present investigation could, theoretically, be extended to all 
athletes, the present recreational population does not include individuals with elite 
physiology. It remains to be confirmed how much high-level endurance performance may 
exhibit similar specific pacing adaptations in HH compared with NH. 
To express VO2 as relative values, a similar 22.7% decrement in VO2max was assumed 
at 3450 m in both HH and NH (based on the 7.7% decreased per 1000m accordingly with 
(Wehrlin & Hallen, 2006)). This decrement might however be hypoxemia-dependent and 
subject to inter-individual variability (Young et al., 1985) and if VO2max has been 
decremented to a larger extent in HH than NH, the volunteers may have finally performed the 
time trial at slightly higher relative VO2 in NH and HH than what has been presented here. 
As terrestrial rather than simulated altitude was chosen for the HH condition, it was 
logistically impossible to blind it to the subjects. However, they started the time trial with 
similar subjective feelings and power output in NH and HH, so that even if it cannot be totally 
ruled out throughout exercise, it is likely that the knowledge of the condition didn’t drastically 
impact the behavior of the subjects.  
The cycle ergometer we used in our experiment was stationary, whereas reduced air 
density in HH reduces the drag forces opposing the forward motion of the practitioner outside 
of the laboratory setting. It should be recognized that although time trial performance was 
decreased at moderate altitude, cycling (up to 40-km time trial at 3400 m) (Olds, 2001) in a 
real open-field competitive format would probably be improved in HH for high-class athletes 
despite a decrease in absolute VO2max and marked cerebrovascular perturbations as were 
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reported here. Also, such “ecological” situations might allow the subject to cope with 
additional important afferent information, the relative wind speed exerted on the face for 
instance. The high wind speeds used in the present study likely prevented the development of 
hyperthermia but the exact role this parameter on the rate of perceived exertion and/or pacing 
processes (especially when it is cycling-speed-dependent) has probably been underestimated 
in models aiming to better understand exercise tolerance and its regulation in hypoxia. 
Some limitations inherent to NIRS measurement should be noted. Part of the detected NIR 
light may be affected by the changes in optical properties of superficial tissue layers between 
the optode and the investigated tissue (e.g. scalp and skull for the brain; skin and fat for the 
muscle)(Cooper et al., 2010; Takahashi et al., 2011). Thus, although we sought to minimize 
the effects of near-surface blood flow by controlling room air temperature, by giving attention 
to ensure NIRS setup to be non-compressive and by using enlarged inter-optode distances (3 
cm for the brain and 4 cm for the muscle) to reach the maximal light path providing a 
sufficient signal-to-noise ratio of the optical density measurements (Rolfe, 2000), we cannot 
rule out the possibility that superficial layers blood flow slightly weighted in the observed 
chromophore concentration changes. Whether changes in blood gases affect skin blood flow 
similarly at sea level and after several hours in NH versus HH remain unknown, but taken 
together we are confident that the behaviour of the present oxygenation changes most 
probably reflected the cortical and muscle tissue oxygenation changes. NIRS penetration 
depth (i.e. ≈ half the inter-optode distance) limits its sensitivity to the upper 1 cm of the 
cerebral cortex  (Boas et al., 2004), so that it is important to consider that the measurements 
obtained are regional and strictly confined to the zone beneath the sensors. Moreover, CBF 
may be heterogeneously distributed at exercise and under hypoxia (Pagani et al., 2011), we 
investigated MCA macrocirculation plus multiple sites of interest by NIRS (prefrontal and 
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motor cortices) and we acknowledge that observed tissue oxygenation cannot be generalized 
to whole brain (or to other muscles from NIRS on vastus lateralis). 
Finally, the validity of transcranial Doppler to measure variation in CBF (and subsequent 
estimation of cDO2) depends critically on the assumption of a constant diameter of the 
investigated artery. We contend that MCAv is a reliable index of changes in global cerebral 
blood flow during exercise in normoxia and hypoxia, as the cross-sectional area of the MCA 
has been shown unchanged within a wide range of changes in PETCO2 (Valdueza et al., 1997) 
and thanks to previous reports suggesting that under the conditions of the present study 
(<5000 m), MCA diameter remains constant (Poulin & Robbins, 1996). 
 
Conclusion 
This study showed that pacing strategy during a 250-kJ cycling time trial is impaired after 24 
h in hypoxia (different trend and higher variability) compared to normoxia and this is likely 
the result from a compromised ability of the central nervous system to voluntarily activate 
skeletal muscles, owing to inadequate oxygen delivery to the brain. Data from the present 
study also strengthen the fact that performance and pacing is significantly down-regulated in 
hypobaric versus normobaric hypoxic condition, in conjunction with altered systemic (e.g. 
SpO2) and prefrontaland motor cortex oxygenation during exercise. Same relative exercise 
intensity and physiological disturbances are achieved in hypobaric condition from the 
production of lower absolute power when compared to normobaria, emphasizing definitively 
that exercise at terrestrial and simulated altitude cannot be carelessly interchangeable. 
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